Skip Navigation Bar
 

Unified Medical Language System® (UMLS®)

2012AB LOINC Source Information

Counts

 (skip to: notes  samples)

Attribute Name Description Count (MRSAT.RRF)
COMMON_ORDER_RANK Ranking of approximately 300 common orders performed by laboratories in USA 67447
COMMON_SI_TEST_RANK Corresponding SI terms for 2000 common tests performed by laboratories in USA 67447
COMMON_TEST_RANK Numeric ranking of approximately 2,000 common tests performed by hospitals 67447
LCL LOINC Class - arbitrary classification of terms in LOINC designed to assist LOINC development and to group related observations together (e.g. ABXBACT = Antibiotic susceptibility) 67447
LCN LOINC Classtype - 1 = Laboratory class; 2 = Clinical class 67447
LCS LOINC status - valid values are "ACTIVE," "TRIAL," "DISCOURAGED," "DEPRECATED." For "DEPRECATED" concepts, the term that should now be used may appear in the LMP element. 67447
LOINC_COMPONENT LOINC component 67447
LRN2 Related names 2 67447
LOINC_TIME_ASPECT LOINC time aspect 67446
LOINC_SYSTEM LOINC system 67427
LOINC_PROPERTY LOINC property 67423
LOINC_SCALE_TYP LOINC scale type 67421
LLR LOINC Date Last Changed YYYYMMDD - date the LOINC term was last changed 67216
LCT LOINC Change Type Code - type of change made to a LOINC term. 66862
LOR LOINC ORDER_OBS field. Defines term as order only, observation only, or both. Values are: BOTH OBSERVATION ORDER. A fourth category, Subset, is used for terms that are subsets of a panel but do not represent a package that is known to be orderable. 53970
LUR Units required when used as OBX segment - a Y/N field that indicates that units are required when this LOINC is included as an OBX segment in a HIPAA attachment 53604
LCA LOINC ACSSYM field - LOINC chemical name synonyms, alternative names and chemical formulae from the Chemical Abstract Society 52399
LOINC_METHOD_TYP LOINC method type 30961
EXAMPLE_UCUM_UNITS The Unified Code for Units of Measure (UCUM) 22339
EXAMPLE_UNITS Example units 21061
HL7_V2_DATATYPE HL7 V2 Datatype 18843
LSU Submitted Units 14380
HL7_V3_DATATYPE HL7 V3 Datatype 13730
LQS Survey Question Source 6284
SOS Scope Statement 5033
LEA LOINC Example Answers - for some tests and measurements, LOINC has supplied examples of valid answers. These values differ from those in the ANSWERLIST field because that details possible values for nominal scale terms. 4921
LQT Survey Question Text 4534
LMM Molecular weights - contains the molecular weights of many chemical moieties when they are provided. 1881
STATUS_REASON Classification of the reason for concept status in LOINC 1741
LMP LOINC Map to Code of the term that has superseded a term with a LCS value of DEPRECATED. 1487
LCD LOINC CDISC common tests 833
MTH_LSU MTH Submitted Units 618
STATUS_TEXT Explanation of concept status in narrative text in LOINC 560
CHANGE_REASON_PUBLIC Detailed explanation about special changes to the term over time. 557
LNC LOINC NAACCR_ID - LOINC terms mapped to North American Association of Central Cancer Registries Identification 449
MTH_COPYRIGHT MTH Copyright 399
LFO LOINC Formula - regression equation details for many OB.US calculated terms. 352
LSP LOINC Species code 267
CONSUMER_NAME An experimental (beta) consumer friendly name 195
CURATED_RANGE_AND_UNITS Curated Range and Units 191
DOCUMENT_SECTION Classification of whether this LOINC code can be used a full document, a section of a document, or both. 144
LNE LOINC CODE_TABLE 79
MTH_LEA MTH LOINC Example Answers - for some tests and measurements, LOINC has supplied examples of valid answers. These values differ from those in the ANSWERLIST field because that details possible values for nominal scale terms. 62
MTH_SOS Metathesaurus version of SOS 49
HL7_FIELD_SUBFIELD_ID A value which indicates the content should be delivered in the named field/subfield of the HL7 message. When NULL, the data should be sent in an OBX segment with this LOINC code stored in OBX-3 and with the value in the OBX-5 34
LCB LOINC Chemical base name from the Chemical Abstract Society 31
MTH_LQT MTH Survey Question Text 28
MTH_LRN2 MTH Related names 2 24
MTH_LFO MTH LOINC Formula - regression equation details for many OB.US calculated terms. 7
MTH_SOS Metathesaurus version of SOS 6
COPYRIGHT Copyright 2
FROMRSAB Root source abbreviation for the "from" identifiers of a map set 1
FROMVSAB Versioned source abbreviation for the "from" identifiers of a map set 1
MAPSETRSAB Root source abbreviation for a map set 1
MAPSETTYPE Indicates the nature of a map set. Its value is map set specific. It can be used to indicate the inclusion of one to one, one to many and choices of maps. 1
MAPSETVERSION Version of the map set 1
MAPSETVSAB Versioned source abbreviation for a map set 1
MTH_MAPFROMCOMPLEXITY Indicates the complexity of "from" expressions used in a map set 1
MTH_MAPFROMEXHAUSTIVE Indicates whether or not the "from" source of a map set is completely mapped 1
MTH_MAPSETCOMPLEXITY Indicates the overall complexity of a map set 1
MTH_MAPTOCOMPLEXITY Indicates the complexity of "to" expressions in a map set 1
MTH_MAPTOEXHAUSTIVE Indicates whether or not the "to" source is completely mapped 1
TORSAB Root source abbreviation for the "to" identifiers of a map set 1
TOVSAB Versioned source abbreviation for the "to" identifiers of a map set 1

Notes

  • Attributes included every discrete piece of information about a concept, an atom, or a relationship that is not part of the basic Metathesaurus concept structure or distributed in one of the relationship files.
  • Attribute Names (ATN) are based on source documentation or NLMs understanding of the source.
  • Sample attribute values (ATV) are provided for each ATN in the source.
  • Sample data highlight examples of ATNs and Attribute Values (ATV) in MRSAT.RRF.
  • See Metathesaurus Documentation for a complete list of attribute names.
  • See Section 2.5 of the UMLS Reference Manual for more information on attributes in the UMLS Metathesaurus.

Sample Data

COMMON_ORDER_RANK

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0550725 A18098485 L2424318 S7461613 AUI 10991-8 COMMON_ORDER_RANK 0 Metronidazole:MCnc:Pt:Ser/Plas:Qn
C0550151 A18138011 L1465913 S7379376 AUI 12930-4 COMMON_ORDER_RANK 0 Thyroxine^9th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn
C0551635 A20870355 L10329426 S12910347 AUI 11508-9 COMMON_ORDER_RANK 0 Progress note:Find:Pt:{Setting}:Doc:Physical therapy
C0486231 A18098795 L2403272 S7395244 AUI 1160-1 COMMON_ORDER_RANK 0 little e Ab:ACnc:Pt:Ser/Plas^BPU:Ord
C0550845 A18330997 L1031237 S7450295 AUI 12732-4 COMMON_ORDER_RANK 0 Interleukin 12:ACnc:Pt:Ser/Plas:Qn
C0796765 A18099996 L1472968 S7349572 AUI 13574-9 COMMON_ORDER_RANK 0 Norfluoxetine:ACnc:Pt:Ser/Plas:Ord
C0796816 A18370296 L1495094 S7461143 AUI 13625-9 COMMON_ORDER_RANK 0 Methoxsalen:MCnc:Pt:Ser/Plas:Qn
C0482486 A18370570 L1836859 S7418573 AUI 1402-7 COMMON_ORDER_RANK 0 Cortisol^1H post 250 ug corticotropin IV rapid:MCnc:Pt:Ser/Plas:Qn
C0798777 A18255384 L1467420 S7407882 AUI 15610-9 COMMON_ORDER_RANK 0 Cat epithelium Ab.IgE.RAST class:ACnc:Pt:Ser:Ord
C0485329 A18333445 L1468217 S7427200 AUI 16795-7 COMMON_ORDER_RANK 0 Echovirus Ab:ACnc:Pt:Ser:Qn
C0800744 A18217957 L3157160 S7374238 AUI 17630-5 COMMON_ORDER_RANK 0 Streptococcus pneumoniae 3 Ab^2nd specimen/1st specimen:Ratio:Pt:Ser:Qn
C1148462 A18218114 L6694346 S7799354 AUI 17942-4 COMMON_ORDER_RANK 0 Bacteria identified^^^2:Prid:Pt:Line:Nom:Intravascular line culture
C0801086 A18256797 L1730903 S7426318 AUI 18037-2 COMMON_ORDER_RANK 0 E wave.max:Vel:Pt:Mitral valve:Qn:US.doppler
C0801226 A18256854 L1487320 S7385075 AUI 18177-6 COMMON_ORDER_RANK 0 Vendor serial number:ID:Pt:Cardiac echo imaging device:Qn
C0801928 A18334553 L6404209 S7452409 AUI 18935-7 COMMON_ORDER_RANK 0 Kanamycin:Susc:Pt:Isolate:OrdQn
C0882232 A18257634 L1839514 S7444878 AUI 19742-6 COMMON_ORDER_RANK 0 Hexahydrophthalic anhydride Ab.IgE:ACnc:Pt:Ser:Qn
C0802630 A18219076 L1491351 S7378438 AUI 19815-0 COMMON_ORDER_RANK 0 Therapeutic results:Desc:Stdy:Endoscopy procedure:Nar
C0802748 A18257766 L1485063 S10619466 AUI 19933-1 COMMON_ORDER_RANK 0 Gas flow.constant^baseline setting:VRat:Pt:Ventilator:Qn
C0803879 A18104201 L4851401 S7372192 AUI 21084-9 COMMON_ORDER_RANK 0 Aspergillus flavus Ab:ACnc:Pt:CSF:Ord:Immune diffusion

COMMON_SI_TEST_RANK

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0549677 A18252369 L6405498 S7376190 AUI 11578-2 COMMON_SI_TEST_RANK 0 Sulfisoxazole:Susc:Pt:Isolate:OrdQn:Gradient strip
C0549750 A18330029 L2269428 S7358068 AUI 10955-3 COMMON_SI_TEST_RANK 0 Pinus palustris Ab.IgE:ACnc:Pt:Ser:Qn
C0549801 A18098573 L6410454 S7429253 AUI 11131-0 COMMON_SI_TEST_RANK 0 Erythroblasts early/100 cells:NFr:Pt:Bone mar:Qn
C0551560 A18175936 L1037304 S7417899 AUI 11487-6 COMMON_SI_TEST_RANK 0 Consultation request.total:Find:Pt:^Patient:Nar
C0552193 A18214737 L1493064 S7375321 AUI 12079-0 COMMON_SI_TEST_RANK 0 Study observation:Find:Pt:Heart.interventricular septum^fetus:Nom:US
C0552240 A18291164 L1493107 S7375377 AUI 12128-5 COMMON_SI_TEST_RANK 0 Study observation:Find:Pt:Yolk sac^fetus:Nar:US
C0550282 A18176306 L6406762 S7420230 AUI 12192-1 COMMON_SI_TEST_RANK 0 Creatinine^2H post peritoneal dialysis:MCnc:Pt:Periton fld:Qn
C0550393 A18177054 L1032820 S7447799 AUI 13312-4 COMMON_SI_TEST_RANK 0 IgA Ab.IgG:ACnc:Pt:Ser/Plas:Qn
C1764785 A18292828 L6417149 S7428215 AUI 13353-8 COMMON_SI_TEST_RANK 0 Eosinophils/100 leukocytes:NFr:Pt:Body fld:Qn:Manual count
C0550404 A18331438 L6427953 S7451455 AUI 13402-3 COMMON_SI_TEST_RANK 0 Isoleucine:MCnc:Pt:Amnio fld:Qn
C0796881 A18138401 L6409161 S7384670 AUI 13690-3 COMMON_SI_TEST_RANK 0 Vanillylmandelate/Creatinine:MCrto:Pt:Urine:Qn
C0797152 A18293236 L1851114 S7461460 AUI 13964-2 COMMON_SI_TEST_RANK 657 Methylmalonate:SCnc:Pt:Ser/Plas:Qn
C0797745 A18332053 L1836793 S10021877 AUI 14569-8 COMMON_SI_TEST_RANK 850 17-Hydroxyprogesterone:SCnc:Pt:Ser/Plas:Qn
C2718219 A18294385 L2268272 S7363545 AUI 15884-0 COMMON_SI_TEST_RANK 0 Quercus alba Ab.IgE.RAST class:ACnc:Pt:Ser:Ord
C0799609 A18140050 L2413071 S7398455 AUI 16458-2 COMMON_SI_TEST_RANK 0 Bethanechol:MCnc:Pt:Ser/Plas:Qn
C0799745 A18371997 L1467349 S7412503 AUI 16598-5 COMMON_SI_TEST_RANK 0 Chlamydia trachomatis C Ab.IgG:ACnc:Pt:Ser:Qn
C0799767 A18217356 L6403210 S7414790 AUI 16620-7 COMMON_SI_TEST_RANK 0 Clarithromycin+Ethambutol:Susc:Pt:Isolate:OrdQn:MIC
C0801325 A18102753 L6701230 S7805517 AUI 18279-0 COMMON_SI_TEST_RANK 0 Hemoglobin F:ACnc:Pt:Stool:Ord:Apt-Downey
C0363888 A18295339 L6404072 S7446678 AUI 1754-1 COMMON_SI_TEST_RANK 0 Albumin:MCnc:Pt:Urine:Qn

COMMON_TEST_RANK

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0485208 A18368659 L6426860 S7412909 AUI 10652-6 COMMON_TEST_RANK 0 Chlamydophila pneumoniae DNA:ACnc:Pt:Sputum/Bronchial:Ord:Probe.amp
C0797850 A18293579 L6427034 S7418439 AUI 14676-1 COMMON_TEST_RANK 0 Cortisol.free:SRat:24H:Urine:Qn
C0796927 A18215646 L6423984 S7429874 AUI 13736-4 COMMON_TEST_RANK 0 Estradiol/Creatinine:MCrto:24H:Urine:Qn
C0549858 A18254123 L6422651 S7383324 AUI 13355-3 COMMON_TEST_RANK 0 Unspecified cells/100 leukocytes:NFr:Pt:Body fld:Qn:Manual count
C0796837 A18292980 L6428259 S7460920 AUI 13646-5 COMMON_TEST_RANK 0 Methaqualone:MCnt:Pt:Hair:Qn
C0798426 A18332475 L2268218 S7423557 AUI 15255-3 COMMON_TEST_RANK 0 (Actinidia chinensis+Cucumis melo+Musa spp+Prunus dulcis+Vitis vinifera) Ab.IgE:ACnc:Pt:Ser:Ord:Multidisk
C0797672 A18331137 L6405780 S7391293 AUI 14496-4 COMMON_TEST_RANK 0 Virus identified:Prid:Pt:Sputum:Nom:IF
C0797792 A18332070 L6415327 S7362242 AUI 14617-5 COMMON_TEST_RANK 0 Appearance:Aper:Pt:Pericard fld:Nom
C0798074 A18100144 L1473060 S7364277 AUI 14901-3 COMMON_TEST_RANK 0 Ranitidine:ACnc:Pt:Ser/Plas:Ord
C0363777 A18294694 L6409259 S7393174 AUI 1646-9 COMMON_TEST_RANK 0 Xylose^post dose PO:MRat:5H:Urine:Qn
C0799717 A18178957 L1467451 S7411197 AUI 16570-4 COMMON_TEST_RANK 0 Centromere Ab:ACnc:Pt:Ser:Ord:IF
C2718100 A18256330 L1491371 S7461175 AUI 17268-4 COMMON_TEST_RANK 0 Methsuximide+Desmethylmethsuximide:MCnc:Pt:Ser/Plas:Qn
C0804665 A18181900 L1484333 S7376400 AUI 21877-6 COMMON_TEST_RANK 0 Surgery procedure for regional nodes at facility.YYY:Prid:Pt:Cancer.XXX:Nom
C0804730 A18104700 L1487014 S7349183 AUI 21942-8 COMMON_TEST_RANK 0 Non cancer directed surgery summary:Type:Pt:Cancer.XXX:Nom
C0879800 A18336417 L1724158 S7419423 AUI 22218-2 COMMON_TEST_RANK 0 Coxsackievirus A4 Ab:Titr:Pt:Ser:Qn
C0880006 A18104975 L1725019 S7364115 AUI 22458-4 COMMON_TEST_RANK 0 Rabies virus Ab:ACnc:Pt:Tiss:Qn
C0364390 A18220547 L6410489 S7430015 AUI 2255-8 COMMON_TEST_RANK 0 Estrogen:MCnc:Pt:Urine:Qn
C0880138 A18220572 L1724719 S7392484 AUI 22610-0 COMMON_TEST_RANK 0 Western equine encephalitis virus Ab:ACnc:Pt:CSF:Ord
C0880220 A18375435 L1731496 S7457967 AUI 22713-2 COMMON_TEST_RANK 0 Lysine:SCnc:Pt:XXX:Qn

LCL

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0549680 A18291488 L1839522 S7367283 AUI 10930-6 LCL ALLERGY Artemia salina Ab.IgE:ACnc:Pt:Ser:Qn
C0364753 A18330150 L6428247 S7460578 AUI 11139-3 LCL CHEM Metanephrine:MCnc:Pt:Urine:Qn
C0551854 A18137343 L8868779 S11022132 AUI 11735-8 LCL OB.US Body weight:Mass:Pt:^Fetus:Qn:US.estimated from AC&BPD&FL.Hadlock 1985
C0552155 A18214722 L1487941 S7375278 AUI 12043-6 LCL OB.US Study observation:Find:Pt:Cerebrum^fetus:Nar:US
C0550360 A18176537 L6697385 S7804956 AUI 12608-6 LCL CHEM Glucose^2H specimen:MCnc:Pt:Dial fld prt:Qn
C0551283 A18331263 L1839904 S7425464 AUI 13107-8 LCL SERO Disialylganglioside GD1a Ab:ACnc:Pt:Ser:OrdQn
C0551293 A18292713 L1839484 S7432312 AUI 13173-0 LCL SERO Fibronectin aggregate Ab.IgA:ACnc:Pt:Ser:Qn
C0797795 A18293552 L6418711 S7362273 AUI 14620-9 LCL SPEC Appearance:Aper:Pt:Plr fld:Nom
C0798243 A18332362 L6410612 S7435035 AUI 15071-4 LCL CHEM Galactose:SRat:24H:Urine:Qn
C0799594 A18177867 L1467218 S7397510 AUI 16442-6 LCL SERO Benzene ring Ab.IgM:ACnc:Pt:Ser:Qn
C0363795 A18179013 L0460875 S10018585 AUI 1661-8 LCL CHEM 11-Ketoandrosterone:MCnc:Pt:Ser:Qn
C0802182 A18103198 L6419604 S7397615 AUI 19285-6 LCL DRUG/TOX Benzodiazepines screen method:Prid:Pt:Urine:Nom:*
C0801505 A18295831 L8574522 S10638972 AUI 18463-0 LCL CHEM Oleoylcarnitine (C18:1):MCnc:Pt:Ser/Plas:Qn
C0801516 A18141165 L6408440 S11755728 AUI 18475-4 LCL CHEM Phenylalanine/Creatinine:SCrto:Pt:Urine:Qn
C0801760 A18141271 L5314098 S7375563 AUI 18746-8 LCL ATTACH.CLINRPT Study report:Find:Pt:Lower GI tract:Doc:Colonoscopy
C0801877 A18256437 L6416563 S7408421 AUI 18884-7 LCL ABXBACT Cefoperazone:Susc:Pt:Isolate:OrdQn
C0802606 A18335018 L1491270 S7449550 AUI 19791-3 LCL ENDO.GI Insertion depth:Len:Stdy:Gastrointestine.upper:Qn:EGD
C0804306 A18181658 L1839223 S7368777 AUI 21512-9 LCL MICRO Salmonella paratyphi A H Ab:Titr:Pt:Ser:Qn:IF
C0364435 A18375616 L0692072 S7447927 AUI 2298-8 LCL CHEM Aldolase:CCnc:Pt:Ser:Qn

LCN

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0488903 A18175195 L1494280 S7449616 AUI 10274-9 LCN 2 Institution inventory number:ID:Pt:Urine tube:Nom
C0484501 A18098166 L0847086 S7384829 AUI 10428-1 LCN 1 Varicella zoster virus immune globulin given:Vol:Pt:^Patient:Qn
C0549733 A18330169 L2269338 S7370246 AUI 11186-4 LCN 1 Setaria italica Ab.IgE:ACnc:Pt:Ser:Qn
C0796807 A18292964 L6408225 S7349009 AUI 13616-8 LCN 1 Nitrite:MCnc:Pt:Water:Qn
C0796894 A18177210 L6420901 S7440201 AUI 13703-4 LCN 1 Adipate/Creatinine:MCrto:Pt:Urine:Qn
C0797187 A18293256 L1472151 S7380609 AUI 13999-8 LCN 1 Transferrin.carbohydrate deficient:ACnc:Pt:Ser/Plas:Qn
C0797650 A18370792 L6698335 S7801477 AUI 14473-3 LCN 1 Chlamydia trachomatis Ag:ACnc:Pt:Penis:Ord:EIA
C0798066 A18139107 L6401785 S7361730 AUI 14892-4 LCN 1 Propranolol:SCnc:Pt:Urine:Qn
C0798396 A18293907 L2268388 S7426254 AUI 15225-6 LCN 1 (Foeniculum vulgare seed+Ocimum basilicum+Pimpinella anisum+Zingiber officinale) Ab.IgE:ACnc:Pt:Ser:Ord:Multidisk
C0798649 A18216648 L1725045 S7455307 AUI 15480-7 LCN 1 Leptospira interrogans serovar Icterohaemorrhagiae Ab:Titr:Pt:Ser:Qn:Aggl
C0799890 A18140199 L2424511 S7349768 AUI 16746-0 LCN 1 Nortrimipramine:MCnc:Pt:Ser/Plas:Qn
C0804038 A18101699 L1491663 S7424934 AUI 16366-7 LCN 1 Diethylpropion:MCnc:Pt:Ser/Plas:Qn
C0801618 A18257067 L1465695 S7368097 AUI 18577-7 LCN 2 ST amplitude.J point+80 ms:Elpot:Pt:Lead V4:Qn:EKG
C0800517 A18294351 L2424582 S7352854 AUI 17397-1 LCN 1 Oxytriphylline:MCnc:Pt:Ser/Plas:Qn
C0800559 A20858964 L1473198 S13458601 AUI 17440-9 LCN 1 Phenothiazines:ACnc:Pt:Ser/Plas:Qn
C0801943 A18295191 L6428348 S7463371 AUI 18950-6 LCN 1 Moxalactam:Susc:Pt:Isolate:OrdQn
C0802342 A18373621 L6407083 S7430413 AUI 19460-5 LCN 1 Ethylamphetamine cutoff:MCnc:Pt:Urine:Qn:Screen
C0879665 A18141775 L2268464 S7368143 AUI 19744-2 LCN 1 Artocarpus heterophyllus Ab.IgE:ACnc:Pt:Ser:Qn
C0804175 A18297404 L4850114 S7361306 AUI 21381-9 LCN 1 Prolactin^1.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn

LCS

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0488459 A18252156 L1484626 S7368232 AUI 10120-4 LCS ACTIVE ST wave displacement.mid.lead AVR:Elpot:Pt:Heart:Qn:EKG
C0485045 A18252528 L6418697 S7361816 AUI 10583-3 LCS ACTIVE Prostaglandin F1 alpha:SCnc:Pt:Semen:Qn
C0551668 A18214407 L1493183 S7357485 AUI 11429-8 LCS ACTIVE Physical findings:Find:Pt:Forearm:Nom:Observed
C0551672 A18369083 L1493195 S7357499 AUI 11431-4 LCS ACTIVE Physical findings:Find:Pt:Genitalia:Nom:Observed
C0550960 A18099787 L1032583 S7419418 AUI 13234-0 LCS ACTIVE Coxsackievirus A4 Ab:ACnc:Pt:CSF:Qn
C0797713 A18332038 L1841218 S7459456 AUI 14537-5 LCS ACTIVE Measles virus Ag:ACnc:Pt:Eye:Ord:IF
C0798504 A18178221 L1484002 S7362886 AUI 15335-3 LCS ACTIVE Pulsativity.index:VelRto:Pt:Penile cavernosal artery:Qn:US.calculated
C0799987 A18216897 L6403673 S7430394 AUI 16849-2 LCS ACTIVE Ethyl benzene:MCnc:Pt:Urine:Qn
C0801786 A18102970 L4854600 S7376374 AUI 18772-4 LCS ACTIVE Surgeon.resident name:Pn:Pt:Surgical procedure:Nom
C0801926 A18257219 L6421126 S7448060 AUI 18933-2 LCS DEPRECATED Imipenem+Cilastatin:Susc:Pt:Isolate:OrdQn
C0802470 A18373152 L6418161 S7463162 AUI 19600-6 LCS ACTIVE Morphine cutoff:MCnc:Pt:Urine:Qn:Confirm
C0364144 A18373297 L1463451 S7405648 AUI 2012-3 LCS ACTIVE Cancer Ag 27-29:ACnc:Pt:Ser/Plas:Ord
C0802944 A18257195 L1484963 S7391731 AUI 20129-3 LCS ACTIVE Volume:Vol:Pt:Breathing bag:Qn:Gas dilution.rebreathing
C0804048 A18374610 L1467619 S7427366 AUI 21254-8 LCS ACTIVE Egg yolk Ab.IgG.RAST class:ACnc:Pt:Ser:Ord
C0881212 A18221300 L1731018 S7429467 AUI 23859-2 LCS ACTIVE Erythrocytes:NCnc:Pt:XXX:Qn:Microscopy.light
C0881662 A18260317 L1724536 S7402832 AUI 24397-2 LCS ACTIVE Brucella sp Ab.IgM:ACnc:Pt:Ser:Ord
C0881817 A18144486 L1729941 S7389395 AUI 24579-5 LCS ACTIVE Views survey:Find:Pt:Bones.long:Nar:XR
C0882536 A18376644 L5391937 S7390705 AUI 24764-3 LCS ACTIVE Views^W contrast intraarticular:Find:Pt:Hip:Nar:XR.fluor
C0941368 A18183726 L1846139 S7378271 AUI 25173-6 LCS ACTIVE Thallium:SCnc:Pt:Bld:Qn

LOINC_COMPONENT

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0485988 A18368753 L1493892 S7365641 AUI 10827-4 LOINC_COMPONENT Reticulum.microscopic observation Reticulum.microscopic observation:Prid:Pt:Tiss:Nom:Gomori stain
C0485635 A18098346 L6692690 S7794786 AUI 10712-8 LOINC_COMPONENT Pneumocystis sp identified Pneumocystis sp identified:Prid:Pt:Lung tiss:Nom
C0484868 A18175381 L1471255 S7432213 AUI 10523-9 LOINC_COMPONENT Fibrinogen Ag Fibrinogen Ag:ACnc:Pt:Tiss:Ord:Immune stain
C0550655 A18330047 L2424501 S7349707 AUI 10983-5 LOINC_COMPONENT Norparamethadione Norparamethadione:MCnc:Pt:Ser/Plas:Qn
C0552249 A18099100 L9076254 S11343931 AUI 12135-0 LOINC_COMPONENT Systolic flow/Diastolic flow Systolic flow/Diastolic flow:VelRto:Pt:Cerebral artery middle^fetus:Qn:US.doppler
C0551223 A18176635 L1033629 S7427863 AUI 12737-3 LOINC_COMPONENT Endothelin Endothelin:ACnc:Pt:Ser/Plas:Qn
C0363554 A18215940 L1838454 S7418666 AUI 1419-1 LOINC_COMPONENT Cortisol^30M post dose insulin IV Cortisol^30M post dose insulin IV:MCnc:Pt:Ser/Plas:Qn
C0799337 A18178781 L6404422 S7458590 AUI 16172-9 LOINC_COMPONENT Magnesium Magnesium:MCnt:Pt:Hair:Qn
C0803753 A18372560 L1490808 S7368932 AUI 17563-8 LOINC_COMPONENT Salmonella sp identified Salmonella sp identified:Prid:Pt:XXX:Nom:Organism specific culture
C0799593 A18370986 L1467217 S7397508 AUI 16441-8 LOINC_COMPONENT Benzene ring Ab.IgG Benzene ring Ab.IgG:ACnc:Pt:Ser:Qn
C0803463 A18181091 L1495728 S7382719 AUI 20660-7 LOINC_COMPONENT Tyrosine Tyrosine:SCnc:Pt:Ser/Plas:Qn
C0804025 A18297223 L2268704 S7405754 AUI 21231-6 LOINC_COMPONENT Cancer pagurus Ab.IgG.RAST class Cancer pagurus Ab.IgG.RAST class:ACnc:Pt:Ser:Ord
C0364482 A18375813 L0554370 S7436776 AUI 2342-4 LOINC_COMPONENT Glucose Glucose:MCnc:Pt:CSF:Qn
C0879761 A18182082 L1725359 S7412836 AUI 22170-5 LOINC_COMPONENT Chlamydophila pneumoniae Ab.IgA Chlamydophila pneumoniae Ab.IgA:Titr:Pt:Ser:Qn
C0880650 A18298438 L1726270 S7455435 AUI 23203-3 LOINC_COMPONENT Leptospira sp Ag Leptospira sp Ag:ACnc:Pt:Tiss:Ord:IF
C0880720 A18181389 L1724695 S7346277 AUI 23285-0 LOINC_COMPONENT Mycoplasma mycoides subspecies mycoides small colony Ab Mycoplasma mycoides subspecies mycoides small colony Ab:ACnc:Pt:Ser:Ord
C0880819 A18182727 L4851735 S7366704 AUI 23406-2 LOINC_COMPONENT Rift valley fever virus Ag Rift valley fever virus Ag:ACnc:Pt:Ser:Ord:Immune diffusion
C0882557 A18376753 L1731154 S7342753 AUI 24980-5 LOINC_COMPONENT Multisection Multisection:Find:Pt:Spine.thoracic:Nar:MRI
C0881351 A18376145 L6408855 S7373767 AUI 24020-0 LOINC_COMPONENT Streptococcus agalactiae Ag Streptococcus agalactiae Ag:ACnc:Pt:Urine:Ord

LRN2

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0551581 A18330264 L1493326 S7445669 AUI 11341-5 LRN2 ; Occupation Hx; Finding; Findings; Point in time; Random; Nominal; H/O History of occupation:Find:Pt:^Patient:Nom:Reported
C0552039 A18253253 L8881080 S11031900 AUI 11922-2 LRN2 ; GA; Point in time; Random; Fetal; Quantitative; QNT; Quant; Quan; from FL.Hohler82; 82; FL chart; from FL.Hohler82; Femur Length; US.est; predicted; Ultrasound; ULS; Sonogram; Sonography; Sonograph; Echography; Est; estimation; Gest; Gestation; Prenatal; OBSTERICAL.ULTRASOUND; OBSTERICAL.ULTRASOUND; Obstetrical; Obstetrics Gestational age:Time:Pt:^Fetus:Qn:US.estimated from FL.Hohler 1982
C0550802 A18253487 L6405573 S7378715 AUI 12370-3 LRN2 Pentothal; Mass concentration; Level; Point in time; Random; Ur; UR; Urn; UA; Quantitative; QNT; Quant; Quan; Drugs; DRUG/TOXICOLOGY; DRUG/TOXICOLOGY Thiopental:MCnc:Pt:Urine:Qn
C0550287 A18214972 L6406754 S7420055 AUI 12586-4 LRN2 ; Creat; Crea; CR; mRate; Mass rate; 4 hours; 240 minutes; 4.0Hr; 4HR; Ur; UR; Urn; UA; Quantitative; QNT; Quant; Quan; Chemistry; UCr Creatinine:MRat:4H:Urine:Qn
C0550128 A18215228 L1463727 S7379187 AUI 12939-5 LRN2 ; TSH; Thyrotropic hormone; Thyroid stimulating hormone; 2h p chal; Arbitrary concentration; Point in time; Random; SerPl; SerPlas; SerP; Serum; SR; Plasma; Pl; Plsm; Quantitative; QNT; Quant; Quan; PST; After; 2 hours; 120 minutes; 120 min; 120min; CHEMISTRY.CHALLENGE TESTING; CHEMISTRY.CHALLENGE TESTING Thyrotropin^2H post XXX challenge:ACnc:Pt:Ser/Plas:Qn
C0551467 A18176853 L1495551 S7355856 AUI 13019-5 LRN2 Identity or presence; Point in time; Random; SerPl; SerPlas; SerP; Serum; SR; Plasma; Pl; Plsm; Nominal; Drugs; DRUG/TOXICOLOGY; DRUG/TOXICOLOGY Pesticides:Prid:Pt:Ser/Plas:Nom
C0798267 A18255095 L6405548 S7377956 AUI 15095-3 LRN2 ; Testost; Testo; Testos; sRate; Substance rate; 1 day; 24 hours; 24HR; Ur; UR; Urn; UA; Quantitative; QNT; Quant; Quan; Chemistry Testosterone:SRat:24H:Urine:Qn
C0798085 A18370455 L1460764 S7371246 AUI 14912-0 LRN2 Basket cells; WBC; White blood cell; Leuc; Leuk; Leukocyte; Lkcs; White blood cells; WBCs; Cell; Cellularity; 100WBC; Number fraction; Percent; Point in time; Random; Blood; WB; Whole blood; Quantitative; QNT; Quant; Quan; Manl; HEMATOLOGY/CELL COUNTS; HEMATOLOGY/CELL COUNTS Smudge cells/100 leukocytes:NFr:Pt:Bld:Qn:Manual count
C0799503 A18255876 L6421279 S7454290 AUI 16340-2 LRN2 ; A-AIB; 2-aminoisobutyric acid; alpha aminoisobutyric acid; 2-aminoisobutyrate; 2-methylalanine; AIB; Mass concentration; Level; Point in time; Random; Ur; UR; Urn; UA; Quantitative; QNT; Quant; Quan; Alfa; Chemistry Alpha aminoisobutyrate:MCnc:Pt:Urine:Qn
C0799823 A18256035 L1467339 S7419135 AUI 16677-7 LRN2 Immune globulin G; Immunoglobulin G; Q fev; C burnetii; Qfever; Coxiella burnettii; Q fever; Arbitrary concentration; Point in time; Random; Serum; SR; Quantitative; QNT; Quant; Quan; ABS; Antibodies; Autoantibody; Antibody; Autoantibodies; Antby; Aby; Anti; Microbiology Coxiella burnetii Ab.IgG:ACnc:Pt:Ser:Qn
C0800357 A18178994 L6414576 S7457944 AUI 17230-4 LRN2 Lys; 2,6-diaminohexanoic acid; Arbitrary concentration; Point in time; Random; Ur; UR; Urn; UA; Ql; Ordinal; QL; Qualitative; Qual; Screen; Chemistry Lysine:ACnc:Pt:Urine:Ord
C0800922 A18218067 L6409503 S7398132 AUI 17815-2 LRN2 ; B-Globulin; Protein beta globulin; Prot; PR; GLB; Globulins; Glob; Glob%; Globul; B-Globulin; TP; Mass fraction; Percent; ?Tm; Ur; UR; Urn; UA; Quantitative; QNT; Quant; Quan; Elph; Elp; Elect; Electrophrs; Electrophhrs; Electr; Elec; Ep; Electro; Tot; Totl; B; Chemistry; PEUR; UPEP Beta globulin/Protein.total:MFr:XXX:Urine:Qn:Electrophoresis
C0801307 A18295234 L1488227 S7413619 AUI 18261-8 LRN2 ; LDLc; LDL-C; Low density lipoprotein cholesterols; Low density lipoprotein cholesterol; Chol; Choles; Cholest; Lipid; Cholesterol total; Cholesterols; Mass concentration; Level; Point in time; Random; SerPl.Ultracent; SerPl.Ultracent; SerPl; SerPlas; SerP; Serum; SR; Plasma; Pl; Plsm; Quantitative; QNT; Quant; Quan; Chemistry Cholesterol.in LDL:MCnc:Pt:Ser/Plas.ultracentrifugate:Qn
C0803052 A18257888 L1463690 S7424662 AUI 20237-4 LRN2 Maximum; Maximal; Largest; Peak; Dias.max; Dias; Diastoli; Diast; Volume; Point in time; Random; LV; Hrt ventr; Ventricular; Cardiac; Quantitative; QNT; Quant; Quan; US.2D.Mod Simp; MOD-SIMP; Method of disks; Method of discs; US.2D.Mod Simp; 2D US; Ultrasound; ULS; Sonogram; Sonography; Sonograph; Echography; Calc; Calculation; Cardiology; LVEDV Diastole.max:Vol:Pt:Heart.ventricle.left:Qn:US.2D.modified Simpson.calculated
C0802119 A18103120 L1473648 S7361861 AUI 19203-9 LRN2 ; PSA Free; fPSA; P-30 antigen; seminin; Kallikrein 3; Substance concentration; Level; Point in time; Random; SerPl; SerPlas; SerP; Serum; SR; Plasma; Pl; Plsm; Quantitative; QNT; Quant; Quan; Antigen; Antigens; Spec; FR; Non-protein bound; Chemistry Prostate specific Ag.free:SCnc:Pt:Ser/Plas:Qn
C0802374 A18257521 L6414255 S7447271 AUI 19492-8 LRN2 ; OH-Alpraz; Hydroxyalpraz; Mass concentration; Level; Point in time; Random; Ur; UR; Urn; UA; Quantitative; QNT; Quant; Quan; Cfm; CNFR; CNFRM; Conf; Confirmation; GCMS; Confirmatory; CtO; Drugs; DRUG/TOXICOLOGY; DRUG/TOXICOLOGY Hydroxyalprazolam cutoff:MCnc:Pt:Urine:Qn:Confirm
C0802462 A18296389 L6416606 S10027723 AUI 19591-7 LRN2 ; 6MAM; 6 MAM; 6-acetylmorphine; Acetylmorphine; 6 mono acetyl morphine; Heroin metabolite; Arbitrary concentration; Point in time; Random; Ur; UR; Urn; UA; Ql; Ordinal; QL; Qualitative; Qual; Scn; Scr; Scrn; Drugs; DRUG/TOXICOLOGY; DRUG/TOXICOLOGY 6-Monoacetylmorphine:ACnc:Pt:Urine:Ord:Screen
C0804181 A18335905 L6407961 S7461426 AUI 21387-6 LRN2 Xylene metabolite; Methylhippuric acid; Mass concentration; Level; Point in time; Random; Ur; UR; Urn; UA; Quantitative; QNT; Quant; Quan; Drugs; DRUG/TOXICOLOGY; DRUG/TOXICOLOGY Methylhippurate:MCnc:Pt:Urine:Qn
C0803303 A18103794 L1468811 S7803575 AUI 20491-7 LRN2 Immune globulin M; Immunoglobulin M; VCA; Viral capsid; EBV VCA; Mono; Mononucleosis; Dilution factor; Titer; Titre; Ttr; Titered; Point in time; Random; Serum; SR; Quantitative; QNT; Quant; Quan; ABS; Antibodies; Autoantibody; Antibody; Autoantibodies; Antby; Aby; Anti; Epstn; Cap; Microbiology Epstein Barr virus capsid Ab.IgM:Titr:Pt:Ser:Qn

LOINC_TIME_ASPECT

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0488763 A18252212 L0775466 S7352403 AUI 10243-4 LOINC_TIME_ASPECT Pt Oxygen content:SCnc:Pt:Vena cava.inferior:Qn
C0550869 A18291469 L4851410 S7374363 AUI 10894-4 LOINC_TIME_ASPECT Pt Aspergillus niger Ab:ACnc:Pt:Ser:Ord:Immune diffusion
C0484504 A18252428 L1471031 S7392034 AUI 10431-5 LOINC_TIME_ASPECT Pt B-cell Ag:ACnc:Pt:Tiss:Ord:Immune stain
C0485939 A18252614 L1485896 S7462222 AUI 10775-5 LOINC_TIME_ASPECT Pt Microscopic observation:Prid:Pt:Tiss:Nom:Bleach stain
C0550747 A18214146 L1037525 S7350374 AUI 10997-5 LOINC_TIME_ASPECT Pt O-desmethylencainide:MCnc:Pt:Ser/Plas:Qn
C0549834 A20855316 L10816764 S13456947 AUI 11115-3 LOINC_TIME_ASPECT Pt Neutrophils/100 cells:NFr:Pt:Bone mar:Qn:Manual count
C0551721 A18291821 L4853958 S7375590 AUI 11529-5 LOINC_TIME_ASPECT Pt Study report:Find:Pt:^Patient:Doc:Surgical pathology
C0550865 A18331305 L1032620 S7372213 AUI 13193-8 LOINC_TIME_ASPECT Pt Aspergillus flavus Ab:ACnc:Pt:CSF:Qn
C0796931 A18138434 L6410510 S7430484 AUI 13741-4 LOINC_TIME_ASPECT Pt Ethylmalonate/Creatinine:MCrto:Pt:Urine:Qn
C0796863 A18253803 L6402714 S10024776 AUI 13672-1 LOINC_TIME_ASPECT Pt 2-Hydroxyglutarate/Creatinine:MCrto:Pt:Urine:Qn
C0797439 A18215977 L9454748 S11748722 AUI 14254-7 LOINC_TIME_ASPECT Pt Ganglioside GQ1b Ab.IgG:Titr:Pt:Ser:Qn
C0797738 A18293521 L6408116 S7346037 AUI 14562-3 LOINC_TIME_ASPECT Pt Mycobacterium tuberculosis DNA:ACnc:Pt:Semen:Ord:Probe.amp.tar
C0798455 A18332531 L2268198 S7358710 AUI 15285-0 LOINC_TIME_ASPECT Pt Platanus acerifolia Ab.IgE:ACnc:Pt:Ser:Qn
C0799504 A18217205 L1471396 S7454213 AUI 16341-0 LOINC_TIME_ASPECT Pt Alpha aminoisobutyrate:ACnc:Pt:Plas:Ord
C0799171 A18139801 L2268454 S7367446 AUI 16003-6 LOINC_TIME_ASPECT Pt Artemisia tridentata Ab.IgE.RAST class:ACnc:Pt:Ser:Ord
C0799287 A18255751 L1840585 S7417145 AUI 16122-4 LOINC_TIME_ASPECT Pt Colorado tick fever virus Ab.IgM:Titr:Pt:Ser:Qn
C0799762 A18217354 L1036827 S7413695 AUI 16615-7 LOINC_TIME_ASPECT Pt Cholesterol.total/Cholesterol.in LDL:MCrto:Pt:Ser/Plas:Qn
C0799955 A18179126 L1472583 S7427682 AUI 16813-8 LOINC_TIME_ASPECT Pt Emetine:ACnc:Pt:Ser/Plas:Qn
C0800665 A18333908 L1468542 S7367112 AUI 17550-5 LOINC_TIME_ASPECT Pt Rubella virus Ab:ACnc:Pt:Ser:Qn:LA

LOINC_SYSTEM

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0489408 A18290871 L1492172 S7367661 AUI 10079-2 LOINC_SYSTEM Heart S' wave duration.lead V4:Time:Pt:Heart:Qn:EKG
C0488499 A18136361 L0831398 S7445646 AUI 10159-2 LOINC_SYSTEM ^Patient History of industrial exposure:Find:Pt:^Patient:Nar:Reported
C0362190 A18136363 L6409811 S7408418 AUI 101-6 LOINC_SYSTEM Isolate Cefoperazone:Susc:Pt:Isolate:OrdQn:Agar diffusion
C0552266 A18291905 L1491686 S7378660 AUI 12153-3 LOINC_SYSTEM Heart.interventricular septum^fetus Thickness.systolic:Len:Pt:Heart.interventricular septum^fetus:Qn:US.measured.real time two dimension
C0550798 A18214901 L6408958 S7377823 AUI 12419-8 LOINC_SYSTEM Urine Terfenadine:MCnc:Pt:Urine:Qn
C0797134 A18100257 L1472311 S7417642 AUI 13946-9 LOINC_SYSTEM RBC Complement+Immunoglobulin:ACnc:Pt:RBC:Ord
C0797384 A18177562 L1468746 S7412459 AUI 14199-4 LOINC_SYSTEM Ser Chlamydia trachomatis B Ab.IgA:Titr:Pt:Ser:Qn:IF
C0797924 A18177793 L6417409 S7436850 AUI 14750-4 LOINC_SYSTEM Synv fld Glucose:SCnc:Pt:Synv fld:Qn
C0799096 A18139764 L2269010 S7369300 AUI 15929-3 LOINC_SYSTEM Ser Schinus molle Ab.IgE.RAST class:ACnc:Pt:Ser:Ord
C0799561 A18101718 L6408741 S7369408 AUI 16408-7 LOINC_SYSTEM Urine Ascorbate:MCnc:Pt:Urine:Qn
C0799961 A18333460 L1468287 S7428015 AUI 16819-5 LOINC_SYSTEM Ser Entamoeba histolytica Ab:ACnc:Pt:Ser:Qn:IF
C0363877 A18217860 L1838762 S7444620 AUI 1743-4 LOINC_SYSTEM Ser/Plas Alanine aminotransferase:CCnc:Pt:Ser/Plas:Qn:With P-5'-P
C0801948 A18257229 L6418335 S7349034 AUI 18955-5 LOINC_SYSTEM Isolate Nitrofurantoin:Susc:Pt:Isolate:OrdQn
C0802569 A18334955 L6422606 S7381085 AUI 19714-5 LOINC_SYSTEM Urine Triazolam:ACnc:Pt:Urine:Ord:Screen
C0803930 A18180943 L2268874 S7420841 AUI 21136-7 LOINC_SYSTEM Ser Cucumis melo spp Ab.IgG.RAST class:ACnc:Pt:Ser:Ord
C0803970 A18374333 L1472162 S7411431 AUI 21176-3 LOINC_SYSTEM CSF Cerebroventricular lining cells:ACnc:Pt:CSF:Ord:Microscopy.light
C0881162 A18259962 L1724320 S7343254 AUI 23800-6 LOINC_SYSTEM Ser (Alternaria alternata+Aspergillus fumigatus+Cladosporium herbarum+Penicillium notatum) Ab.IgE:ACnc:Pt:Ser:Ord:Multidisk
C0879985 A18182212 L1725569 S7347619 AUI 22430-3 LOINC_SYSTEM Ser Neisseria gonorrhoeae Ab:Titr:Pt:Ser:Qn
C0880067 A18259248 L1724733 S7368998 AUI 22530-0 LOINC_SYSTEM Ser Salmonella typhi little d Ab:ACnc:Pt:Ser:Ord

LOINC_PROPERTY

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0549753 A18291500 L2269261 S7358050 AUI 10957-9 LOINC_PROPERTY ACnc Pinus elliottii Ab.IgE:ACnc:Pt:Ser:Qn
C0550976 A18369140 L1461755 S7426982 AUI 11594-9 LOINC_PROPERTY ACnc Echovirus 16 Ab:ACnc:Pt:Ser:Qn
C0551738 A18330359 L1473330 S7435852 AUI 11620-2 LOINC_PROPERTY Find Activity:Find:Pt:Respiratory system^fetus:Nar:US
C0796855 A18215147 L1468721 S7346613 AUI 13664-8 LOINC_PROPERTY Titr Myelin associated glycoprotein-sulfated glucuronic paragloboside Ab.IgM:Titr:Pt:Ser:Qn
C0796860 A18369860 L6419614 S10024740 AUI 13669-7 LOINC_PROPERTY MCrto 2-Hydroxy-3-Methylvalerate/Creatinine:MCrto:Pt:Urine:Qn
C0797179 A18215849 L6422061 S7360315 AUI 13991-5 LOINC_PROPERTY MFr Prealbumin/Protein.total:MFr:Pt:Urine:Qn:Electrophoresis
C0797621 A18138855 L6416750 S7413713 AUI 14444-4 LOINC_PROPERTY MCnc Cholesterol:MCnc:Pt:Urine:Qn
C0797876 A18293595 L1491815 S7425525 AUI 14702-5 LOINC_PROPERTY SCnc Disopyramide:SCnc:Pt:Ser/Plas:Qn
C0799563 A18294663 L6425698 S7370474 AUI 16410-3 LOINC_PROPERTY ACnc Asparagine:ACnc:Pt:Urine:Ord
C0363818 A18255561 L6413034 S10026379 AUI 1684-0 LOINC_PROPERTY MCnc 3-Methoxy-4-Hydroxyphenylglycol:MCnc:Pt:Urine:Qn
C0800191 A18256249 L1462261 S7454377 AUI 17062-1 LOINC_PROPERTY Titr Legionella pneumophila 2 Ab:Titr:Pt:Ser:Qn
C1145733 A18334070 L6419559 S7396327 AUI 17896-2 LOINC_PROPERTY Prid Bacteria identified^^^5:Prid:Pt:Sputum:Nom:Aerobic culture
C0801441 A18373054 L6693986 S7794821 AUI 18399-6 LOINC_PROPERTY Titr Polio virus 3 Ab:Titr:Pt:CSF:Qn:Comp fix
C0801577 A18102896 L1492486 S7363512 AUI 18536-3 LOINC_PROPERTY Time QT interval:Time:Pt:Lead II:Qn:EKG
C0803727 A18374423 L1495295 S7352200 AUI 20928-8 LOINC_PROPERTY MCnt Oxalate:MCnt:Pt:Plant:Qn
C0804331 A18374766 L2269107 S7372900 AUI 21537-6 LOINC_PROPERTY ACnc Spinacia oleracea Ab.IgG.RAST class:ACnc:Pt:Ser:Ord
C0804451 A18220093 L2271727 S7404620 AUI 21661-4 LOINC_PROPERTY Prid CYP2D6 gene mutation analysis del:Prid:Pt:Bld/Tiss:Nom:Molgen
C0804525 A18181835 L1476240 S7367969 AUI 21735-6 LOINC_PROPERTY Prid SNCA gene mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen
C0879726 A18182065 L6416329 S7401191 AUI 22129-1 LOINC_PROPERTY ACnc Borrelia burgdorferi Ab.IgG:ACnc:Pt:Synv fld:Ord

LOINC_SCALE_TYP

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0551124 A18213749 L1033080 S7368426 AUI 10906-6 LOINC_SCALE_TYP Qn Saint Louis encephalitis virus Ab.IgG:Titr:Pt:Ser:Qn:IF
C0551009 A18291713 L2271056 S7443647 AUI 11259-9 LOINC_SCALE_TYP Ord Hepatitis C virus RNA:ACnc:Pt:Ser/Plas:Ord:Probe.amp.tar
C0551622 A18175892 L1037881 S7455836 AUI 11379-5 LOINC_SCALE_TYP Qn Level of education:Time:Pt:^Patient:Qn:Reported
C0551802 A18175411 L9082417 S11326337 AUI 11683-0 LOINC_SCALE_TYP Qn Blood flow.mean:Vel:Pt:Ovarian artery.left:Qn:US.doppler
C0552126 A18292054 L1492199 S7364031 AUI 12009-7 LOINC_SCALE_TYP Qn RR duration:Time:Pt:Heart^fetus:Qn:US.measured
C0551388 A18292212 L6416244 S7397627 AUI 12364-6 LOINC_SCALE_TYP Ord Benzodiazepines:ACnc:Pt:Gast fld:Ord
C0551269 A18292250 L1495212 S7380000 AUI 12441-2 LOINC_SCALE_TYP Qn Tolmetin:MCnc:Pt:Ser/Plas:Qn
C0550015 A18369786 L1461925 S7449981 AUI 12763-9 LOINC_SCALE_TYP Qn Insulin^19M post XXX challenge:MCnc:Pt:Ser/Plas:Qn
C0482436 A18254085 L2403605 S7384146 AUI 1330-0 LOINC_SCALE_TYP Ord V Ab:ACnc:Pt:Ser/Plas^donor:Ord
C0797229 A18100319 L1471772 S7413859 AUI 14041-8 LOINC_SCALE_TYP Qn Choriogonadotropin.beta subunit:ACnc:Pt:CSF:Qn
C0879938 A18102034 L1725420 S7806846 AUI 17039-9 LOINC_SCALE_TYP Qn La Crosse virus Ab.IgM:Titr:Pt:Ser:Qn
C0800449 A18371281 L6425089 S7347821 AUI 17328-6 LOINC_SCALE_TYP Ord Neisseria meningitidis B Ag:ACnc:Pt:Urine:Ord:LA
C0801090 A18295618 L1481615 S7427563 AUI 18041-4 LOINC_SCALE_TYP Qn Ejection:Time:Pt:Aortic valve:Qn:US.doppler
C0801950 A18103054 L6408264 S7349861 AUI 18957-1 LOINC_SCALE_TYP OrdQn Novobiocin:Susc:Pt:Isolate:OrdQn
C0802050 A20851562 L10831004 S13453368 AUI 19113-0 LOINC_SCALE_TYP Qn IgE:ACnc:Pt:Ser/Plas:Qn
C0802280 A18141639 L6413358 S7413324 AUI 19389-6 LOINC_SCALE_TYP Ord Chlorpheniramine:ACnc:Pt:Urine:Ord:Screen
C0802532 A20858977 L6401636 S13458595 AUI 19672-5 LOINC_SCALE_TYP Qn Phenothiazines cutoff:MCnc:Pt:Urine:Qn:Screen
C0364189 A18218733 L6419912 S7407978 AUI 2057-8 LOINC_SCALE_TYP Qn Catecholamines:MCnc:Pt:Urine:Qn
C0803750 A18297008 L6405308 S7368935 AUI 20951-0 LOINC_SCALE_TYP Nom Salmonella sp serotype:Prid:Pt:Isolate:Nom:Aggl

LLR

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0489362 A18097805 L1492168 S7363884 AUI 10033-9 LLR 19980820 R' wave duration.lead V6:Time:Pt:Heart:Qn:EKG
C0488521 A18290951 L0814299 S7445775 AUI 10171-7 LLR 19961126 History of symptoms & diseases:Find:Pt:Eyes:Nar:Reported
C1959619 A18329718 L2406794 S7395286 AUI 10408-3 LLR 20020403 little i Ag:ACnc:Pt:RBC:Ord
C0549769 A20078175 L10338399 S12911566 AUI 11197-1 LLR 20110929 Sardina pilchardus Ab.IgE:ACnc:Pt:Ser:Qn
C0552281 A18330659 L1485542 S7391862 AUI 12168-1 LLR 19990125 Volume^post void:Vol:Pt:Urinary bladder^fetus:Qn:US.measured
C0552200 A18330630 L1493076 S7375325 AUI 12086-5 LLR 20070312 Study observation:Find:Pt:Heart.valves^fetus:Nom:US
C0550723 A18176402 L6421545 S7461189 AUI 12346-3 LLR 20061026 Methyclothiazide:ACnc:Pt:Urine:Ord
C0549935 A18369673 L1465903 S7418775 AUI 12564-1 LLR 19980824 Cortisol^9th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn
C0549994 A18330935 L1465031 S7437720 AUI 12640-9 LLR 19980824 Glucose^6.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn
C0551485 A18369217 L6405595 S7379727 AUI 12708-4 LLR 20061026 Tin:MCnc:Pt:Urine:Qn
C0800750 A18176916 L2267527 S7374196 AUI 13145-8 LLR 20010824 Streptococcus pneumoniae 26 Ab^1st specimen:ACnc:Pt:Ser:Qn
C0551141 A18254038 L1840155 S7373127 AUI 13242-3 LLR 20010129 Sporothrix schenckii Ab.IgM:ACnc:Pt:Ser:Qn
C0551018 A18370099 L1462187 S7444196 AUI 13252-2 LLR 19980318 Herpes simplex virus 2 Ab.IgM:ACnc:Pt:CSF:Qn
C0797535 A18216010 L1491021 S7462127 AUI 14355-2 LLR 20120622 Microscopic observation:Prid:Pt:Cvx:Nom:KOH preparation
C0797790 A18332068 L6425164 S7349927 AUI 14615-9 LLR 20061026 Nuclear Ab:Titr:Pt:Periton fld:Qn
C0799011 A18371581 L2268349 S7411779 AUI 15844-4 LLR 20011128 Chenopodium ambrosioides Ab.IgE.RAST class:ACnc:Pt:Ser:Ord
C0799756 A18333333 L1471844 S7413340 AUI 16609-0 LLR 20020403 Chlorphentermine:ACnc:Pt:Bld:Qn
C0799293 A18217083 L1467358 S7443607 AUI 16128-1 LLR 19980604 Hepatitis C virus Ab:ACnc:Pt:Ser:Ord
C0799716 A18140096 L1469055 S7408800 AUI 16569-6 LLR 19980604 Ceftriaxone Ab.IgE:MCnc:Pt:Ser:Qn

LCT

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0484627 A18098178 L1470841 S7434303 AUI 10457-0 LCT MIN Actin Ag:ACnc:Pt:Tiss:Ord:Immune stain
C0484718 A18368525 L1471060 S7428190 AUI 10478-6 LCT MIN Eosinophil major basic protein Ag:ACnc:Pt:Tiss:Ord:Immune stain
C0550461 A18136990 L1036596 S7357206 AUI 11058-5 LCT ADD Phosphofructokinase:CCnc:Pt:RBC:Qn
C0551623 A18098696 L1035467 S7459245 AUI 11380-3 LCT ADD Marital status and living arrangements:Find:Pt:^Patient:Nar:Reported
C0482418 A18369724 L2403012 S7353066 AUI 1292-2 LCT DEL P2 Ab:ACnc:Pt:Ser/Plas^BPU:Ord:Aggl RBC
C0552088 A18330567 L8885516 S11036784 AUI 11971-9 LCT MAJ Long axis.mean:Len:Pt:Fibula.diaphysis^fetus:Qn:Estimated from gestational age.Merz 1987
C0550324 A18215502 L6420374 S7421445 AUI 13393-4 LCT MAJ Cystathionine:MCnc:Pt:Amnio fld:Qn
C0797923 A18177792 L1493865 S7436849 AUI 14749-6 LCT ADD Glucose:SCnc:Pt:Ser/Plas:Qn
C0798923 A18101295 L2268953 S7445890 AUI 15756-0 LCT NAM Holcus lanatus Ab.IgE.RAST class:ACnc:Pt:Ser:Ord
C0799713 A18101777 L6423281 S7408213 AUI 16566-2 LCT MAJ Cefazolin:MCnc:Pt:Urine:Qn
C0800186 A18102068 L1471350 S7454622 AUI 17057-1 LCT ADD Legionella pneumophila Ag:ACnc:Pt:XXX:Ord
C0800239 A18256273 L1722220 S7409199 AUI 17111-6 LCT MIN Cells.CD12/100 cells:NFr:Pt:Bld:Qn
C0800377 A18295140 L1495084 S7460280 AUI 17253-6 LCT MAJ Mercury:MCnc:Pt:Milk:Qn
C0363974 A18295790 L0501530 S7463581 AUI 1839-0 LCT MIN Ammonia:SCnc:Pt:Bld:Qn
C0802615 A18141830 L5814846 S7350163 AUI 19800-2 LCT MIN Number of specimens obtained:Num:Stdy:Gastrointestine.upper:Qn:EGD
C0804265 A18219966 L2269306 S7362931 AUI 21471-8 LCT NAM Punica granatum Ab.IgE:ACnc:Pt:Ser:Qn
C0802860 A18296250 L1459466 S7354930 AUI 20045-1 LCT MAJ Peak inspiratory flow^at 2.0 liter per second on ventilator:Pres:Pt:Respiratory system.airway opening:Qn
C0364191 A18219393 L1726422 S7411404 AUI 2059-4 LCT MAJ Cerebroside sulfatase:ACnc:Pt:Ser/Plas:Ord
C0804589 A20862854 L10820595 S13465595 AUI 21800-8 LCT NAM t(1;19)(q23.3;p13.3)(PBX1,TCF3) fusion transcript:Arb:Pt:Bld/Tiss:Ord:Molgen

LOR

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0484512 A18175345 L1471126 S7404005 AUI 10439-8 LOR Both CD3 Ag:ACnc:Pt:Tiss:Ord:Immune stain
C0485044 A18136732 L7984303 S10024342 AUI 10582-5 LOR Both pH:LsCnc:Pt:Cvm:Qn
C0485967 A18214049 L1493536 S7462277 AUI 10803-5 LOR Observation Microscopic observation:Prid:Pt:Tiss:Nom:Quinacrine fluorescent stain
C0363415 A18214938 L2418366 S7458720 AUI 1252-6 LOR Observation Major crossmatch^post immediate spin:Imp:Pt:Ser/Plas:Nom
C0362219 A18215277 L7983141 S10027116 AUI 130-5 LOR Observation Cefsulodin:Titr:Pt:Isolate+Ser:Qn:SBT
C0798047 A18332254 L7975053 S10024334 AUI 14873-4 LOR Both pH:LsCnc:Pt:BldCo:Qn
C0797712 A18177705 L6696362 S7807738 AUI 14536-7 LOR Both Measles virus Ag:ACnc:Pt:Skin:Ord:IF
C0800120 A18294971 L6696257 S7806141 AUI 16989-6 LOR Observation Hydrogen/Expired gas^3.5H post dose glucose:VFr:Pt:Exhl gas:Qn
C0799287 A18255751 L1840585 S7417145 AUI 16122-4 LOR Both Colorado tick fever virus Ab.IgM:Titr:Pt:Ser:Qn
C0799405 A18333145 L6421952 S7355353 AUI 16240-4 LOR Both Pentobarbital:MCnc:Pt:Urine:Qn:Confirm
C0800094 A18372185 L1485744 S7444817 AUI 16963-1 LOR Observation Hexacarboxylporphyrin:MCnc:Pt:Bld:Qn
C0800119 A18256183 L6700029 S7806139 AUI 16988-8 LOR Observation Hydrogen/Expired gas^2H post dose glucose:VFr:Pt:Exhl gas:Qn
C0879657 A18257626 L1724639 S7411901 AUI 19734-3 LOR Both Chicken droppings Ab.IgE:ACnc:Pt:Ser:Qn
C0802139 A18218692 L2274871 S7423382 AUI 19227-8 LOR Observation Deoxyhemoglobin/Hemoglobin.total:MFr:Pt:BldV:Qn
C0812461 A18103133 L1485370 S7398593 AUI 19231-0 LOR Observation Bicarbonate^^standard:SCnc:Pt:BldC:Qn
C0803909 A18219796 L2269102 S7384458 AUI 21115-1 LOR Observation Vaccinium myrtillus Ab.IgG.RAST class:ACnc:Pt:Ser:Ord
C0804092 A18297369 L1467694 S7435735 AUI 21298-5 LOR Observation Gelatin porcine Ab.IgE.RAST class:ACnc:Pt:Ser:Ord
C0879763 A18259067 L1725363 S7412847 AUI 22172-1 LOR Both Chlamydophila pneumoniae Ab.IgG:Titr:Pt:Ser:Qn
C0879982 A18182208 L1725649 S7346332 AUI 22427-9 LOR Both Mycoplasma pneumoniae Ab.IgM:Titr:Pt:Ser:Qn

LUR

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0549702 A18252694 L1032772 S7427639 AUI 10927-2 LUR Y Elk meat Ab.IgE:ACnc:Pt:Ser:Qn
C0484477 A18329712 L0847085 S7448219 AUI 10402-6 LUR Y Immune serum globulin given:Vol:Pt:^Patient:Qn
C0551276 A18368578 L1032987 S7397016 AUI 10862-1 LUR Y Basement membrane Ab:Titr:Pt:Ser:Qn
C0550249 A18175593 L1487421 S7407441 AUI 10876-1 LUR Y Carnitine esters:MCnc:Pt:Ser/Plas:Qn
C0550674 A18175651 L2419964 S7425969 AUI 10986-8 LUR Y Doxycycline:MCnc:Pt:Ser/Plas:Qn
C0550133 A18098508 L1838683 S7379214 AUI 11033-8 LUR Y Thyrotropin^45M post dose TRH IV:MCnc:Pt:Ser/Plas:Qn
C0551833 A18098875 L9088031 S11326387 AUI 11714-3 LUR Y Blood flow.systolic.max:Vel:Pt:Heart.ventricle.left.outflow tract:Qn:US.doppler
C0551845 A18330431 L9076916 S11326406 AUI 11726-7 LUR Y Blood flow.systolic.max:Vel:Pt:{Circulatory system}:Qn:US.doppler
C0550369 A18137773 L6696155 S7804982 AUI 12635-9 LUR Y Glucose^6th specimen:MCnc:Pt:Dial fld prt:Qn
C0796802 A18177179 L6409833 S10027666 AUI 13611-9 LUR Y 6-Beta-Hydroxycortisol:MRat:24H:Urine:Qn
C0550556 A18138168 L6699369 S7797962 AUI 13506-1 LUR Y Urea nitrogen renal clearance:VRat:Pt:Urine+Ser/Plas:Qn
C0796712 A18292503 L9456335 S11752409 AUI 13518-6 LUR Y Lymphocytes.variant/100 leukocytes:NFr:Pt:Body fld:Qn:Manual count
C0797610 A18293459 L6410877 S7446058 AUI 14432-9 LUR Y Albumin/Globulin:MCrto:Pt:Amnio fld:Qn
C0798476 A18293981 L1491314 S7391755 AUI 15306-4 LUR Y Volume:Vol:Pt:Testis.left:Qn:US.derived.HWL
C0363862 A18333724 L5809040 S7438107 AUI 1728-5 LUR Y Adenosine monophosphate.cyclic/Creatinine:MCrto:Pt:Ser/Plas:Qn
C0799762 A18217354 L1036827 S7413695 AUI 16615-7 LUR Y Cholesterol.total/Cholesterol.in LDL:MCrto:Pt:Ser/Plas:Qn
C0800963 A18831189 L2268112 S7442631 AUI 17856-6 LUR Y Hemoglobin A1c/Hemoglobin.total:MFr:Pt:Bld:Qn:HPLC
C0481965 A18257154 L6403212 S7414807 AUI 188-3 LUR Y Clarithromycin:Susc:Pt:Isolate:Qn:MLC
C0802386 A18831399 L9577709 S12039436 AUI 19505-7 LUR Y Methotrimeprazine cutoff:MCnc:Pt:Urine:Qn:Confirm

LCA

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0484922 A18098215 L0813280 S7425332 AUI 10536-1 LCA DIPRYRIDAMOLE Dipyridamole:MCnc:Pt:Ser/Plas:Qn
C0485606 A18329805 L6404819 S7350324 AUI 10697-1 LCA NYSTEX Nystatin:Susc:Pt:Isolate:OrdQn:MIC
C0550449 A18098437 L6415193 S7356227 AUI 10883-7 LCA EX LAX Phenolphthalein:MCnt:Pt:Stool:Qn
C0551439 A18175730 L1038616 S7456070 AUI 11097-3 LCA APLIDAL Lindane:MCnc:Pt:Ser/Plas:Qn
C0550459 A18330199 L1037437 S7357161 AUI 11224-3 LCA 2 AMINOETHYL DIHYDROGEN PHOSPHATE Phosphoethanolamine:MCnc:Pt:CSF:Qn
C0551259 A18137671 L6408633 S7365322 AUI 12414-9 LCA RAUSERPOL Resperine:MCnc:Pt:Urine:Qn
C0549943 A18137717 L1463741 S7428541 AUI 12529-4 LCA EPIRENAMINE Epinephrine^2H post XXX challenge:MCnc:Pt:Plas:Qn
C0550712 A18369654 L1472855 S7459597 AUI 12532-8 LCA ANCOLAN Meclizine:ACnc:Pt:Ser/Plas:Ord
C0549932 A18253588 L1465381 S7418726 AUI 12561-7 LCA EF CORTELAN Cortisol^6th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn
C0549950 A18330518 L1464384 S7429916 AUI 12596-3 LCA BETA ESTRADIOL Estradiol^3H post XXX challenge:MCnc:Pt:Ser/Plas:Qn
C0549982 A18369717 L1463771 S7437350 AUI 12652-4 LCA D GLUCOPYRANOSE Glucose^2M post XXX challenge:MCnc:Pt:Ser/Plas:Qn
C0549982 A18369717 L1463771 S7437350 AUI 12652-4 LCA GLU Glucose^2M post XXX challenge:MCnc:Pt:Ser/Plas:Qn
C0796755 A18370266 L1472766 S7447727 AUI 13564-0 LCA HALTRAN Ibuprofen:ACnc:Pt:Ser/Plas:Ord
C0550540 A18369956 L1465551 S7381676 AUI 12958-5 LCA L LIOTHYRONINE Triiodothyronine^7th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn
C0482478 A18370108 L6403305 S7418454 AUI 1390-4 LCA EVACORT Cortisol.free^48H post 40 ug corticotropin IM BID 3 day:MCnc:24H:Urine:Qn
C0798048 A18332255 L1495700 S7356195 AUI 14874-2 LCA DONPHEN Phenobarbital:SCnc:Pt:Ser/Plas:Qn
C0550216 A18138255 L6422167 S7364445 AUI 13387-6 LCA S ARGININE Arginine:MCnc:Pt:Amnio fld:Qn
C0796835 A18292979 L1459713 S10030812 AUI 13644-0 LCA TOTAL XYLENES 1,3-Dimethylbenzene:MCnc:Pt:Bld:Qn
C0482493 A18331601 L3157814 S7418624 AUI 1413-4 LCA ALA CORT Cortisol^2D post 500 ug corticotropin IM:MCnc:Pt:Ser/Plas:Qn

LOINC_METHOD_TYP

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0485752 A18214026 L6699345 S7797681 AUI 10728-4 LOINC_METHOD_TYP Organism specific culture Trichomonas sp identified:Prid:Pt:Genital:Nom:Organism specific culture
C0488584 A18136309 L0837980 S7357500 AUI 10198-0 LOINC_METHOD_TYP Observed Physical findings:Find:Pt:Genitourinary tract:Nar:Observed
C0549677 A18252369 L6405498 S7376190 AUI 11578-2 LOINC_METHOD_TYP Gradient strip Sulfisoxazole:Susc:Pt:Isolate:OrdQn:Gradient strip
C0485695 A18098348 L6425672 S7369399 AUI 10715-1 LOINC_METHOD_TYP Microscopy.light Schistosoma sp identified:Prid:Pt:Urine sed:Nom:Microscopy.light
C0485975 A18329946 L1493979 S7462288 AUI 10811-8 LOINC_METHOD_TYP Silver stain.Grimelius Microscopic observation:Prid:Pt:Tiss:Nom:Silver stain.Grimelius
C0551589 A18291761 L1493313 S7445700 AUI 11349-8 LOINC_METHOD_TYP Reported History of past illness:Find:Pt:^Patient:Nom:Reported
C0798416 A18255167 L2268391 S7411830 AUI 15245-4 LOINC_METHOD_TYP Multidisk (Brassica oleracea var capitata+Capsicum annuum+Lycopersicon lycopersicum+Spinacia oleracea) Ab.IgE:ACnc:Pt:Ser:Ord:Multidisk
C0798579 A18294034 L1839944 S7384701 AUI 15410-4 LOINC_METHOD_TYP EIA Varicella zoster virus Ab.IgG:ACnc:Pt:Ser:Ord:EIA
C0801057 A18140937 L1487519 S7424557 AUI 18007-5 LOINC_METHOD_TYP US Diameter:Len:Pt:Vena cava.superior:Qn:US
C0799738 A18140107 L1467502 S7412043 AUI 16591-0 LOINC_METHOD_TYP IF Chlamydia sp Ab.IgG:ACnc:Pt:CSF:Qn:IF
C0800706 A18140688 L1468299 S7371176 AUI 17591-9 LOINC_METHOD_TYP IF Smith extractable nuclear Ab:ACnc:Pt:Ser:Ord:IF
C0800923 A18218068 L6412866 S7398126 AUI 17816-0 LOINC_METHOD_TYP Electrophoresis Beta globulin/Protein.total:MFr:Pt:Body fld:Qn:Electrophoresis
C0802988 A18335208 L1729184 S7399367 AUI 20173-1 LOINC_METHOD_TYP US.doppler Blood flow.diastole.max:Vel:Pt:Aortic valve.regurgitant jet:Qn:US.doppler
C0801849 A18257199 L1849681 S7438571 AUI 18851-6 LOINC_METHOD_TYP US Grade:Type:Pt:Placenta^fetus:Nar:US
C0803042 A18103649 L1494083 S7442275 AUI 20227-5 LOINC_METHOD_TYP US.M-mode Height:Len:Pt:Region of interest.XXX:Qn:US.M-mode
C0803981 A18335443 L1471493 S7412600 AUI 21187-0 LOINC_METHOD_TYP Probe.amp.tar Chlamydia trachomatis DNA:ACnc:Pt:Cnjt:Ord:Probe.amp.tar
C0804407 A18258704 L1481804 S7404343 AUI 21614-3 LOINC_METHOD_TYP Molgen CDKN2A gene deletion:Arb:Pt:Bld/Tiss:Ord:Molgen
C0804427 A18142951 L1476201 S7394434 AUI 21636-6 LOINC_METHOD_TYP Molgen BRCA1 gene mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen
C0804519 A18143023 L1476237 S7353409 AUI 21729-9 LOINC_METHOD_TYP Molgen PSAP gene mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen

EXAMPLE_UCUM_UNITS

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0485044 A18136732 L7984303 S10024342 AUI 10582-5 EXAMPLE_UCUM_UNITS [pH] pH:LsCnc:Pt:Cvm:Qn
C0549773 A18136336 L1032872 S7370754 AUI 11199-7 EXAMPLE_UCUM_UNITS k[IU]/L Silver Ab.IgE:ACnc:Pt:Ser:Qn
C0552053 A18099022 L8884970 S11031931 AUI 11936-2 EXAMPLE_UCUM_UNITS d Gestational age:Time:Pt:^Fetus:Qn:US.estimated from HL.Jeanty 1984
C0551194 A18369527 L1033077 S7380259 AUI 12261-4 EXAMPLE_UCUM_UNITS {titer} Toxoplasma gondii Ab.IgG:Titr:Pt:Ser:Qn:EIA
C0550329 A18292319 L1463858 S7423016 AUI 12590-6 EXAMPLE_UCUM_UNITS ng/dL Dehydroepiandrosterone^2nd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn
C0797852 A20866546 L10809642 S13444415 AUI 14678-7 EXAMPLE_UCUM_UNITS nmol/L Cortisol^PM trough specimen:SCnc:Pt:Ser/Plas:Qn
C0797129 A18331744 L6404385 S7457723 AUI 13941-0 EXAMPLE_UCUM_UNITS % Lymphocytes/100 leukocytes:NFr:Pt:Body fld:Qn:Manual count
C0797788 A18293548 L6425162 S7349924 AUI 14613-4 EXAMPLE_UCUM_UNITS {titer} Nuclear Ab:Titr:Pt:Body fld:Qn
C0363626 A18293720 L1835630 S7436943 AUI 1492-8 EXAMPLE_UCUM_UNITS mg/dL Glucose^1.5H post 0.5 g/kg glucose IV:MCnc:Pt:Ser/Plas:Qn
C0363842 A18177877 L6424052 S7432462 AUI 1708-7 EXAMPLE_UCUM_UNITS U/L Acetylcholinesterase:CCnc:Pt:Amnio fld:Qn
C0364149 A18335204 L0501533 S7406542 AUI 2017-2 EXAMPLE_UCUM_UNITS umol/h/mg{protein} Carbamoyl phosphate synthetase(ammonia):CCnt:Pt:Tiss:Qn
C0802088 A18218666 L1473626 S7406916 AUI 19167-6 EXAMPLE_UCUM_UNITS umol/L Carcinoembryonic Ag:SCnc:Pt:Ser/Plas:Qn
C0364094 A18373688 L0525703 S7398554 AUI 1961-2 EXAMPLE_UCUM_UNITS mmol/L Bicarbonate:SCnc:Pt:BldC:Qn
C0364101 A18103420 L1726922 S7398737 AUI 1968-7 EXAMPLE_UCUM_UNITS mg/dL Bilirubin.glucuronidated+Bilirubin.albumin bound:MCnc:Pt:Ser/Plas:Qn
C0802747 A18141911 L1490163 S10619463 AUI 19932-3 EXAMPLE_UCUM_UNITS L/min Gas flow.constant setting:VRat:Pt:Ventilator:Qn
C0802753 A18103552 L1474530 S7435391 AUI 19938-0 EXAMPLE_UCUM_UNITS L/min Gas flow.max^post therapy:VRat:Pt:Respiratory system.airway:Qn
C0802756 A18257772 L1491216 S7435404 AUI 19941-4 EXAMPLE_UCUM_UNITS L/min Gas flow.oxygen:VRat:Pt:Oxygen delivery system:Qn
C0803559 A18258212 L1488271 S7413993 AUI 20759-7 EXAMPLE_UCUM_UNITS ug/g Chromium:MCnt:Pt:Tiss:Qn
C0803959 A18335797 L1487620 S7410455 AUI 21165-6 EXAMPLE_UCUM_UNITS % Cells.CD5/Gated cells.total:NFr:Pt:XXX:Qn

EXAMPLE_UNITS

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0550743 A18213580 L6401462 S7349524 AUI 11075-9 EXAMPLE_UNITS ng/mL Norfentanyl:MCnc:Pt:Urine:Qn
C0552012 A18176165 L1473973 S7436170 AUI 11895-0 EXAMPLE_UNITS days Gestational age:Time:Pt:^Fetus:Qn:US.estimated from BD
C0549913 A18369213 L6426672 S7408016 AUI 12519-5 EXAMPLE_UNITS pg/mL Catecholamines^5th specimen post XXX challenge:MCnc:Pt:Urine:Qn
C0796927 A18215646 L6423984 S7429874 AUI 13736-4 EXAMPLE_UNITS ug/g creatinine Estradiol/Creatinine:MCrto:24H:Urine:Qn
C0797061 A18100223 L6414826 S10017531 AUI 13872-7 EXAMPLE_UNITS ug/24 h 11-Deoxycortisol:MRat:24H:Urine:Qn
C0797129 A18331744 L6404385 S7457723 AUI 13941-0 EXAMPLE_UNITS % Lymphocytes/100 leukocytes:NFr:Pt:Body fld:Qn:Manual count
C0797913 A18100180 L1835697 S7435568 AUI 14739-7 EXAMPLE_UNITS pmol/L Gastrin^2M post 0.2 U/kg secretin:SCnc:Pt:Ser/Plas:Qn
C0798100 A18293718 L1495726 S7381552 AUI 14927-8 EXAMPLE_UNITS mmol/L Triglyceride:SCnc:Pt:Ser/Plas:Qn
C0363629 A18371072 L6427567 S7436946 AUI 1495-1 EXAMPLE_UNITS mg/dL Glucose^1.5H post 100 g glucose PO:MCnc:Pt:Urine:Qn
C0798662 A18255313 L1463992 S7354056 AUI 15493-0 EXAMPLE_UNITS titer Parainfluenza virus 3 Ab:Titr:Pt:Ser:Qn:HAI
C0363720 A18371676 L1835977 S7457140 AUI 1588-3 EXAMPLE_UNITS ug/uL Lutropin^1.5H post dose gonadotropin releasing hormone:MCnc:Pt:Ser/Plas:Qn
C0800355 A18294758 L1469118 S7457834 AUI 17228-8 EXAMPLE_UNITS titer Lymphocytic choriomeningitis virus Ab:Titr:Pt:CSF:Qn
C0800803 A18295427 L1838449 S7377975 AUI 17691-7 EXAMPLE_UNITS ng/mL Testosterone^30M post XXX challenge:MCnc:Pt:Ser/Plas:Qn
C0802777 A18373815 L2274841 S7352744 AUI 19962-0 EXAMPLE_UNITS % Oxyhemoglobin/Hemoglobin.total^post bronchodilation:MFr:Pt:BldA:Qn:Pulse oximetry
C0802823 A18820156 L9579882 S12040690 AUI 20008-9 EXAMPLE_UNITS mm Hg Oxygen^on oxygen.low flow & asleep:PPres:Stdy^max:BldC:Qn:Transcutaneous O2 monitor
C0802131 A18296154 L1485817 S7352382 AUI 19218-7 EXAMPLE_UNITS mol/L Oxygen content:SCnc:Pt:BldA:Qn
C0802155 A18296166 L1460781 S7459940 AUI 19252-6 EXAMPLE_UNITS % Megakaryocytes/100 leukocytes:NFr:Pt:Bld:Qn
C0802711 A18141890 L1846174 S7406741 AUI 19896-0 EXAMPLE_UNITS mm Hg Carbon dioxide^during XXX treatment:PPres:Pt:BldC:Qn
C0803449 A18258089 L1494168 S7445185 AUI 20645-8 EXAMPLE_UNITS mcmol/dL; mcmol/L; umol/L Histidine:SCnc:Pt:Ser/Plas:Qn

HL7_V2_DATATYPE

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0550041 A18098411 L1839001 S7450136 AUI 10833-2 HL7_V2_DATATYPE NM/ST Insulin^7H post 75 g glucose PO:MCnc:Pt:Ser/Plas:Qn
C0484734 A18098072 L6407281 S7438496 AUI 10336-6 HL7_V2_DATATYPE NM/ST Gonadotropin peptide:MCnc:Pt:Urine:Qn
C0551953 A18369297 L1491510 S7424425 AUI 11836-4 HL7_V2_DATATYPE NM Diameter.long:Len:Pt:Kidney.right^fetus:Qn:US.measured
C0550611 A18098478 L6411383 S7462821 AUI 10978-5 HL7_V2_DATATYPE NM/ST Amitriptyline+Nortriptyline:MCnc:Pt:Urine:Qn
C0551853 A18253116 L8895298 S11022131 AUI 11734-1 HL7_V2_DATATYPE NM Body weight:Mass:Pt:^Fetus:Qn:US.estimated from AC&BPD&FL.Hadlock 1984
C0552027 A18330543 L8877422 S11031884 AUI 11910-7 HL7_V2_DATATYPE TM Gestational age:Time:Pt:^Fetus:Qn:US.estimated from CRL.Hadlock 1992
C0552080 A18176201 L1484663 S7456680 AUI 11963-6 HL7_V2_DATATYPE NM Long axis:Len:Pt:Femur.diaphysis^fetus:Qn:US.measured
C0552102 A18214701 L1493142 S7355608 AUI 11986-7 HL7_V2_DATATYPE NM Perimeter:Len:Pt:Head^fetus:Qn:US.traced
C0552103 A18137475 L1491307 S7355609 AUI 11987-5 HL7_V2_DATATYPE NM Perimeter:Len:Pt:Thorax^fetus:Qn:US.derived
C0802312 A18369627 L6410324 S7424049 AUI 12477-6 HL7_V2_DATATYPE NM/ST Dextromethamphetamine:MCnc:Pt:Urine:Qn
C0550500 A18369225 L6696571 S7795173 AUI 12848-8 HL7_V2_DATATYPE NM/ST Protein^6th specimen:MCnc:Pt:Dial fld prt:Qn
C0550390 A18099525 L1037432 S7447430 AUI 13374-4 HL7_V2_DATATYPE NM/ST Hydroxyproline:MCnc:Pt:CSF:Qn
C0797576 A18254375 L6415866 S7383576 AUI 14397-4 HL7_V2_DATATYPE NM/ST Urea nitrogen:MCnc:Pt:Gast fld:Qn
C0798202 A18177978 L6401552 S7353002 AUI 15029-2 HL7_V2_DATATYPE NM/ST Androsterone:SCnc:Pt:Ser/Plas:Qn
C0798216 A18177338 L6423648 S7418500 AUI 15043-3 HL7_V2_DATATYPE NM/ST Cortisol:SCnc:Pt:Urine:Qn
C0798329 A18139270 L6420115 S7413207 AUI 15158-9 HL7_V2_DATATYPE NM/ST Chloride:SCnc:Pt:Stool:Qn
C0799616 A18294690 L6416271 S7398643 AUI 16465-7 HL7_V2_DATATYPE NM/ST Bile acid:MCnc:Pt:Urine:Qn
C0800133 A18333557 L2417861 S7447471 AUI 17002-7 HL7_V2_DATATYPE NM/ST Hydroxytriazolam:MCnc:Pt:Ser/Plas:Qn:Confirm
C0800605 A18140625 L1838112 S7361147 AUI 17486-2 HL7_V2_DATATYPE NM/ST Progesterone^2H post XXX challenge:MCnc:Pt:Ser/Plas:Qn

LSU

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0551047 A18136494 L1033123 S7446978 AUI 10903-3 LSU titer Hyaluronidase Ab:Titr:Pt:Ser:Qn
C0550399 A18252777 L1036749 S7448376 AUI 11051-0 LSU mg/dL Immunoglobulin light chains.lambda:MCnc:Pt:Ser:Qn
C0549880 A18099888 L1722332 S7410739 AUI 13338-9 LSU % Cells.CD8+CD57+/100 cells:NFr:Pt:Bld:Qn
C0798525 A18371323 L6410635 S7436554 AUI 15356-9 LSU mg/24hr Globulins:MRat:24H:Urine:Qn
C0800166 A18217557 L1469689 S7806864 AUI 17037-3 LSU titer La Crosse virus Ab:Titr:Pt:CSF:Qn
C0800191 A18256249 L1462261 S7454377 AUI 17062-1 LSU titer Legionella pneumophila 2 Ab:Titr:Pt:Ser:Qn
C0803224 A18335327 L6407041 S7429465 AUI 20409-9 LSU RBCS/uL Erythrocytes:NCnc:Pt:Urine:Qn:Test strip
C0803838 A18373480 L6409645 S10025864 AUI 21042-7 LSU ug/mg creatinine 3-Hydroxydodecanoate/Creatinine:MCrto:Pt:Urine:Qn
C0803952 A18104238 L1487588 S7409573 AUI 21158-1 LSU % Cells.CD20/Gated cells.total:NFr:Pt:XXX:Qn
C0879686 A18297231 L1725028 S7441565 AUI 22081-4 LSU titer Afipia felis Ab.IgG:Titr:Pt:Ser:Qn
C0880260 A18375480 L1725695 S7358763 AUI 22759-5 LSU titer Platelet Ab:Titr:Pt:Ser:Qn
C0879961 A18220473 L1725660 S7455364 AUI 22405-5 LSU titer Leptospira interrogans serovar Pomona Ab:Titr:Pt:Ser:Qn
C0882417 A18375971 L1726491 S7429591 AUI 23635-6 LSU units/kg bw Erythropoietin given:ACnt:Pt:Dose:Qn
C0941322 A18260719 L6414702 S11752892 AUI 25115-7 LSU mmol/mole creatinine Methylmalonate/Creatinine:SCrto:24H:Urine:Qn
C0881312 A18298944 L6693099 S7799758 AUI 23976-4 LSU titer Blastomyces dermatitidis Ab:Titr:Pt:CSF:Qn:Comp fix
C0881480 A18260206 L1723477 S7359338 AUI 24174-5 LSU titer Polio virus 3 Ab^2nd specimen:Titr:Pt:Ser:Qn:Neut
C0881580 A18337620 L1723044 S7365412 AUI 24298-2 LSU titer Respiratory syncytial virus Ab^1st specimen:Titr:Pt:Ser:Qn
C0881650 A18299168 L2403336 S7395232 AUI 24384-0 LSU IU/mL little c Ab:ACnc:Pt:Ser/Plas:Qn
C0941351 A18144932 L6413569 S7421517 AUI 25155-3 LSU per HPF Cystine crystals:Naric:Pt:Urine sed:Qn:Microscopy.light.HPF

HL7_V3_DATATYPE

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0551950 A18176101 L4852084 S7424408 AUI 11833-1 HL7_V3_DATATYPE PQ Diameter.largest pocket.mean:Len:Pt:Am fld space^fetus:Qn:US.measured
C0550610 A18175648 L1034242 S7457166 AUI 10977-7 HL7_V3_DATATYPE PQ Alprazolam:MCnc:Pt:Bld:Qn
C0550247 A18252851 L6402956 S7406697 AUI 11211-0 HL7_V3_DATATYPE PQ Carbon dioxide:SCnc:Pt:Body fld:Qn
C0550459 A18330199 L1037437 S7357161 AUI 11224-3 HL7_V3_DATATYPE PQ Phosphoethanolamine:MCnc:Pt:CSF:Qn
C0551733 A18291855 L1033324 S7427058 AUI 11614-5 HL7_V3_DATATYPE PQ Abortions.spontaneous:Num:Pt:^Patient:Qn:Reported
C0551914 A20078182 L3166541 S7424533 AUI 11797-8 HL7_V3_DATATYPE PQ Diameter:Len:Pt:Mitral valve:Qn:US.measured
C0552203 A18292097 L1493070 S7375328 AUI 12091-5 HL7_V3_DATATYPE ED Study observation:Find:Pt:Heart.ventricle.right.outflow tract^fetus:Nar:US
C0549930 A18330873 L1464841 S7418705 AUI 12559-1 HL7_V3_DATATYPE PQ Cortisol^4th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn
C0549997 A18253624 L1465032 S7437752 AUI 12642-5 HL7_V3_DATATYPE PQ Glucose^7.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn
C0549961 A18253671 L1465542 S7433678 AUI 12669-8 HL7_V3_DATATYPE PQ Follitropin^7th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn
C0797080 A18370501 L1495118 S7463291 AUI 13891-7 HL7_V3_DATATYPE PQ Motilin:MCnc:Pt:Ser/Plas:Qn
C0363714 A18371568 L6417854 S7453667 AUI 1582-6 HL7_V3_DATATYPE PQ Lactose^1H post 50 g lactose PO:MCnc:Pt:Ser/Plas:Qn
C0797601 A18216025 L6402735 S7398817 AUI 14423-8 HL7_V3_DATATYPE PQ Bilirubin:MCnc:Pt:Synv fld:Qn
C0797909 A18100633 L4849959 S7435523 AUI 14735-5 HL7_V3_DATATYPE PQ Gastrin^10M post 0.2 U/kg secretin:SCnc:Pt:Ser/Plas:Qn
C0797945 A18370400 L1487988 S7437851 AUI 14771-0 HL7_V3_DATATYPE PQ Glucose^post CFst:SCnc:Pt:Ser/Plas:Qn
C0798103 A18139119 L1851254 S7381652 AUI 14930-2 HL7_V3_DATATYPE PQ Triiodothyronine:SCnc:Pt:Ser/Plas:Qn
C0799596 A18294682 L2413028 S7397689 AUI 16444-2 HL7_V3_DATATYPE PQ Benzophenone:MCnc:Pt:Ser/Plas:Qn
C0799984 A18294344 L2420650 S7430329 AUI 16845-0 HL7_V3_DATATYPE PQ Ethionamide:MCnc:Pt:Ser/Plas:Qn
C0800362 A18372327 L6424790 S7458630 AUI 17236-1 HL7_V3_DATATYPE PQ Magnesium:SCnc:Pt:Stool:Qn

LQS

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0943760 A18185316 L5813000 S7435374 AUI 28110-5 LQS CLINICAL CARE CLASSIFICATION L26.3 Gas exchange impairment:Find:Pt:Respiratory system:Ord:Observed.CCC
C0945579 A18301157 L5813041 S7448601 AUI 28124-6 LQS CLINICAL CARE CLASSIFICATION K25.6 Infection unspecified:Find:Pt:Immune system:Ord:Observed.CCC
C0943791 A18223616 L5809756 S7401766 AUI 28145-1 LQS CLINICAL CARE CLASSIFICATION B03.0 Bowel elimination alteration:Find:Pt:Gastrointestinal system:Ord:Observed.CCC
C0943924 A18146293 L6402002 S7371049 AUI 28299-6 LQS OMAHA III.26 Skin.behavior:Find:Pt:^Patient:Ord:Observed.OMAHA
C0943960 A18378492 L1845680 S7371082 AUI 28341-6 LQS OMAHA IV.36 Sleep and rest pattern.behavior:Find:Pt:^Patient:Ord:Observed.OMAHA
C0943977 A18108129 L1850262 S7377566 AUI 28358-0 LQS OMAHA IV.43 Technical procedure.status:Find:Pt:^Patient:Ord:Observed.OMAHA
C0944027 A18378555 L1847433 S7417240 AUI 28416-6 LQS OMAHA II.06 Communication with community resources.knowledge:Find:Pt:^Family:Ord:Observed.OMAHA
C0944065 A18185496 L1848780 S7423354 AUI 28460-4 LQS OMAHA III.22 Dentition.knowledge:Find:Pt:^Family:Ord:Observed.OMAHA
C1830918 A18272549 L8566579 S10636937 AUI 46840-5 LQS OMAHA I.04 Neighborhood &or workplace safety.behavior:Find:Pt:^Community:Ord:Observed.OMAHA
C1830996 A18195547 L6422065 S7360398 AUI 46918-9 LQS OMAHA III.48 Pregnancy function.behavior:Find:Pt:^Family:Ord:Observed.OMAHA
C2598390 A18391634 L8582240 S10639722 AUI 52720-0 LQS CARE I.a01 Other useful information:Find:Pt:^Patient:Nom:CARE
C2734035 A18316297 L9094412 S11334150 AUI 56099-5 LQS PhenX.020601030000 Hand dominance - coloring:Find:Pt:^Patient:Nom:ALSPAC
C2734070 A18238964 L9081492 S11342018 AUI 56118-3 LQS PhenX.010101020001 Proxy name:Pn:Pt:Proxy:Nom
C2926078 A18124392 L9454506 S11745768 AUI 58278-3 LQS PhenX.041201040100 Date of deep vein thrombosis diagnosis:TmStp:Pt:^Patient:Qn
C2925921 A18356080 L9457451 S11747638 AUI 58302-1 LQS PhenX.040501010000 Ever told by doctor that you had rheumatic heart or heart valve problems:Find:Pt:^Patient:Ord
C2926090 A18240227 L9452954 S11742822 AUI 58329-4 LQS PhenX.040701040000 Cardiopulmonary resuscitation &or cardioversion performed within 24 hours of death:Find:Pt:^Patient:Ord
C2973107 A18872132 L9581387 S12036227 AUI 61530-2 LQS PhenX.050501190100 How often did you take saw palmetto:Find:Pt:^Patient:Ord:PhenX
C3169348 A19508149 L10083798 S12608403 AUI 62529-3 LQS PhenX.060900 PhenX measure - environmental exposures - day care - pre-school attendance:-:Pt:^Patient:-:PhenX
C3169666 A19525917 L10083835 S12608694 AUI 62585-5 LQS PhenX.080500 PhenX measure - oral health - existence of cleft lip or palate:-:Pt:^Patient:-:PhenX

SOS

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0488608 A18252194 L1849697 S7357491 AUI 10210-3 SOS Physical findings (of general status) describes general observations and readily observable attributes of the patient, including affect and demeanor, apparent age compared to actual age, gender, ethnicity, nutritional status based on appearance, body build and habitus (e.g., muscular, cachectic, obese), developmental or other deformities, gait and mobility, personal hygiene, evidence of distress, and voice quality and speech. Physical findings:Find:Pt:General status:Nar:Observed
C0488638 A18097935 L7977471 S10022093 AUI 10222-8 SOS Surgical operation note (surgical complications) is a record of problems that occurred during surgery. The complications may have been known risks or unanticipated problems. Surgical operation note surgical complications:Imp:Pt:^Patient:Nar
C0551052 A18291077 L1033044 S7806831 AUI 10904-1 SOS California encphalitis virus has more than 20 strains- most of which include "strain" in the name, One of these, La Crosse vIrus, has a name that does not signal that it is a strain of California encephalitis. La Crosse virus Ab.IgG:Titr:Pt:Ser:Qn:IF
C0549741 A18175145 L1032850 S7353762 AUI 10945-4 SOS not same as chymopapain Papain Ab.IgE:ACnc:Pt:Ser:Qn
C0551497 A18291689 L6424422 S11324485 AUI 11218-5 SOS Term used for test for microalbumin using test strip such as Roche Micral (TM) Microalbuminuria Urine Test Strip or Bayer Clinitech (R) Microalbumin Reagent Strip Albumin:MCnc:Pt:Urine:Qn:Detection limit <= 20 mg/L test strip
C0551783 A18253055 L9079700 S11326307 AUI 11664-0 SOS Minumum value of the maximum Doppler shift frequency envelope. Blood flow.diastolic.min:Vel:Pt:Uterine artery.right:Qn:US.doppler
C0551822 A18253072 L9074114 S11326386 AUI 11703-6 SOS Maximum value of the Doppler shift frequency envelope. Blood flow.systolic.max:Vel:Pt:Ductus arteriosus^fetus:Qn:US.doppler
C0551944 A18176034 L1490318 S7424389 AUI 11827-3 SOS Longest hilum-cortex dimension. Measured in the plane that contains the longest rostral caudal diameter and, perpendicular to it, the longest hilum-cortex dimension. Diameter.hilum-cortex:Len:Pt:Kidney.right^fetus:Qn:US.measured
C0551966 A18176113 L1033260 S7424449 AUI 11849-7 SOS Mean diameter predicted for estimated gestational age by use regression formula derived from a standard population. Diameter.mean:Len:Pt:Abdomen^fetus:Qn:Estimated from gestational age
C0552011 A18137431 L1473969 S7436280 AUI 11894-3 SOS This term pertains only to the FETUS. Method Reference can be supplied by DICOM Supplement 23-Structured Reporting, Relationship Module (C.6.29). Gestational age:Time:Pt:^Fetus:Qn:US.estimated from area corrected BPC
C0552067 A18329568 L1490572 S7447764 AUI 11949-5 SOS Used to list and describe the criteria used by the ultrasonographer to identify individual fetuses in a multiple gestation. Identification criteria:Find:Pt:^Fetus:Nom:US
C0798777 A18255384 L1467420 S7407882 AUI 15610-9 SOS We reviewed the major allergy testing manufacturers and found that they all use the same allergen code, e1, but use different test descriptions (dander, epithelium, hair) Cat epithelium Ab.IgE.RAST class:ACnc:Pt:Ser:Ord
C0799120 A18255655 L2268897 S7362458 AUI 15953-3 SOS This is FOOD allergen Prunus domestica Ab.IgE.RAST class:ACnc:Pt:Ser:Ord
C0801048 A18218156 L1481605 S7422830 AUI 17998-6 SOS MC685; Time from peak AR gradient to zero baseline Deceleration:Time:Pt:Aortic valve.regurgitant jet:Qn:US.doppler
C0801541 A18179801 L1491013 S7462124 AUI 18500-9 SOS Thin prep is an automated method of preparing the smear;cells are first treated/lysed to diminish obstructions such as blood, then spread very thinly by the machine. Microscopic observation:Prid:Pt:Cvx:Nom:Cyto stain.thin prep
C0802823 A18820156 L9579882 S12040690 AUI 20008-9 SOS Transcutaneous monitors measure saturation Oxygen^on oxygen.low flow & asleep:PPres:Stdy^max:BldC:Qn:Transcutaneous O2 monitor
C0802826 A18864689 L9586019 S12040695 AUI 20011-3 SOS Transcutaneous monitors measure saturation Oxygen^on oxygen.low flow & awake:PPres:Stdy^min:BldC:Qn:Transcutaneous O2 monitor
C0804441 A18336091 L1476204 S7403800 AUI 21650-7 SOS Some mutations predictive of HIV1 resistance CCR5 gene mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen
C0804832 A18297807 L1487085 S7364917 AUI 22045-9 SOS Text area for information that is given only in coded form elsewhere or for which the abstract provides no other place. Overflow data can also be placed here. Problematic coding issues can also be discussed in this section... NAACCR Data Standards and Data Dictionary Version 11 Remarks recorded:Find:Pt:Cancer.XXX:Nar

LEA

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0551741 A18098805 L1473335 S7435868 AUI 11621-0 LEA Not observed, normal, abnormal &/or more specific code Activity:Find:Pt:Trunk^fetus:Nom:US
C0798654 A18216655 L1468235 S7346184 AUI 15485-6 LEA Titer group 1 Mycoplasma gallisepticum Ab:ACnc:Pt:Ser:Ord:EIA
C0941450 A18298874 L3157173 S7374660 AUI 25277-5 LEA Greater than 4 Streptococcus pneumoniae 8 Ab.IgG^2nd specimen/1st specimen:Ratio:Pt:Ser:Qn
C0945202 A18260060 L3157167 S7374390 AUI 25278-3 LEA Greater than 4 Streptococcus pneumoniae 51 Ab.IgG^2nd specimen/1st specimen:Ratio:Pt:Ser:Qn
C0941456 A18260798 L3157085 S7374018 AUI 25284-1 LEA Greater than 4 Streptococcus pneumoniae 19 Ab.IgG^2nd specimen/1st specimen:Ratio:Pt:Ser:Qn
C0942049 A18183959 L1836184 S7419920 AUI 26019-0 LEA % Creatine kinase.macromolecular.type 1/Creatine kinase.total:CFr:Pt:Ser/Plas:Qn
C0943688 A18262292 L1847353 S7375393 AUI 28026-3 LEA Minimal Standard Terminology (MST);SNOMED;ICD-9 Study observation:Find:Stdy:Rectum+Colon:Nar:Flexible sigmoidoscopy
C0944969 A18340443 L1841041 S7430508 AUI 29529-5 LEA Detect/Nondetect Acetaminophen:ACnc:Pt:XXX:Ord
C0945073 A18301836 L2419939 S7425885 AUI 29652-5 LEA Dothiepin 30 ug/L Dothiepin:MCnc:Pt:Ser/Plas:Qn
C0945074 A18301920 L2419941 S7425887 AUI 29653-3 LEA Dothiepin 500 nmol/L Dothiepin:SCnc:Pt:Ser/Plas:Qn
C0945784 A18263157 L1840283 S7366206 AUI 29668-1 LEA R.australis antibody titre 2 Rickettsia australis Ab:Titr:Pt:Ser:Qn
C0945140 A18301964 L1839474 S7455335 AUI 29735-8 LEA Leptospira Medanensis (MAT) Negative Leptospira interrogans serovar Medanensis Ab:ACnc:Pt:Ser:Ord:Aggl
C1113783 A18108889 L5516447 S7350847 AUI 29856-2 LEA Positive Anaplasma phagocytophilum Ab.IgG:ACnc:Pt:Ser:Ord
C1148143 A18187686 L2420929 S7357566 AUI 32459-0 LEA Cataract Physical findings:Find:Pt:Optic lens:Nom:Observed
C1114064 A18263474 L2270624 S7360127 AUI 30179-6 LEA Titer 8 Powassan virus Ab.IgM:Titr:Pt:XXX:Qn:IF
C1114103 A18224658 L2268527 S7419699 AUI 30223-2 LEA T Coxsackievirus B4 Ab:ACnc:Pt:Ser:Ord
C1114324 A18302456 L6418413 S7351453 AUI 30480-8 LEA Normal Orotate:ACnc:Pt:Urine:Ord
C1114695 A18186797 L2271187 S7416774 AUI 30900-5 LEA Adult cell titre @4celcius: 16 RR <64 Cold agglutinin:Titr:Pt:Ser/Plas:Qn:Aggl.adult RBC
C1114382 A18302489 L2267605 S7359292 AUI 30547-4 LEA Negative;Positive Polio virus 2 Ab:ACnc:Pt:Ser:Ord

LQT

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C2734014 A18200566 L9076937 S11326507 AUI 56079-7 LQT How much did you weigh before your most recent pregnancy? Body weight^pre most recent pregnancy:Mass:Pt:^Patient:Qn
C2926066 A18240209 L9456000 S11747576 AUI 58263-5 LQT If yes: For the above condition have you ever had Angiography (dye in the arteries of the legs)? Ever had angiography for claudication or peripheral arterial disease:Find:Pt:^Patient:Ord
C2926607 A20090096 L10343734 S12897528 AUI 58287-4 LQT Has a doctor ever said you had rheumatic fever (inflammatory rheumatism)? Ever told by doctor that you had rheumatic fever:Find:Pt:^Patient:Nom
C2973026 A18816530 L9581030 S12033093 AUI 61448-7 LQT Each time you eat Mexican foods, how much do you usually eat? Each time you ate mexican foods, how much did you usually eat in the past 30D:Find:Pt:^Patient:Ord:PhenX
C2973104 A20848808 L10830555 S13449719 AUI 61527-8 LQT HOW MANY YEARS did you take Regular One-a-Day type, Centrum® or Thera-type MULTIPLE VITAMINS? How many Y did you take regular one a day type, centrum or thera type multiple vitamins:Time:Pt:^Patient:Qn:PhenX
C2973129 A18883283 L9583366 S12035958 AUI 61552-6 LQT During the past month, how often did you eat a green leafy or lettuce SALAD, with or without other vegetables? How often did you eat a green leafy or lettuce salad, with or without other vegetables in past 30D:Find:Pt:^Patient:Ord:PhenX
C3171831 A19504182 L10079357 S12597368 AUI 63741-3 LQT For whom did {you/SP} work at {your/his/her} main job or business? (what is the name of the company, business, organization or employer?) For whom did you work at you main job or business:Find:Pt:^Patient:Nom:PhenX
C3173940 A19505044 L10097532 S12598395 AUI 64407-0 LQT Has your child ever had an itchy rash that was coming and going for at least 6 months? Has your child ever had an itchy rash that was coming and going for at least 6Mo:Find:Pt:^Patient:Ord:PhenX
C3173056 A19513419 L10082080 S12594514 AUI 63823-9 LQT Did you ever get a blistering sunburn? Did you ever get a blistering sunburn:Find:Pt:^Patient:Ord:PhenX
C3173376 A20086557 L10332017 S12915176 AUI 63977-3 LQT What type of container does your child most often use for beverages? What type of container does your child most often use for beverages:Type:Pt:^Patient:Nom:PhenX
C3173379 A20093817 L10338710 S12915399 AUI 63980-7 LQT Which statement best describes your child's nighttime feedings? Which statement best describes your child's nighttime feedings:Find:Pt:^Patient:Nom:PhenX
C3173407 A20082897 L10332914 S12900993 AUI 63995-5 LQT How many natural teeth do you have? How many natural teeth do you have:Num:Pt:^Patient:Ord:PhenX
C3173673 A20852596 L10810643 S13453454 AUI 64176-1 LQT In the last 3 years, how many such illnesses, with (increased) phlegm, did you have which lasted a week or more? In the last 3 Ys, how many such illnesses, with increased phlegm, did you have which lasted a W or more:NRat:Pt:^Patient:Qn:PhenX
C3173488 A19531269 L10097602 S12598926 AUI 64205-8 LQT Have you ever had treatment for heart trouble in the past 10 years? Have you ever had treatment for heart trouble in the past 10Y:Find:Pt:^Patient:Ord:PhenX
C3173213 A19517827 L10099812 S12592530 AUI 64237-1 LQT Please specify chest operations you had. Chest operations you had:Find:Pt:^Patient:Nom:PhenX
C3173246 A19509102 L10093515 S12590666 AUI 65120-8 LQT Are people important to him/her? Are people important to your child:Find:Pt:^Patient:Ord:PhenX
C3173988 A19509388 L10098466 S12606103 AUI 64442-7 LQT Over the past 3 months, I have had attacks of wheezing: Over the past 3Mo, I have had attacks of wheezing:Find:Pt:^Patient:Ord:PhenX
C3174032 A19518130 L10088882 S12601610 AUI 64464-1 LQT I get embarrassed using my medication in public. I get embarrassed using my medication in public:Find:Pt:^Patient:Ord:PhenX
C3174064 A19505079 L10085856 S12601294 AUI 64480-7 LQT I cannot move far from my bed or chair. I cannot move far from my bed or chair:Find:Pt:^Patient:Ord:PhenX

LMM

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0551215 A18253526 L1036395 S7402190 AUI 12426-3 LMM 523.42 Brodifacoum:MCnc:Pt:Ser/Plas:Qn
C0551220 A18176379 L1036116 S7421223 AUI 12312-5 LMM 42.080 Cyclopropane:MCnc:Pt:Bld:Qn
C0551253 A18137900 L1459733 S10031062 AUI 13006-2 LMM 147.00 1,4-Dichlorobenzene:MCnc:Pt:Ser/Plas:Qn
C0363510 A18331569 L0462523 S7404793 AUI 1374-8 LMM 3425 Calcitonin^3H post 15 mg/kg calcium gluconate IV:MCnc:Pt:Ser/Plas:Qn
C0482513 A18370791 L3157936 S7418816 AUI 1447-2 LMM 362.47 Cortisol^pre 40 ug corticotropin IM 3 day:MCnc:Pt:Ser/Plas:Qn
C0482481 A18370527 L6410158 S7418467 AUI 1394-6 LMM 362.47 Cortisol.free^pre 50 ug corticotropin IM 3 day:MCnc:24H:Urine:Qn
C0482494 A18254562 L1835930 S7418655 AUI 1415-9 LMM 362.47 Cortisol^30M post 1 ug/kg CRH IV:MCnc:Pt:Ser/Plas:Qn
C0363574 A18177647 L1835986 S7418769 AUI 1440-7 LMM 362.47 Cortisol^9H post 1 mg dexamethasone PO overnight:MCnc:Pt:Ser/Plas:Qn
C0482511 A18100505 L3156463 S7418800 AUI 1445-6 LMM 362.47 Cortisol^pre 1 mg dexamethasone PO overnight:MCnc:Pt:Ser/Plas:Qn
C0363604 A18254824 L1836309 S7433597 AUI 1470-4 LMM 33000 Follitropin^1H post 100 ug lutenizing releasing hormone IV:MCnc:Pt:Ser/Plas:Qn
C0363610 A18177801 L1836341 S7433673 AUI 1476-1 LMM 33000 Follitropin^75M post 100 ug lutenizing releasing hormone IV:MCnc:Pt:Ser/Plas:Qn
C0700436 A18216376 L1460503 S7437722 AUI 1544-6 LMM 180.2 Glucose^6H post 100 g glucose PO:MCnc:Pt:Ser/Plas:Qn
C0363677 A18255295 L6410666 S7437724 AUI 1546-1 LMM 180.2 Glucose^6H post 100 g glucose PO:MCnc:Pt:Urine:Qn
C0363688 A18100839 L0527669 S7437847 AUI 1557-8 LMM 180.2 Glucose^post CFst:MCnc:Pt:BldV:Qn
C0363696 A18255409 L1838096 S7450021 AUI 1564-4 LMM 5807.65 Insulin^2H post 75 g glucose PO:MCnc:Pt:Ser/Plas:Qn
C0799902 A18372095 L2419421 S7424756 AUI 16758-5 LMM 221.04 Dicamba:MCnc:Pt:Ser/Plas:Qn
C0800682 A18217923 L2424736 S7369241 AUI 17567-9 LMM 258.23 Sasapyrine:MCnc:Pt:Ser/Plas:Qn
C0363753 A18178815 L0480395 S7364994 AUI 1622-0 LMM 42270 Renin^5H post 600 ug furosemide PO:CCnc:Pt:Plas:Qn
C0799576 A18371935 L1495250 S7368592 AUI 16424-4 LMM 398.39 Salicylazosulfapyridine:MCnc:Pt:Ser:Qn

STATUS_REASON

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0485021 A18098263 L1486924 S7405111 AUI 10559-3 STATUS_REASON Duplicate Calcium:SCnc:Pt:Smpls:Qn
C0485028 A18136721 L0782518 S7413932 AUI 10566-8 STATUS_REASON Duplicate Choriogonadotropin:SCnc:Pt:Smpls:Qn
C1764761 A18213722 L1471127 S7404024 AUI 10440-6 STATUS_REASON Duplicate CD30 Ag:ACnc:Pt:Tiss:Ord:Immune stain
C2713229 A18291790 L1493225 S7357542 AUI 11439-7 STATUS_REASON Duplicate Physical findings:Find:Pt:Mouth & Throat & Teeth:Nom:Observed
C2607952 A18136905 L2268459 S7367458 AUI 10962-9 STATUS_REASON Duplicate Artemisia tridentata Ab.IgE:ACnc:Pt:Ser:Qn
C0550962 A20855321 L1471184 S7420615 AUI 11472-8 STATUS_REASON Erroneous Cryptococcus neoformans Ag:ACnc:Pt:XXX:Ord
C0551723 A20858906 L6885657 S8029905 AUI 11538-6 STATUS_REASON Duplicate Study.total:Find:Pt:Chest:Doc:CT
C0551801 A18136705 L1486191 S7399504 AUI 11682-2 STATUS_REASON Duplicate Blood flow.mean:Vel:Pt:Heart.ventricle.right.outflow tract:Qn:US.doppler
C0550548 A18253429 L6887551 S8045590 AUI 12264-8 STATUS_REASON Duplicate Epstein Barr virus early restricted Ab:MCnc:Pt:Body fld:Qn
C0482406 A18253709 L1470935 S7350337 AUI 1274-0 STATUS_REASON Duplicate O NOS Ag:ACnc:Pt:RBC^BPU:Ord:Aggl RBC
C0551364 A18370015 L1840115 S7376102 AUI 13098-9 STATUS_REASON Erroneous Sulfatide Ab.IgG:ACnc:Pt:Ser:OrdQn
C2718226 A18370052 L1836831 S7374024 AUI 13165-6 STATUS_REASON Duplicate Streptococcus pneumoniae 19 Ab:ACnc:Pt:Ser:Qn
C2718196 A18293699 L6421988 S7356824 AUI 14880-9 STATUS_REASON Duplicate Phosphate:SCnc:Pt:Urine:Qn
C0549873 A18138318 L1729758 S7410237 AUI 13492-4 STATUS_REASON Duplicate Cells.CD4+HLA-DR+:NFr:Pt:Bld:Qn
C0549876 A18331474 L1729748 S7410718 AUI 13493-2 STATUS_REASON Duplicate Cells.CD8+CD25+:NFr:Pt:Bld:Qn
C2718150 A18331522 L1471624 S7448191 AUI 13630-9 STATUS_REASON Duplicate Immune complex:ACnc:Pt:Ser/Plas:Qn:Conglutinin assay
C0797320 A18177275 L0575839 S8050241 AUI 14134-1 STATUS_REASON Duplicate Hemoglobin.free:MCnc:Pt:Ser:Qn
C0798540 A18139412 L6421624 S7463219 AUI 15371-8 STATUS_REASON Erroneous Morphine:MCnc:Pt:Meconium:Ord
C2713217 A18138795 L6420274 S7418135 AUI 14289-3 STATUS_REASON Duplicate Coproporphyrin:ACnc:24H:Urine:Ord

LMP

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0482254 A18175437 L1471375 S7447602 AUI 1057-9 LMP 14985-6 I (int) subtype:ACnc:Pt:RBC^patient:Ord:Aggl RBC
C1764823 A18175568 L1486332 S7462293 AUI 10816-7 LMP 6678-7 Microscopic observation:Prid:Pt:Tiss:Nom:Toluidine blue O stain
C0551720 A20862728 L6910517 S8029907 AUI 11528-7 LMP 18748-4 Study.total:Find:Pt:XXX:Doc:Radiology.XXX
C0551640 A18291792 L1491803 S7365724 AUI 11456-1 LMP 8687-6 Review of symptoms and diseases:Find:Pt:^Patient:Nom:Reported
C0482350 A18330398 L1462288 S7395277 AUI 1182-5 LMP 14990-6 little i -2 Ag:ACnc:Pt:RBC^donor:Ord:Aggl RBC
C0550992 A18253436 L6413815 S7429698 AUI 12276-2 LMP 10851-4 Escherichia coli O157:H7:ACnc:Pt:Stool:Ord:Organism specific culture
C0550654 A18176430 L1037524 S7423944 AUI 12385-1 LMP 3862-0 Desmethyldoxepin:MCnc:Pt:Ser/Plas:Qn
C1764779 A18137740 L6413520 S7420037 AUI 12571-6 LMP 12190-5 Creatinine:MCnc:Pt:Body fld:Qn
C2718244 A18215345 L1837413 S7374138 AUI 13166-4 LMP 13138-3 Streptococcus pneumoniae 23 Ab:ACnc:Pt:Ser:Qn
C1764785 A18292828 L6417149 S7428215 AUI 13353-8 LMP 12209-3 Eosinophils/100 leukocytes:NFr:Pt:Body fld:Qn:Manual count
C0549869 A18254192 L1729745 S7410127 AUI 13491-6 LMP 13332-2 Cells.CD4+CD25+:NFr:Pt:Bld:Qn
C0796881 A18138401 L6409161 S7384670 AUI 13690-3 LMP 3124-5 Vanillylmandelate/Creatinine:MCrto:Pt:Urine:Qn
C2713141 A18177483 L0464608 S7418580 AUI 1405-0 LMP 1404-3 Cortisol^1H post dose U/kg insulin IV:MCnc:Pt:Plas:Qn
C2718216 A18254540 L1473584 S7361853 AUI 14120-0 LMP 12841-3 Prostate specific Ag.free/Prostate specific Ag.total:MFr:Pt:Ser/Plas:Qn
C2713103 A18139247 L6418822 S7367160 AUI 15116-7 LMP 15115-9 Arsenic:SCnc:Pt:Urine:Qn
C0363642 A18255083 L0464602 S7437141 AUI 1508-1 LMP 1507-3 Glucose^1H post 75 g glucose PO:MCnc:Pt:Ser:Qn
C2718183 A18333419 L1472963 S7349282 AUI 16743-7 LMP 13572-3 Nordiazepam:ACnc:Pt:Ser/Plas:Ord
C2718159 A18372264 L1485763 S7456069 AUI 17077-9 LMP 16965-6 Lindane:MCnc:Pt:Bld:Qn
C2713158 A18140705 L1459709 S7373818 AUI 17613-1 LMP 13140-9 Streptococcus pneumoniae 1 Ab^2nd specimen:ACnc:Pt:Ser:Qn

LCD

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0549853 A18369520 L6420573 S7428640 AUI 12248-1 LCD Y Epithelial cells.renal:ACnc:Pt:Urine sed:Ord:Microscopy.light
C0551085 A18099150 L6418130 S7462306 AUI 12235-8 LCD Y Microscopic observation:Prid:Pt:Urine sed:Nom:Microscopy.light
C0549977 A18099363 L1461949 S7437143 AUI 12646-6 LCD Y Glucose^1H post XXX challenge:MCnc:Pt:Ser/Plas:Qn
C0797848 A18293577 L1490323 S7418299 AUI 14674-6 LCD Y Corticotropin:SCnc:Pt:Plas:Qn
C0796820 A18292975 L1460275 S7450287 AUI 13629-1 LCD Y Interleukin 1 beta:MCnc:Pt:Ser/Plas:Qn
C0796849 A18138392 L6402361 S7383870 AUI 13658-0 LCD Y Urobilinogen:ACnc:Pt:Urine:Ord
C0797155 A18293239 L6405346 S7370259 AUI 13967-5 LCD Y Sex hormone binding globulin:SCnc:Pt:Ser/Plas:Qn
C0797166 A18215839 L1460058 S7453123 AUI 13978-2 LCD Y Alpha 1 globulin/Protein.total:MFr:Pt:Ser/Plas:Qn:Electrophoresis
C0797178 A18138641 L6414386 S7453143 AUI 13990-7 LCD Y Alpha 1 globulin/Protein.total:MFr:Pt:Urine:Qn:Electrophoresis
C0797183 A18370556 L6403795 S7435146 AUI 13995-6 LCD Y Gamma globulin/Protein.total:MFr:Pt:Urine:Qn:Electrophoresis
C0797471 A18177599 L6413796 S7429410 AUI 14290-1 LCD Y Erythrocytes:ACnc:Pt:Urine sed:Qn:Manual count
C0797762 A18215425 L1842279 S7448661 AUI 14586-2 LCD Y Aldosterone:SCnc:Pt:Ser/Plas:Qn
C0797893 A18100621 L1849306 S7430227 AUI 14719-9 LCD Y Ethanol:SCnc:Pt:Ser/Plas:Qn
C0798040 A18371034 L2423583 S7354313 AUI 14866-8 LCD Y Parathyrin.intact:SCnc:Pt:Ser/Plas:Qn
C0798101 A18332265 L1850373 S7381602 AUI 14928-6 LCD Y Triiodothyronine.free:SCnc:Pt:Ser/Plas:Qn
C0798111 A18216307 L6402349 S7383614 AUI 14938-5 LCD Y Urea nitrogen:SCnc:Pt:Urine:Qn
C0798184 A18371100 L1474735 S7449148 AUI 15011-0 LCD Y Aldosterone^supine:SCnc:Pt:Ser/Plas:Qn
C0482544 A18178008 L0779743 S7437848 AUI 1558-6 LCD Y Glucose^post CFst:MCnc:Pt:Ser/Plas:Qn
C0799525 A18294638 L1475633 S7463614 AUI 16362-6 LCD Y Ammonia:SCnc:Pt:Plas:Qn

MTH_LSU

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C1952938 A18273065 L6697623 S7792896 AUI 47700-0 MTH_LSU ![MICRO SIGN]!mol/L Methionine:SCnc:Pt:Bld.dot:Qn
C1953528 A18234558 L6694688 S11747312 AUI 48139-0 MTH_LSU ![MICRO SIGN]!mol/mmol de creatinine Erythro-4,5-Dihydroxyhexanoate/Creatinine:SCrto:Pt:Urine:Qn
C1952748 A18195872 L6697356 S11748514 AUI 47542-6 MTH_LSU ![MICRO SIGN]!mol/mmol de creatinine Gamma hydroxybutyrate/Creatinine:SCrto:Pt:Urine:Qn
C1952934 A18389115 L6695077 S11752624 AUI 47697-8 MTH_LSU ![MICRO SIGN]!mol/mmol de creatinine Mandelate/Creatinine:SCrto:Pt:Urine:Qn
C1952948 A18234319 L6700174 S11752899 AUI 47708-3 MTH_LSU mmol/mmol d'uree Methylmalonate/Urea:SCrto:Pt:Ser/Plas:Qn
C1953083 A18311866 L6700257 S11754900 AUI 47779-4 MTH_LSU ![MICRO SIGN]!mol/mmol de creatinine Octadecanoate/Creatinine:SCrto:Pt:Urine:Qn
C1953086 A18118612 L6694177 S7797143 AUI 47781-0 MTH_LSU ![MICRO SIGN]!mol/L Sulfocysteine:SCnc:Pt:Amnio fld:Qn
C1953120 A18350589 L6698182 S11739368 AUI 47809-9 MTH_LSU ![MICRO SIGN]!mol/mmol de creatinine 2-Hydroxysebacate/Creatinine:SCrto:Pt:Urine:Qn
C1953122 A18196047 L6699483 S10024989 AUI 47810-7 MTH_LSU ![MICRO SIGN]!mol/L 2-Methyl,3-Hydroxyvalerate:SCnc:Pt:Plas:Qn
C1953125 A18196050 L6700761 S11739397 AUI 47812-3 MTH_LSU ![MICRO SIGN]!mol/mmol de creatinine 2-Methylglutaconate/Creatinine:SCrto:Pt:Urine:Qn
C1953141 A18118629 L6697003 S10026357 AUI 47820-6 MTH_LSU ![MICRO SIGN]!mol/L 3-Hydroxyvalerate:SCnc:Pt:Plas:Qn
C1953144 A18196056 L6693156 S11739568 AUI 47822-2 MTH_LSU ![MICRO SIGN]!mol/mmol de creatinine 3-Methyladipate/Creatinine:SCrto:Pt:Urine:Qn
C1953148 A18273146 L6693215 S11739648 AUI 47824-8 MTH_LSU ![MICRO SIGN]!mol/mmol de creatinine 5-Hydroxycaproate/Creatinine:SCrto:Pt:Urine:Qn
C1953157 A18350604 L6696641 S7795929 AUI 47830-5 MTH_LSU nmol/min/mg de proteines Argininosuccinate synthase:CCnt:Pt:CVS:Qn
C1952646 A18117948 L6698308 S7801219 AUI 47839-6 MTH_LSU nmol/min/mg de proteines Carnitine acyltransferase II:CCnt:Pt:WBC:Qn
C1953166 A18196064 L6695904 S7802119 AUI 47846-1 MTH_LSU ![MICRO SIGN]!g/dL Cortisol^post 2 mg dexamethasone PO 2.5 day high dose q6h:MCnc:Pt:Ser/Plas:Qn
C1953171 A18311897 L6698404 S7802127 AUI 47851-1 MTH_LSU ![MICRO SIGN]!g/dL Cortisol^post dose dexamethasone:MCnc:Pt:Ser/Plas:Qn
C1953195 A18157457 L6696556 S7795052 AUI 47873-5 MTH_LSU nmol/min/mg de proteines Propionyl CO-A carboxylase:CCnt:Pt:Amnio fld cells:Qn
C1978081 A18197420 L6889674 S10021331 AUI 50246-8 MTH_LSU ![MICRO SIGN]!g/24h 17-Hydroxycorticosteroids^2D post high dose dexamethasone:MRat:24H:Urine:Qn

STATUS_TEXT

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0550047 A18369747 L1461723 S7457160 AUI 12674-8 STATUS_TEXT All lutropin sources that we could reach report concentrations in international units (IU) per volume. The drug lutropin is prescribed in terms of international units per volume. Avoid mapping to this term. If you find counter examples please send us the package insert and/or a contact point for a laboratory director who is reporting mass or molar units. Lutropin^15M pre XXX challenge:SCnc:Pt:Ser/Plas:Qn
C0550048 A18330978 L1462840 S7457182 AUI 12675-5 STATUS_TEXT All lutropin sources that we could reach report concentrations in international units (IU) per volume. The drug lutropin is prescribed in terms of international units per volume. Avoid mapping to this term. If you find counter examples please send us the package insert and/or a contact point for a laboratory director who is reporting mass or molar units. Lutropin^20M post XXX challenge:SCnc:Pt:Ser/Plas:Qn
C0550057 A18292402 L1465767 S7457261 AUI 12683-9 STATUS_TEXT All lutropin sources that we could reach report concentrations in international units (IU) per volume. The drug lutropin is prescribed in terms of international units per volume. Avoid mapping to this term. If you find counter examples please send us the package insert and/or a contact point for a laboratory director who is reporting mass or molar units. Lutropin^8th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn
C0550815 A18292460 L1495163 S7381716 AUI 12800-9 STATUS_TEXT Scale and property discrepency. Trimeprazine:MCnc:Pt:Ser/Plas:Ord
C0482419 A18369939 L2403017 S7353067 AUI 1293-0 STATUS_TEXT Test reported non-existent P2 Ab:ACnc:Pt:Ser/Plas^donor:Ord:Aggl RBC
C0551312 A18138087 L1839549 S7346561 AUI 13096-3 STATUS_TEXT Invalid scale Myelin associated glycoprotein Ab.IgM:ACnc:Pt:Ser:OrdQn
C0551367 A18215311 L1840010 S7378186 AUI 13105-2 STATUS_TEXT Invalid scale Tetrasialylganglioside GQ1b Ab.IgG:ACnc:Pt:Ser:OrdQn
C0551277 A18099722 L1839620 S7398300 AUI 13110-2 STATUS_TEXT Invalid scale Beta tubulin Ab.IgM:ACnc:Pt:Ser:OrdQn
C1704287 A18370018 L1467059 S7346559 AUI 13113-6 STATUS_TEXT Invalid scale Myelin associated glycoprotein Ab.IgM:ACnc:Pt:Ser/Plas:OrdQn
C0551317 A18370019 L1837088 S7348301 AUI 13114-4 STATUS_TEXT Invalid scale Neuronal nuclear type 2 Ab:ACnc:Pt:Ser:OrdQn
C0551316 A18292683 L1836009 S7348278 AUI 13115-1 STATUS_TEXT Invalid scale Neuronal nuclear type 1 Ab:ACnc:Pt:Ser:OrdQn
C1704284 A18098993 L1463978 S10021972 AUI 13124-3 STATUS_TEXT Invalid scale Sulfate-3-Glucuronyl paragloboside Ab:ACnc:Pt:Ser/Plas:OrdQn
C0798300 A18370406 L1491083 S7432162 AUI 15129-0 STATUS_TEXT This test is reported in mg FEU and mg DDU- with DVT decision thresholds that differ by a factor of 2.. It is very important to report the results more specifically to one of the map to options.. Fibrin D-dimer:MCnc:Pt:PPP:Qn:EIA
C0798318 A20858955 L6407111 S7431389 AUI 15147-2 STATUS_TEXT Property of ARat must have scale = Qn Acetone:ARat:24H:Urine:Ord
C0798534 A18101061 L6406657 S7416617 AUI 15365-0 STATUS_TEXT Property & scale do not match Codeine:MCnc:Pt:Meconium:Ord
C0363724 A18178620 L1836892 S7457165 AUI 1592-5 STATUS_TEXT All lutropin sources that we could reach report concentrations in international units (IU) per volume. The drug lutropin is prescribed in terms of international units per volume. Avoid mapping to this term. If you find counter examples please send us the package insert and/or a contact point for a laboratory director who is reporting mass or molar units. Lutropin^1H post dose gonadotropin releasing hormone:MCnc:Pt:Ser/Plas:Qn
C0482562 A18371735 L3166800 S7457274 AUI 1600-6 STATUS_TEXT All lutropin sources that we could reach report concentrations in international units (IU) per volume. The drug lutropin is prescribed in terms of international units per volume. Avoid mapping to this term. If you find counter examples please send us the package insert and/or a contact point for a laboratory director who is reporting mass or molar units. Lutropin^pre dose gonadotropin releasing hormone:MCnc:Pt:Ser/Plas:Qn
C0799451 A18178837 L1840199 S7376121 AUI 16287-5 STATUS_TEXT Invalid scale Sulfatide Ab:ACnc:Pt:Ser:OrdQn
C0799453 A18255853 L1840003 S7463093 AUI 16289-1 STATUS_TEXT Invalid scale Monosialoganglioside GM1 Ab:ACnc:Pt:Ser:OrdQn

CHANGE_REASON_PUBLIC

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0549835 A20874034 L10811091 S13457013 AUI 11104-7 CHANGE_REASON_PUBLIC Changed method from "Microscopic" to make term consistent with other hematology differential terms. Test is still performed by microscopic observation. Normoblasts.basophilic/100 cells:NFr:Pt:Bone mar:Qn:Manual count
C0549791 A20866517 L10817959 S13442268 AUI 11105-4 CHANGE_REASON_PUBLIC Changed method from "Microscopic" to make term consistent with other hematology differential terms. Test is still performed by microscopic observation. Basophils/100 cells:NFr:Pt:Bone mar:Qn:Manual count
C0549817 A20862715 L10813721 S13454987 AUI 11108-8 CHANGE_REASON_PUBLIC Changed method from "Microscopic" to make term consistent with other hematology differential terms. Test is still performed by microscopic observation. Lymphocytes/100 cells:NFr:Pt:Bone mar:Qn:Manual count
C0549821 A20847797 L10810899 S13455437 AUI 11110-4 CHANGE_REASON_PUBLIC Changed method from "Microscopic" to make term consistent with other hematology differential terms. Test is still performed by microscopic observation. Megakaryocytes/100 cells:NFr:Pt:Bone mar:Qn:Manual count
C0549827 A20847798 L10825461 S13456589 AUI 11113-8 CHANGE_REASON_PUBLIC Changed method from "Microscopic" to make term consistent with other hematology differential terms. Test is still performed by microscopic observation. Myeloblasts/100 cells:NFr:Pt:Bone mar:Qn:Manual count
C0549849 A20866522 L10811341 S13459301 AUI 11121-1 CHANGE_REASON_PUBLIC Changed method from "Microscopic" to make term consistent with other hematology differential terms. Test is still performed by microscopic observation. Prolymphocytes/100 cells:NFr:Pt:Bone mar:Qn:Manual count
C0551559 A18098748 L3165821 S7417843 AUI 11488-4 CHANGE_REASON_PUBLIC Changed class from ATTACH.CLINRPT to DOC.CLINRPT. Edit made because this term is conformant to the Document Ontology axis values and therefore are being placed in this class. Consultation note:Find:Pt:{Setting}:Doc:{Provider}
C0551637 A20870357 L10811337 S13459263 AUI 11510-5 CHANGE_REASON_PUBLIC Based on Clinical LOINC Committee approval on 8/16/2011, the Component was changed from Subsequent evaluation note to Progress note. The term "Subsequent evaluation" seems to be used infrequently and is more commonly referred to as a Progress note. Also changed class from ATTACH.CLINRPT to DOC.CLINRPT since this term is conformant to the Document Ontology axis values and therefore being placed in this class. Progress note:Find:Pt:{Setting}:Doc:Psychology
C0550515 A20858940 L10812911 S13448230 AUI 12284-6 CHANGE_REASON_PUBLIC Component was changed from Somatotropin releasing hormone to reflect correct nomenclature Growth hormone-releasing hormone:ACnc:Pt:Ser/Plas:Qn
C0797662 A20855363 L10822556 S13456566 AUI 14486-5 CHANGE_REASON_PUBLIC Component changed from "Mycoplasma sp+Ureaplasma sp", property from "ACnc" and scale from "Ord" based on the fact that the two can be distinguished by culture. Mycoplasma sp & Ureaplasma sp:Prid:Pt:Penis:Nom:Organism specific culture
C0801778 A20081895 L4853921 S7375739 AUI 18764-1 CHANGE_REASON_PUBLIC Deprecated term based on Clinical LOINC Committee approval on 8/16/2011. Term is a duplicate of 28575-9. Subsequent evaluation note:Find:Pt:{Setting}:Doc:Nurse practitioner
C0800560 A20874077 L6411811 S13458605 AUI 17441-7 CHANGE_REASON_PUBLIC Changed component name from "Phenothiazine" (singular) to "Phenothiazines" (pleural) to better reflect its long term intended meaning and current conventions. . Phenothiazine is a distinct chemical but has never been used in human medicine. (It was used for parasitic diseases in animals decades ago but not now). The word phenothiazine has always been used to mean the class of drugs that are derived from phenothiazine and laboratories that use phenothiazine and phenothiazines to mean the measure of any drug of phenothiazine class contained in the specimen. Phenothiazines:ACnc:Pt:Urine:Qn
C0800931 A18809015 L9580834 S12031269 AUI 17824-4 CHANGE_REASON_PUBLIC In order to confirm CD8 T-cells, CD3 is required to identify the fact these are T-cells. Cells.CD3+CD8+/100 cells:NFr:Pt:Body fld:Qn
C0802384 A18820198 L9579736 S12039442 AUI 19503-2 CHANGE_REASON_PUBLIC Changed component from Levomepromazine to to Methotrimeprazine to reflect the current International Nonproprietary Name (INN) which is also listed as the USAN and the BAN name at the present. There may be some countries that still use Levomeprazine which we made a synonym. Methotrimeprazine:ACnc:Pt:Urine:Ord:Confirm
C0802386 A18831399 L9577709 S12039436 AUI 19505-7 CHANGE_REASON_PUBLIC Changed component from Levomepromazine to to Methotrimeprazine to reflect the current International Nonproprietary Name (INN) which is also listed as the USAN and the BAN name at the present. There may be some countries that still use Levomeprazine which we made a synonymn. Methotrimeprazine cutoff:MCnc:Pt:Urine:Qn:Confirm
C0802532 A20858977 L6401636 S13458595 AUI 19672-5 CHANGE_REASON_PUBLIC Changed component name from "Phenothiazine" (singular) to "Phenothiazines" (pleural) to better reflect its long term intended meaning and current conventions. . Phenothiazine is a distinct chemical but has never been used in human medicine. (It was used for parasitic diseases in animals decades ago but not now). The word phenothiazine has always been used to mean the class of drugs that are derived from phenothiazine and laboratories that use phenothiazine and phenothiazines to mean the measure of any drug of phenothiazine class contained in the specimen. Phenothiazines cutoff:MCnc:Pt:Urine:Qn:Screen
C0804225 A20859009 L10828541 S13457388 AUI 21431-2 CHANGE_REASON_PUBLIC Property changed from ACnc to reflect the fact that interpretation is based on a cut-off value (threshold) Opiates:Threshold:Pt:Urine:Ord:Screen>2000 ng/mL
C0804503 A20851604 L10819489 S13455096 AUI 21713-3 CHANGE_REASON_PUBLIC Changed Component part from c.A8344G to m.8344A>G since variant is located on a mitochondrial sequence and to harmonize with HGVS nomenclature guidelines. MT-TK gene.m.8344A>G:Arb:Pt:Bld/Tiss:Ord:Molgen
C0804564 A20866618 L10826900 S13443656 AUI 21775-2 CHANGE_REASON_PUBLIC Updated Component part to harmonize with ISCN guidelines and current LOINC nomenclature. Changed gene name FKHR to FOXO1, the recommended gene name by the HUGO Gene Nomenclature Committee (HGNC). Cells.t(1;13)(p36.13;q14.1)(PAX7,FOXO1)/Cells.total:NFr:Pt:Bld/Tiss:Qn:Molgen

LNC

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0804828 A18181981 L1487026 S7411738 AUI 22041-8 LNC 2640 Chemotherapy Rx:Find:Pt:Cancer.XXX:Nar
C0804622 A18297687 L1474987 S7416674 AUI 21834-7 LNC 140 Coding system:Type:Pt:Census tract at cancer XXX Dx.alternate:Nom
C0804623 A18336210 L1488635 S7416656 AUI 21835-4 LNC 170 Coding system.current:Type:Pt:Race:Nom
C0804629 A18181883 L1473970 S7442976 AUI 21841-2 LNC 230 Age at cancer Dx:Num:Pt:Cancer.XXX:Qn
C0804630 A18220190 L1485519 S7398947 AUI 21842-0 LNC 250 Birthplace:ID:Pt:^Patient:Nom
C0804637 A18258894 L3165516 S7416675 AUI 21849-5 LNC 330 Coding system:Type:Pt:Occupation & Industry Hx:Nom
C0804641 A18104656 L1481843 S7369893 AUI 21853-7 LNC 380 Sequence number central.patient:Arb:Pt:Cancer.XXX:Ord
C0804644 A18258901 L2399573 S7445247 AUI 21856-0 LNC 420 Histology ICD-O-2:Prid:Pt:Cancer.XXX:Nom
C0804645 A18143093 L2399554 S7397441 AUI 21857-8 LNC 430 Behavior ICD-O-2:Prid:Pt:Cancer.XXX:Nom
C0804650 A18258114 L1470169 S7371916 AUI 21862-8 LNC 500 Source of document used to abstract:Type:Pt:Cancer.XXX:Nom
C0804653 A18103904 L1487100 S7446347 AUI 21865-1 LNC 540 Hospital.reporting:ID:Pt:Cancer.XXX:Nom
C0804668 A18297708 L8583023 S10646050 AUI 21880-0 LNC 690 Radiation Rx therapy:Type:Pt:Cancer.XXX:Nom
C0804681 A18220214 L1487109 S7364801 AUI 21893-3 LNC 820 Regional lymph nodes positive:Num:Pt:Cancer.XXX:Qn
C0804686 A18374985 L1488639 S7385338 AUI 21898-2 LNC 870 Version used:Type:Pt:Extent of disease coding system:Nom
C0804688 A18258917 L1487040 S7364812 AUI 21900-6 LNC 890 Regional lymph nodes.pathology:Class:Pt:Cancer.XXX:Nom
C0804690 A18104676 L1487038 S7373317 AUI 21902-2 LNC 910 Stage group.pathology:Class:Pt:Cancer.XXX:Nom
C0804694 A18104677 L1487033 S7364805 AUI 21906-3 LNC 950 Regional lymph nodes.clinical:Class:Pt:Cancer.XXX:Nom
C0804697 A18258922 L1487042 S7423904 AUI 21909-7 LNC 980 Descriptor.clinical:Find:Pt:Cancer.XXX:Nar
C0804701 A18220225 L1487035 S7425588 AUI 21913-9 LNC 1020 Distant metastases.other:Class:Pt:Cancer.XXX:Nom

LFO

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0552115 A18253290 L9092611 S11342123 AUI 11998-2 LFO Pulsatility index = (blood flow.systolic.max - blood flow.diastolic.min) / blood flow.mean Pulsatility index:VelRto:Pt:Cerebral artery anterior:Qn:US.doppler
C0552118 A18098855 L9081507 S11342127 AUI 12001-4 LFO Pulsatility index = (blood flow.systolic.max - blood flow.diastolic.min) / blood flow.mean Pulsatility index:VelRto:Pt:Ovarian artery.left:Qn:US.doppler
C0551852 A18291923 L8891398 S11022130 AUI 11733-3 LFO log 10 (BODY WEIGHT [g]) = 1.6758 + 0.01707 * (abdominal circumference [cm]) + 0.042478 * (biparietal diameter [cm]) + 0.05216 * (femur length [cm]) + 0.01604 * (head circumference [cm]) Body weight:Mass:Pt:^Fetus:Qn:US.estimated from AC&BPD&FL&HC.Roberts 1985
C0551854 A18137343 L8868779 S11022132 AUI 11735-8 LFO log 10 (BODY WEIGHT [g]) = 1.335 + 0.0316 * (biparietal diameter [cm]) + 0.0457 * (abdominal circumference [cm]) + 0.1623 * (femur length [cm]) - 0.0034 * (abdominal circumference [cm]) * (femur length [cm]) Body weight:Mass:Pt:^Fetus:Qn:US.estimated from AC&BPD&FL.Hadlock 1985
C0551856 A18098532 L8868780 S11022134 AUI 11737-4 LFO log 10 (BODY WEIGHT [g]) = - 2.84421 + 1.85628 * log 10 (biparietal diameter [mm]) + 1.34008 * log 10 (abdominal diameter [mm]) Body weight:Mass:Pt:^Fetus:Qn:US.estimated from AC&BPD.Eik-Nes 1982
C0551868 A18253126 L8868782 S11022144 AUI 11749-9 LFO log 10 (BODY WEIGHT [g]) = 1.6961 + 0.02253 * (head circumference [cm]) + 0.01645 * (abdominal circumference [cm]) + 0.06439 * (femur length [cm]) Body weight:Mass:Pt:^Fetus:Qn:US.estimated from AC&FL&HC.Weiner 1985
C0551869 A18291931 L8887612 S11022145 AUI 11750-7 LFO log 10 (BODY WEIGHT [g]) = 1.3598 + 0.051 * (abdominal circumference [cm]) + 0.1844 * (femur length [cm]) - 0.0037 * (abdominal circumference [cm]) * (femur length [cm]) Body weight:Mass:Pt:^Fetus:Qn:US.estimated from AC&FL.Hadlock 1984
C0551873 A18253129 L8883800 S11022148 AUI 11754-9 LFO log 10 (BODY WEIGHT [g]) = 1.182 + 0.0273 * (head circumference [cm]) + 0.07057 * (abdominal circumference [cm]) - 0.00063 * (abdominal circumference [cm]) ^ 2 - 0.0002184 * (head circumference [cm]) * (abdominal circumference [cm]) Body weight:Mass:Pt:^Fetus:Qn:US.estimated from AC&HC.Hadlock 1984
C0552008 A18369347 L8892552 S11031851 AUI 11891-9 LFO GESTATIONAL AGE [wk] = 7.607 + 0.7645 * (abdominal circumference [cm]) + 0.00393 * (abdominal circumference [cm]) ^ 2 Gestational age:Time:Pt:^Fetus:Qn:US.estimated from AC.Hadlock 1982
C0552256 A18214752 L9087314 S11343937 AUI 12142-6 LFO SD ratio = blood flow.systolic.max / blood flow.diastolic.min Systolic flow/Diastolic flow:VelRto:Pt:Uterine artery.left:Qn:US.doppler
C0552257 A18214753 L9092811 S11343938 AUI 12143-4 LFO SD ratio = blood flow.systolic.max / blood flow.diastolic.min Systolic flow/Diastolic flow:VelRto:Pt:Uterine artery.right:Qn:US.doppler
C0552246 A18099110 L9095518 S11343939 AUI 12144-2 LFO SD ratio = blood flow.systolic.max / blood flow.diastolic.min Systolic flow/Diastolic flow:VelRto:Pt:^Patient:Qn:US.doppler
C0551890 A18214311 L1031663 S7400135 AUI 11771-3 LFO Lookup table Body weight.25th:Prctl:Pt:^Population distribution:Qn:Estimated.pop birth wgt gestational age corr.ref
C0551891 A18176074 L1032094 S7400139 AUI 11772-1 LFO Lookup table Body weight.50th:Prctl:Pt:^Population distribution:Qn:Estimated.pop birth wgt gestational age corr.ref
C0551892 A18137355 L1032296 S7400142 AUI 11773-9 LFO Lookup table Body weight.75th:Prctl:Pt:^Population distribution:Qn:Estimated.pop birth wgt gestational age corr.ref
C0551961 A18136575 L1033306 S7424415 AUI 11844-8 LFO liver length (mm) = 6.32 + 1.34 * abdominal circumference (cm) Diameter.long.mean:Len:Pt:Liver^fetus:Qn:Estimated from abdominal circumference
C0551966 A18176113 L1033260 S7424449 AUI 11849-7 LFO ABDOMINAL DIAMETER [mm] = -29.525 + 0.6043653 * (gestational age [days]) - 0.000418794 * (gestational age [days]) ^ 2 + 0.000000214518 * (gestational age [days]) ^ 3 Diameter.mean:Len:Pt:Abdomen^fetus:Qn:Estimated from gestational age
C0552019 A18369354 L8896449 S11031867 AUI 11902-4 LFO GESTATIONAL AGE [wk] = 9.54 + 1.482 * (biparietal diameter [cm]) + 0.1676 * (biparietal diameter [cm]) ^ 2 Gestational age:Time:Pt:^Fetus:Qn:US.estimated from BPD.Hadlock 1984
C0552020 A18292017 L8869950 S11031868 AUI 11903-2 LFO Lookup table Gestational age:Time:Pt:^Fetus:Qn:US.estimated from BPD.Hansmann 1985

LSP

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0798602 A18371355 L1466771 S7350534 AUI 15433-6 LSP MA Anaplasma marginale Ab:ACnc:Pt:Ser:Ord:Aggl
C0798605 A18332620 L1467072 S7379424 AUI 15436-9 LSP CH;TU Avian encephalomyelitis virus Ab:ACnc:Pt:Ser:Ord:EIA
C0798610 A18101099 L2401312 S7448655 AUI 15441-9 LSP CH Infectious bronchitis virus Conn-42 Ab:Titr:Pt:Ser:Qn:HAI
C0798613 A18139443 L6068481 S7448780 AUI 15444-3 LSP AV Influenza virus A Ab:ACnc:Pt:Ser:Ord:Immune diffusion
C0798615 A18255047 L4851942 S7379954 AUI 15446-8 LSP CH Avian leukosis virus Ag:Titr:Pt:Eggylk:Qn:EIA
C0798618 A18255049 L1462228 S7380507 AUI 15449-2 LSP AV Avian paramyxovirus 2 Ab:Titr:Pt:Ser:Qn:HAI
C0798620 A18332630 L4851418 S7381302 AUI 15451-8 LSP AV Avian pox virus Ab:ACnc:Pt:Ser:Ord:Immune diffusion
C0798621 A18139446 L4851419 S7381508 AUI 15452-6 LSP AV Avian reovirus Ab:ACnc:Pt:Ser:Ord:Immune diffusion
C0798623 A18178281 L1724824 S7365633 AUI 15454-2 LSP CH;TU Reticuloendotheliosis virus Ab:ACnc:Pt:Ser:Ord:EIA
C0798624 A18216631 L4851429 S7399897 AUI 15455-9 LSP MA Bluetongue virus Ab:ACnc:Pt:Ser:Ord:Immune diffusion
C0798626 A18178283 L1468608 S7400514 AUI 15457-5 LSP AV Bordetella avium Ab:Titr:Pt:Ser:Qn:Aggl
C0798628 A18101106 L1459871 S7401610 AUI 15459-1 LSP MA Bovine herpesvirus 1 Ab:Titr:Pt:Ser:Qn:Neut
C0798630 A18371366 L4851430 S7401689 AUI 15461-7 LSP BO Bovine leukemia virus Ab:ACnc:Pt:Ser:Ord:Immune diffusion
C0798636 A18139450 L1459881 S7429058 AUI 15467-4 LSP MA Equine herpesvirus 1 Ab:Titr:Pt:Ser:Qn:Neut
C0798639 A18101111 L1466584 S7429185 AUI 15470-8 LSP MA Equine influenza virus A2 Ab:ACnc:Pt:Ser:Ord
C0798640 A18178296 L1466586 S7429188 AUI 15471-6 LSP MA Equine influenza virus A2 Ab:Titr:Pt:Ser:Qn:HAI
C0798642 A18216641 L1468694 S7429018 AUI 15473-2 LSP EQ Equine arteritis virus Ab:Titr:Pt:Ser:Qn:Neut
C0798649 A18216648 L1725045 S7455307 AUI 15480-7 LSP MA Leptospira interrogans serovar Icterohaemorrhagiae Ab:Titr:Pt:Ser:Qn:Aggl
C0798653 A18216653 L1466908 S7346183 AUI 15484-9 LSP AV Mycoplasma gallisepticum Ab:ACnc:Pt:Ser:Ord:Aggl

CONSUMER_NAME

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0549806 A18098586 L9454904 S11752020 AUI 11156-7 CONSUMER_NAME WBC morphology Leukocyte morphology finding:Prid:Pt:Bld:Nom
C0551274 A18291009 L1032593 S7432124 AUI 11561-8 CONSUMER_NAME Acetylcholine receptor blocking Ab Acetylcholine receptor blocking Ab:ACnc:Pt:Ser:Qn
C0551275 A18097986 L1032594 S7432306 AUI 11562-6 CONSUMER_NAME Acetylcholine receptor modulation Ab Acetylcholine receptor modulation Ab:ACnc:Pt:Ser:Qn
C0550486 A18175601 L1033972 S7361859 AUI 10886-0 CONSUMER_NAME Free PSA serum/plasma Prostate specific Ag.free:MCnc:Pt:Ser/Plas:Qn
C0550178 A18098509 L1032595 S7432025 AUI 11034-6 CONSUMER_NAME Acetylcholine receptor binding Ab Acetylcholine receptor binding Ab:SCnc:Pt:Ser:Qn
C0550440 A18098779 L1036157 S7352555 AUI 11556-8 CONSUMER_NAME Oxygen (O2) pressure in blood Oxygen:PPres:Pt:Bld:Qn
C0550246 A18097983 L1036097 S7406644 AUI 11557-6 CONSUMER_NAME Carbon dioxide pressure in blood Carbon dioxide:PPres:Pt:Bld:Qn
C0550447 A18368330 L7982948 S10024330 AUI 11558-4 CONSUMER_NAME pH (acidity) in blood pH:LsCnc:Pt:Bld:Qn
C0797306 A18137324 L1473584 S7361853 AUI 12841-3 CONSUMER_NAME Free/Total PSA serum/plasme Prostate specific Ag.free/Prostate specific Ag.total:MFr:Pt:Ser/Plas:Qn
C0798130 A18139141 L6421071 S11324486 AUI 14957-5 CONSUMER_NAME Microalbumin urine Albumin:MCnc:Pt:Urine:Qn:Detection limit <= 20 mg/L
C0800968 A18295534 L1486911 S7405060 AUI 17861-6 CONSUMER_NAME Calcium serum/plasma serum/plasma Calcium:MCnc:Pt:Ser/Plas:Qn
C0799300 A18333098 L1459589 S7397926 AUI 16135-6 CONSUMER_NAME Beta 2 glycoprotein 1 Ab.IgG Beta 2 glycoprotein 1 Ab.IgG:ACnc:Pt:Ser:Qn
C0363876 A18179501 L1842213 S7444642 AUI 1742-6 CONSUMER_NAME Alanine aminotransferase serum/plasma Alanine aminotransferase:CCnc:Pt:Ser/Plas:Qn
C0363885 A18293666 L2271407 S7446614 AUI 1751-7 CONSUMER_NAME Albumin serum/plasma Albumin:MCnc:Pt:Ser/Plas:Qn
C0802169 A18334713 L6419581 S7396635 AUI 19270-8 CONSUMER_NAME Barbiturates screen in urine Barbiturates:ACnc:Pt:Urine:Ord:Screen
C0803372 A18180413 L2274800 S7406882 AUI 20563-3 CONSUMER_NAME Carboxyhemoglobin % in blood Carboxyhemoglobin/Hemoglobin.total:MFr:Pt:Bld:Qn
C0802272 A18180520 L6426638 S7406851 AUI 19381-3 CONSUMER_NAME Marijuana (THC) screen in urine Carboxy tetrahydrocannabinol:ACnc:Pt:Urine:Ord:Screen
C0802428 A18218918 L6411306 S7460762 AUI 19554-5 CONSUMER_NAME Methamphetamine (Meth) screen in urine Methamphetamine:ACnc:Pt:Urine:Ord:Screen
C0802442 A18180389 L6428267 S7461363 AUI 19568-5 CONSUMER_NAME Methylenedioxymethamphetamine Ecstasy (MDMA) screen in urine Methylenedioxymethamphetamine:ACnc:Pt:Urine:Ord:Screen

CURATED_RANGE_AND_UNITS

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0551274 A18291009 L1032593 S7432124 AUI 11561-8 CURATED_RANGE_AND_UNITS <15;% inhibition Acetylcholine receptor blocking Ab:ACnc:Pt:Ser:Qn
C0551275 A18097986 L1032594 S7432306 AUI 11562-6 CURATED_RANGE_AND_UNITS 0-20;% modulation Acetylcholine receptor modulation Ab:ACnc:Pt:Ser:Qn
C0488728 A18329524 L7984692 S10029495 AUI 10230-1 CURATED_RANGE_AND_UNITS 50-75;% Ejection fraction:VFr:Pt:Heart.ventricle.left:Qn
C0550178 A18098509 L1032595 S7432025 AUI 11034-6 CURATED_RANGE_AND_UNITS <0.4;nmol/L Acetylcholine receptor binding Ab:SCnc:Pt:Ser:Qn
C0550221 A18291826 L1035966 S7396969 AUI 11555-0 CURATED_RANGE_AND_UNITS -2 to +3;mEq/L&#124;-2 to +3;mmol/L Base excess:SCnc:Pt:Bld:Qn
C0797306 A18137324 L1473584 S7361853 AUI 12841-3 CURATED_RANGE_AND_UNITS >25;% Prostate specific Ag.free/Prostate specific Ag.total:MFr:Pt:Ser/Plas:Qn
C0798130 A18139141 L6421071 S11324486 AUI 14957-5 CURATED_RANGE_AND_UNITS <20;mg/L Albumin:MCnc:Pt:Urine:Qn:Detection limit <= 20 mg/L
C0797497 A18331128 L6426370 S7397637 AUI 14316-4 CURATED_RANGE_AND_UNITS neg Benzodiazepines:ACnc:Pt:Urine:Ord:Screen
C0797802 A18216111 L1485374 S7398560 AUI 14627-4 CURATED_RANGE_AND_UNITS 24-28:mmol/L Bicarbonate:SCnc:Pt:BldV:Qn
C0800968 A18295534 L1486911 S7405060 AUI 17861-6 CURATED_RANGE_AND_UNITS 9-10.5;mg/mL Calcium:MCnc:Pt:Ser/Plas:Qn
C0363876 A18179501 L1842213 S7444642 AUI 1742-6 CURATED_RANGE_AND_UNITS 0-25;U/L Alanine aminotransferase:CCnc:Pt:Ser/Plas:Qn
C0363885 A18293666 L2271407 S7446614 AUI 1751-7 CURATED_RANGE_AND_UNITS 3.5-5.5;g/dL Albumin:MCnc:Pt:Ser/Plas:Qn
C0802209 A18218769 L6409052 S7381430 AUI 19312-8 CURATED_RANGE_AND_UNITS neg Tricyclic antidepressants:ACnc:Pt:Urine:Ord:Screen
C0364060 A18180387 L0521379 S7396970 AUI 1925-7 CURATED_RANGE_AND_UNITS -2 to +2:mmol.L Base excess:SCnc:Pt:BldA:Qn
C0364061 A18334709 L0521381 S7396971 AUI 1926-5 CURATED_RANGE_AND_UNITS -2 to +2:mmol.L Base excess:SCnc:Pt:BldC:Qn
C0802237 A18141611 L6421660 S7344866 AUI 19343-3 CURATED_RANGE_AND_UNITS neg Amphetamine:ACnc:Pt:Urine:Ord:Screen
C0802272 A18180520 L6426638 S7406851 AUI 19381-3 CURATED_RANGE_AND_UNITS neg Carboxy tetrahydrocannabinol:ACnc:Pt:Urine:Ord:Screen
C0802425 A18373675 L6421513 S7460695 AUI 19550-3 CURATED_RANGE_AND_UNITS neg Methadone:ACnc:Pt:Urine:Ord:Screen
C0802442 A18180389 L6428267 S7461363 AUI 19568-5 CURATED_RANGE_AND_UNITS neg Methylenedioxymethamphetamine:ACnc:Pt:Urine:Ord:Screen

DOCUMENT_SECTION

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0488486 A18368266 L0781260 S7411970 AUI 10154-3 DOCUMENT_SECTION SECTION Chief complaint:Find:Pt:^Patient:Nar:Reported
C0488491 A18290941 L0693178 S7445593 AUI 10155-0 DOCUMENT_SECTION SECTION History of allergies:Find:Pt:^Patient:Nar:Reported
C0488495 A18252174 L0814379 S7445612 AUI 10157-6 DOCUMENT_SECTION SECTION History of family member diseases:Find:Pt:Family:Nar:Reported
C0488501 A18097909 L0838059 S7445660 AUI 10160-0 DOCUMENT_SECTION SECTION History of medication use:Find:Pt:^Patient:Nar:Reported
C0488505 A18368271 L0838067 S7445704 AUI 10162-6 DOCUMENT_SECTION SECTION History of pregnancies:Find:Pt:Reproductive system:Nar:Reported
C0488507 A18175096 L0838055 S7445713 AUI 10164-2 DOCUMENT_SECTION SECTION History of present illness:Find:Pt:^Patient:Nar:Reported
C0488555 A18097923 L0813876 S7446304 AUI 10183-2 DOCUMENT_SECTION SECTION Hospital discharge medications:Find:Pt:^Patient:Nar
C0488557 A18213626 L0813870 S7446309 AUI 10184-0 DOCUMENT_SECTION SECTION Hospital discharge physical findings:Find:Pt:^Patient:Nar
C0488564 A18097925 L0838113 S7365734 AUI 10187-3 DOCUMENT_SECTION SECTION Review of systems:Find:Pt:^Patient:Nar:Reported
C2713002 A18252645 L7984081 S10022039 AUI 10830-8 DOCUMENT_SECTION SECTION Surgical operation note complications:Imp:Pt:^Patient:Nar
C0488608 A18252194 L1849697 S7357491 AUI 10210-3 DOCUMENT_SECTION SECTION Physical findings:Find:Pt:General status:Nar:Observed
C0488615 A18290963 L7981391 S10022034 AUI 10213-7 DOCUMENT_SECTION SECTION Surgical operation note anesthesia:Find:Pt:^Patient:Nar
C0488623 A18290966 L7982745 S10022053 AUI 10215-2 DOCUMENT_SECTION SECTION Surgical operation note findings:Find:Pt:^Patient:Nar
C0488625 A18290968 L7977468 S10022060 AUI 10216-0 DOCUMENT_SECTION SECTION Surgical operation note fluids:Type:Pt:^Patient:Nar
C0488627 A18097931 L7976156 S10022063 AUI 10217-8 DOCUMENT_SECTION SECTION Surgical operation note indications:Imp:Pt:^Patient:Nar
C0488632 A18097932 L7974849 S10022076 AUI 10219-4 DOCUMENT_SECTION SECTION Surgical operation note preoperative Dx:Imp:Pt:^Patient:Nar
C0488636 A18329521 L7974852 S10022088 AUI 10221-0 DOCUMENT_SECTION SECTION Surgical operation note specimens taken:Find:Pt:^Patient:Nar
C0551729 A18291660 L4854115 S7376446 AUI 11537-8 DOCUMENT_SECTION SECTION Surgical drains:Find:Pt:Surgical procedure:Nar
C0551512 A18291721 L6072253 S7436072 AUI 11283-9 DOCUMENT_SECTION SECTION Acuity assessment:Fcn:Enctr^frst:^Patient:Nom

LNE

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0804618 A18143075 L1495342 S7385341 AUI 21830-5 LNE CR0050 Version:Type:Pt:NAACCR message:Nom
C0804625 A18374956 L1485275 S7445102 AUI 21837-0 LNE CR0190 Hispanic origin:Type:Pt:^Patient:Nom:Best estimate
C0804626 A18374959 L1488854 S7430351 AUI 21838-8 LNE CR0200 Ethnicity:Type:Pt:^Patient:Nom:Computed
C0804627 A18258883 L1488851 S7423749 AUI 21839-6 LNE CR0210 Derivation method:Type:Pt:Ethnicity computation:Nom:*
C0804628 A20074742 L10328264 S12898590 AUI 21840-4 LNE CR0220 Gender:Type:Pt:^Patient:Nom:NAACCR v.11
C0804630 A18220190 L1485519 S7398947 AUI 21842-0 LNE CR0250 Birthplace:ID:Pt:^Patient:Nom
C0804633 A18181886 L3167533 S7449387 AUI 21845-3 LNE CR0290 Information source:Type:Pt:Usual occupation Hx:Nom:*
C0804634 A18258890 L3167531 S7449386 AUI 21846-1 LNE CR0300 Information source:Type:Pt:Usual industry Hx:Nom:*
C0804637 A18258894 L3165516 S7416675 AUI 21849-5 LNE CR0330 Coding system:Type:Pt:Occupation & Industry Hx:Nom
C0804640 A18336215 L5805862 S7411165 AUI 21852-9 LNE CR0364 Census tract certainty 1970&80&90:Type:Pt:Census tract:Nom:*
C0804641 A18104656 L1481843 S7369893 AUI 21853-7 LNE CR0380 Sequence number central.patient:Arb:Pt:Cancer.XXX:Ord
C0804645 A18143093 L2399554 S7397441 AUI 21857-8 LNE CR430 Behavior ICD-O-2:Prid:Pt:Cancer.XXX:Nom
C0804646 A18374246 L1487096 S7438567 AUI 21858-6 LNE CR440 Grade:Prid:Pt:Cancer.XXX:Nom
C0804647 A18374248 L1476370 S7416668 AUI 21859-4 LNE CR0460 Coding system.original:Type:Pt:Cancer.XXX.anatomic site:Nom
C0804648 A18335465 L1487054 S7416669 AUI 21860-2 LNE CR0480 Coding system.original:Type:Pt:Cancer.XXX.morphology:Nom
C0804649 A18142308 L1487057 S7426235 AUI 21861-0 LNE CR0490 Dx confirmed by:Type:Pt:Cancer.XXX:Nom
C0804650 A18258114 L1470169 S7371916 AUI 21862-8 LNE CR0500 Source of document used to abstract:Type:Pt:Cancer.XXX:Nom
C0804652 A18142310 L1487113 S7463275 AUI 21864-4 LNE CR0520 Most recent screening result for:Type:Pt:Cancer.XXX:Nom
C0804660 A18336219 L1485365 S7364899 AUI 21872-7 LNE CR0610 Relationship between this hospital and cancer Dx:Type:Episode:Cancer.XXX:Nom

MTH_LEA

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C1651674 A18269997 L5814537 S7384982 AUI 41897-0 MTH_LEA ONETOUCH![REGISTERED SIGN]! II, ONETOUCH![REGISTERED SIGN]! PROFILE![REGISTERED SIGN]!, ONETOUCH![REGISTERED SIGN]! SURESTEP![REGISTERED SIGN]!, ONETOUCH![REGISTERED SIGN]! FASTTAKE![REGISTERED SIGN]!, ONETOUCH![REGISTERED SIGN]! BASIC![REGISTERED SIGN]!, ONETOUCH![REGISTERED SIGN]! ULTRA![REGISTERED SIGN]!, ONETOUCH![REGISTERED SIGN]! ULTRASMART![REGISTERED SIGN]!, INDUO![REGISTERED SIGN]!, GLUCOMETER ELITE XL DIABETES CARE SYSTEM, ASCENSIA![REGISTERED SIGN]! CONTOURTM, ASCENSIA![TRADE MARK SIGN]! BREEZE![TRADE MARK SIGN]!, ACCU-CHEK![REGISTERED SIGN]! ACTIVE METER, ACCU-CHEK![REGISTERED SIGN]! ADVANTAGE SYSTEM, ACCU-CHEK![REGISTERED SIGN]! COMPACT METER, ACCU-CHEK![REGISTERED SIGN]! COMPLETE METER, ACCU-CHEK![REGISTERED SIGN]! VOICEMATE SYSTEM, PMP SELFCHECK![TRADE MARK SIGN]! GLUCO Vendor device name:ID:Pt:Glucose meter device:Nom
C1633474 A18153971 L5813632 S7414894 AUI 41960-6 MTH_LEA Bayer DCA 2000+ analyzer, A1C home test![TRADE MARK SIGN]! , Nycocard![REGISTERED SIGN]! HBA1C Class:Type:Pt:HbA1c measurement device:Nom
C1645325 A18346652 L5814543 S7384986 AUI 41966-3 MTH_LEA BODYGEM![REGISTERED SIGN]! Vendor device name:ID:Pt:Metabolism measurement device:Nom
C1978289 A18274624 L6912031 S8043114 AUI 50415-9 MTH_LEA 2mg Dexamethason-Shorttest: Basal Cortisol concentration was 5 ![MICRO SIGN]!g/dl. Cortisol^pre 2 mg dexamethasone PO overnight:MCnc:Pt:Ser/Plas:Qn
C1978290 A18197563 L6899661 S8043110 AUI 50416-7 MTH_LEA 2 mg Dexamethason-Shorttest: Cortisol concentration post 2 mg Dexa was 1 ![MICRO SIGN]!g/dl. Cortisol^post 2 mg dexamethasone PO overnight:MCnc:Pt:Ser/Plas:Qn
C1978295 A18390708 L6895533 S8043111 AUI 50421-7 MTH_LEA CRH-Test: basal cortisol concentration 30 ![MICRO SIGN]!g/dl. Cortisol^pre 100 ug CRH IV:MCnc:Pt:Ser/Plas:Qn
C1978296 A18352137 L6903789 S8043073 AUI 50422-5 MTH_LEA CRH-Test: 20 minute cortisol concentration 50 ![MICRO SIGN]!g/dl. Cortisol^20M post 100 ug CRH IV:MCnc:Pt:Ser/Plas:Qn
C1953571 A18234578 L6696012 S7803428 AUI 48164-8 MTH_LEA "NSE in the body fluid was 123 ![MICRO SIGN]!g/L" Enolase.neuron specific:MCnc:Pt:Body fld:Qn
C1953572 A18195377 L6695481 S7796939 AUI 48165-5 MTH_LEA "The SCCA in the body fluid was 30![MICRO SIGN]!g/L" Squamous cell carcinoma Ag:MCnc:Pt:Body fld:Qn
C1953922 A18389273 L6892463 S8016781 AUI 48419-6 MTH_LEA The C1q binding circulating immune complexes (IgG) is 23 ![MICRO SIGN]!g/ml. Immune complex.IgG:MCnc:Pt:Ser/Plas:Qn:C1q binding assay
C1953928 A18118945 L6701835 S7797775 AUI 48425-3 MTH_LEA The troponin T in was 2 ![MICRO SIGN]!G/L. Troponin T.cardiac:MCnc:Pt:Bld:Qn
C1954000 A18312212 L6692698 S10020240 AUI 48497-2 MTH_LEA Pro-Hepcidin in serum is 234 ![MICRO SIGN]!g/L. Pro-hepcidin:MCnc:Pt:Ser/Plas:Qn
C1954705 A18235076 L6904819 S8016780 AUI 48997-1 MTH_LEA The C1q binding IgG IC in the body fluid are 13 ![MICRO SIGN]!g/ml. Immune complex.IgG:MCnc:Pt:Body fld:Qn:C1q binding assay
C1954710 A18273811 L6697488 S7806122 AUI 49002-9 MTH_LEA The albumin excretiion in urine is 30 ![MICRO SIGN]!g/minute. Albumin:MRat:XXX:Urine:Qn
C1978040 A18274451 L6888416 S8017571 AUI 50201-3 MTH_LEA 190 ![MICRO SIGN]!g/dl. Iron^4th specimen:MCnc:Pt:Ser/Plas:Qn
C1977690 A18313114 L6884224 S8017573 AUI 50202-1 MTH_LEA 160 ![MICRO SIGN]!g/dl. Iron^5th specimen:MCnc:Pt:Ser/Plas:Qn
C1977691 A18313115 L6896652 S8017575 AUI 50203-9 MTH_LEA 170 ![MICRO SIGN]!g/dl. Iron^6th specimen:MCnc:Pt:Ser/Plas:Qn
C1977692 A18235721 L6892557 S8017577 AUI 50204-7 MTH_LEA 190 ![MICRO SIGN]!g/dl. Iron^7th specimen:MCnc:Pt:Ser/Plas:Qn
C1977693 A18313119 L6896653 S8017579 AUI 50205-4 MTH_LEA 196 ![MICRO SIGN]!g/dl. Iron^8th specimen:MCnc:Pt:Ser/Plas:Qn

MTH_SOS

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0881628 A18259977 L9459588 S11759933 AUI 24357-6 MTH_SOS Depending upon the dipstick the results for Glucose, bilirubin, ketones and protein may be reported as an ordinal (present, absent or None, 1+, 2+, 3+,) or as a quantitative value (e.g. 25 mg/dL ). The panel includes both versions to accommodate these two variations. However, one of each of these four pairs 1) Glucose [Mass/volume] , Glucose [Presence] 2) Bilirubin [Mass/volume], Bilirubin [Presence] 3) Ketones [Mass/volume], Ketones [Presence] 4) Protein [Mass/volume], Protein [Presence]must be included in the panel, and the required status is marked as Conditional ![COPYRIGHT SIGN]! to remind users that if one item in the pair is not included in the panel the other must be. Urinalysis macro (dipstick) panel:-:Pt:Urine:-
C1717121 A18117712 L6082802 S7392199 AUI 46075-8 MTH_SOS Complete item 2 if ADL self-performance score for TRANSFER (G.1.b.A) is 0,1,2, or 3 AND at least one of the following are present:![BULLET]! Resident received physical therapy involving gait training (P.1.b.c)![BULLET]! Physical therapy was ordered for the resident involving gait training (T.1.b)![BULLET]! Resident received nursing rehabilitation for walking (P.3.f)![BULLET]! Physical therapy involving walking has been discontinued within the past 180 daysSkip to item 3 if resident did not walk in last 7 days(FOR FOLLOWING FIVE ITEMS,BASE CODING ONTHE EPISODE WHENTHE RESIDENT WALKEDTHE FARTHEST WITHOUT SITTING DOWN. INCLUDEWALKING DURING REHABILITATION SESSIONS.) Walking when most self sufficient:-:Pt:^Patient:Set
C1830060 A18350261 L6410873 S7445930 AUI 47214-2 MTH_SOS Used to quantify insulin resistance. Formulat is Glucose (mg/dL)) x Insulin (mU/mL) / 405 or Glucose (mmol/L)x Insulin (![MICRO SIGN]!U/mL) / 22.5 Homeostasis model assessment:ACnc:Pt:Ser/Plas:Qn
C1954718 A18351343 L6692682 S7794736 AUI 49010-2 MTH_SOS Assay is used to measure platelet P2Y12 receptor blockade known to occur with some drugs including the thienopyridine class of drugs, including clopidogrel (Plavix![REGISTERED SIGN]!). VerifyNow P2Y12 Assay from Accumetrics uses adenosine-5-diphosphate(ADP/PGE1) to induce platelet activation. Activated platelets bind fibrinogen in proportion to the number of expressed platelet GPIIb/IIIa receptors. Light transmittance increases as activated platelets bind and aggregate the fibrinogen-coated beads. A turbidimetric based optical detection system measures change in optical signal caused by aggregation and reports results in P2Y12 Reaction Units(PRU). Information from VerifyNow P2Y12 Assay package insert from Accumetrics dated 2006 09 01 Platelet aggregation.adenosine diphosphate induced:ACnc:Pt:PRP:Qn
C1954719 A18273819 L6692683 S7794739 AUI 49011-0 MTH_SOS A whole blood assay for detecting platelet inhibition or dysfunction due to aspirin therapy. This in vitro assay uses citrated whole blood in the point of care or laboratory setting. Not for use in patients with underlying congenital platelet abnormalities, patients with non-aspirin induced acquired platelet abnormalities or in patients receiving non-aspirin platelet agents (may be used in patients treated with COX-2 inhibitors, e.g., (Celebrex![REGISTERED SIGN]!)).The VerifyNow assay incorporates the agonist arachidonic acid to activate platelets, and measures platelet function based upon the ability of activated platelets to bind fibrinogen. Fibrinogen-coated microparticles aggregate in whole blood in proportion to the number of unblocked platelets GP IIb/IIIa receptors. Light transmittance increases in as activated platelets bind and aggregate fibrinogen-coated beads. The instrument measures this change in optical signal caused by aggregation.Information from VerifyNow Aspirin Assay package insert from www.Accumetrics.com accessed 2090618. Platelet aggregation.arachidonate induced:ACnc:Pt:PRP:Qn
C1977246 A18390122 L6905092 S8018916 AUI 49498-9 MTH_SOS In the Hematology world estimated cell counts have existed for many moons and they are reported either qualitatively or quantitatively and done strictly by blood smear review.Smear Estimated WBC and Platelet counts that aren't just reported as reduced/adequate/many that are actually estimated as a numeric result like an estimate of 4 K/cumm for WBC or 400 K/cumm for platelets. Like doing a retic count by counting so many fields on the smear type of estimate.This WBC estimate count is a manual quantitative count. We report a number. See laboratory procedure:A.WBC Count Smear Estimate:1.Use the 50X oil immersion objective.2.Count the number of both intact and disrupted WBCs in each of 10 microscopic fields in different areas of the slide where RBCs slightly overlap. Divide the total number by 10 to establish the mean number of WBCs/field and multiply this mean by 3,000 to get the estimated WBC count/mm3. Do not round off the mean, e.g., if the mean is 5.7 do not round off to 6 but leave the figure at one place past the decimal point for greater accuracy.3.If the quantitative WBC count is <25,000, the estimated smear count should be within 1,500 cells of this figure. Estimate counts are less reliable at >25,000 cells/mm3.III.REFERENCES:A.A Color Atlas and Instruction Manual of Peripheral Blood Cells Morphology, by Barbara H. O'Connor, 1984, p. 20.B.Principles and Procedures, Barbara A. Brown, 6th Edition, 1993, p. 104. Leukocytes:NCnc:Pt:Bld:Qn:Estimate
C3169358 A19525769 L10086616 S12607770 AUI 62637-4 MTH_SOS The Pediatric Sleep Questionnaire (PSQ) protocol is a parent questionnaire for children from 2 through 18 years, and rated on a simple three-point scale ("yes," "no," or "don't know") for all items except the inattention/hyperactivity items that are rated on a four-point Likert scale. This protocol provides an overall total score and five sleep scales: (1) Sleep-Related Breathing Disorders (SRBD), (2) Snoring, (3) Sleepiness, (4) Behavior, and (5) Periodic Limb Movement Disorder (PLMD). The PSQ can be licensed and obtained at: http://techtransferstore.umich.edu/ProductDetails.asp?ProductCode=PSQ-3766, ![COPYRIGHT SIGN]! 2007 The Regents of the University of Michigan PhenX - respiratory - sleep apnea - child protocol:-:Pt:^Patient:-:PhenX
C3169724 A19534745 L10089528 S12606969 AUI 62651-5 MTH_SOS Male participants are also asked about contraception use in the last 12 months. The NSFG provides a card of response categories to the respondent. For example, in question 1 for males, an investigator would provide the respondent with a card listing the categories: "Condom or rubber; Withdrawal or pulling out; Vasectomy or male sterilization; Pill; Tubal ligation ("tubes tied") or female sterilization; Injection (Depo-Provera![REGISTERED SIGN]! or Lunelle); Spermicidal foam/jelly/cream/film/suppository; Hormonal implant (Norplant![REGISTERED SIGN]!); Rhythm or safe period; Something else." PhenX - contraceptive methods - male protocol:-:Pt:^Patient:-:PhenX
C3169733 A19521615 L10092561 S12607316 AUI 62660-6 MTH_SOS Female participants are asked whether they have ever used Evista![REGISTERED SIGN]! or Nolvadex![REGISTERED SIGN]! and then asked length of time they used it as well as whether they are currently using it. They are asked whether they are using any over-the-counter preparations for hormone replacement or post-menopause symptoms. Lastly, they are asked about their use of prescription female hormones (number of months taken, types, dosage). Note: PhenX staff removed embedded dates of original study for clarity of Toolkit users. PhenX - hormonal therapy protocol:-:Pt:^Patient:-:PhenX
C3169735 A19512695 L10101531 S12607329 AUI 62662-2 MTH_SOS The interviewer asks the female participant whether she has ever received a human papillomavirus (HPV) vaccination. If she answers yes, the interviewer asks her age and how many shots she received. If the participant answers "yes" to question 1, the interviewer should complete the rest of the protocol. If the participant answers "no" then the protocol is deemed complete. The PhenX Working Group notes that GARDASIL![REGISTERED SIGN]! is also known as Silgard. European Medicines Agency. (September 25, 2009). Silgard European Public Assessment Report. Retrieved from http://www.emea.europa.eu/humandocs/Humans/EPAR/silgard/silgard.htm. Waknine, Yael. (October 2, 2006). International Approvals: Singulair and Gardasil/Silgard. Medscape Today. Retrieved from http://www.medscape.com/viewarticle/545374. PhenX - human papillomavirus vaccine use protocol:-:Pt:^Patient:-:PhenX
C3169763 A19517131 L10083820 S12608604 AUI 62690-3 MTH_SOS Procedure for the measurement of intraocular pressure (IOP) using the TONO-PEN![REGISTERED SIGN]! XL Applanation Tonometer. TONO-PEN![REGISTERED SIGN]! is a registered trademark Reichert, Inc. This procedure is used to measure intraocular pressure (IOP). An elevated IOP can be dangerous because people with varying degrees of IOP elevation may develop damage to the optic nerve. PhenX measure - intraocular pressure:-:Pt:^Patient:-:PhenX
C3169764 A19521630 L10092569 S12607365 AUI 62691-1 MTH_SOS Intraocular pressure (IOP) is measured using the TONO-PEN![REGISTERED SIGN]! XL instrument. The cornea is prepared by introducing one drop of anesthetic onto the surface of the eye and the TONO-PEN![REGISTERED SIGN]! is used to obtain four valid IOP measurements. The instrument calculates an average and the examiner records the average. The instrument also provides the reliability level of the measurement. Only those readings that have a 5% variability level are recorded as they are considered to be accurate. This protocol uses TONO-PEN![REGISTERED SIGN]! to measure intraocular pressure. This instrument has the advantages of portability and is relatively easy to use. Other hand-held instruments can be used to measure intraocular pressure. If other instruments are used, the reproducibility of the measurements should be comparable to those acquired with this protocol. In addition, when other instruments are used to collect these measurements, the manufacturer and model of equipment should be recorded. These other devices may require some different steps than are described in this protocol. Investigators should follow the equipment manufacturer's instructions to ensure quality control. PhenX - intraocular pressure protocol:-:Pt:^Patient:-:PhenX
C3171737 A19526014 L10092553 S12607234 AUI 62769-5 MTH_SOS The Montreal Cognitive Assessment (MoCA![COPYRIGHT SIGN]!) is a screening instrument for mild cognitive impairment and more severe cognitive deficits. It is an interviewer-administered questionnaire in which the respondent performs certain tasks, such as drawing and counting, to assess various cognitive domains, such as attention, memory, orientation, language, conceptual thinking and planning. Please consult www.mocatest.org for permission and requirements to use the MoCA test. PhenX - global mental status - adult protocol:-:Pt:^Patient:-:PhenX
C3171738 A19512765 L10089557 S12607238 AUI 62770-3 MTH_SOS The Ages & Stages Questionnaires![REGISTERED SIGN]!, Third Edition (ASQ-3) screens infants and young children from 1 month to 66 months for developmental delays in five areas. The ASQ-3 is completed by a parent (or child's caregiver) or by an examiner asking a parent (or child's caregiver) questions about the child. The protocol includes scoring instructions. Additionally, the Brookes Publishing Company offers an optional online management system for ASQ-3 called ASQ Online. The Ages & Stages Questionnaires![REGISTERED SIGN]!, Third Edition (ASQ-3) is a proprietary, fee-based instrument that is available for purchase from Brookes Publishing Company. PhenX - global mental status - child protocol:-:Pt:^Patient:-:PhenX
C3171740 A19517171 L10101609 S12607996 AUI 62772-9 MTH_SOS Logical Memory is an interviewer-administered test that is a part of the Wechsler Memory Scale![REGISTERED SIGN]!, Fourth Edition (WMS![REGISTERED SIGN]!-IV). The interviewer reads the respondent a story and asks the respondent to repeat details of the story from memory. The test can be performed as both an immediate and delayed recall. The protocol includes scoring instructions that accounts for specific versus paraphrased details. Logical Memory is a subtest of the Wechsler Memory Scale![REGISTERED SIGN]!, Fourth Edition (WMS![REGISTERED SIGN]!-IV). Each WMS-III or WMS-IV subtest is a part of a complete WMS-III/IV assessment and is not sold separately. To administer a subtest requires a licensing agreement from Pearson. Researchers should complete and return an application to pas.licensing@pearson.com. The current fee for each subtest use is $1.25 each - subject to a minimum license fee. PhenX - verbal memory protocol:-:Pt:^Patient:-:PhenX
C3171742 A19521668 L10089652 S12608012 AUI 62774-5 MTH_SOS Visual Reproductions is an interviewer-administered test that is a part of the Wechsler Memory Scale![REGISTERED SIGN]! Fourth Edition (WMS![REGISTERED SIGN]!-IV). The interviewer shows the respondent a series of simple images and asks the respondent to draw them from memory. The test can be performed as both an immediate and delayed recall. The protocol includes scoring instructions that account for accuracy and speed. Visual Reproductions is a component of The Wechsler Memory Scale![REGISTERED SIGN]!, Fourth Edition. Each WMS-III or WMS-IV subtest is a part of a complete WMS-III/IV assessment and is not sold separately. To administer a subtest requires a licensing agreement from Pearson. Researchers should complete and return an application to pas.licensing@pearson.com. The current fee for each subtest use is $1.25 each - subject to a minimum license fee. PhenX - visual memory protocol:-:Pt:^Patient:-:PhenX
C3171743 A19508442 L10083893 S12609114 AUI 62775-2 MTH_SOS Digit span is an interviewer-administered test that is part of the Wechsler Adult Intelligence Scale![REGISTERED SIGN]!, Fourth Edition (WAIS![REGISTERED SIGN]!-IV). The examiner reads the respondent a series of number sequences and then asks the respondent to repeat the numbers back in forward and reverse order. The protocol also includes detailed scoring instructions. Digit Span is a subtest of the Wechsler Adult Intelligence Scale![REGISTERED SIGN]!, Fourth Edition (WAIS![REGISTERED SIGN]!-IV). Each WAIS-IV subtest is a part of a complete WAIS-IV assessment and is not sold separately. To administer a subtest requires a licensing agreement from Pearson. Researchers should complete and return an application to pas.licensing@pearson.com. The current fee for each subtest use is $1.25 each - subject to a minimum license fee. PhenX measure - working memory:-:Pt:^Patient:-:PhenX
C3171782 A19508462 L10089515 S12606889 AUI 62814-9 MTH_SOS The participant is asked to complete a one-mile walk test as quickly as possible on a track. A technician utilizes a stopwatch to time the walk. The participant wears a heart rate monitor that records h/her heart rate continuously through the test. After the test is completed the technician records the heart rate from the last 10 seconds of the test. In addition, the participant's age, sex, and body weight are needed to complete an equation to determine maximal oxygen consumption (VO2max). Polar![REGISTERED SIGN]! is a trademark of Polar Electro Oy PhenX - cardiorespiratory fitness - 1 mile walk protocol:-:Pt:^Patient:-:PhenX
C3171783 A19504160 L10101486 S12606897 AUI 62815-6 MTH_SOS The participant is asked to walk on a treadmill at a 5% grade for 4 minutes. A technician utilizes a stopwatch to time the walk. The participant wears a heart rate monitor that records h/her heart rate continuously through the test. After the test is completed the technician records the heart rate from the last 15 seconds of the test. In addition, the participant's age and gender are needed to complete an equation to determine maximal oxygen consumption (VO2max). Polar![REGISTERED SIGN]! is a trademark of Polar Electro Oy PhenX - cardiorespiratory fitness - treadmill protocol:-:Pt:^Patient:-:PhenX

HL7_FIELD_SUBFIELD_ID

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0551623 A18098696 L1035467 S7459245 AUI 11380-3 HL7_FIELD_SUBFIELD_ID PID-16 Marital status and living arrangements:Find:Pt:^Patient:Nar:Reported
C0551624 A18252926 L1483838 S7459246 AUI 11381-1 HL7_FIELD_SUBFIELD_ID PID-16 Marital status and living arrangements:Find:Pt:^Patient:Nom:Reported
C0802049 A18295881 L1494191 S7446323 AUI 19111-4 HL7_FIELD_SUBFIELD_ID PID-21 Hospital number:ID:Pt:^Mother:Nom
C0803906 A18297287 L1485516 S7398943 AUI 21112-8 HL7_FIELD_SUBFIELD_ID PID-7.1 Birth date:TmStp:Pt:^Patient:Qn
C0804623 A18336210 L1488635 S7416656 AUI 21835-4 HL7_FIELD_SUBFIELD_ID PID-10.3 Coding system.current:Type:Pt:Race:Nom
C0804624 A18374955 L1488647 S7416670 AUI 21836-2 HL7_FIELD_SUBFIELD_ID PID-10.3 Coding system.original:Type:Pt:Race:Nom
C0804626 A18374959 L1488854 S7430351 AUI 21838-8 HL7_FIELD_SUBFIELD_ID PID-22 Ethnicity:Type:Pt:^Patient:Nom:Computed
C0804630 A18220190 L1485519 S7398947 AUI 21842-0 HL7_FIELD_SUBFIELD_ID PID-23 Birthplace:ID:Pt:^Patient:Nom
C0804805 A18104733 L1494285 S7462431 AUI 22018-6 HL7_FIELD_SUBFIELD_ID PID-27 Military patient number:ID:Pt:^Patient:Nom
C1146896 A18340607 L2419239 S7422498 AUI 31211-6 HL7_FIELD_SUBFIELD_ID PID-29 Date of death:TmStp:Pt:^Patient:Qn
C1315098 A18264804 L3168147 S7364179 AUI 32624-9 HL7_FIELD_SUBFIELD_ID PID-10 Race:Type:Pt:^Patient:Nom
C1624675 A18308808 L5812826 S7419034 AUI 42062-0 HL7_FIELD_SUBFIELD_ID PID-11.9;PID-12 County--current:Prid:Pt:Cancer.XXX:Nom
C1626258 A18270066 L9076276 S11344139 AUI 42077-8 HL7_FIELD_SUBFIELD_ID PID-13 Telephone:Tele:Pt:^Patient:Nom
C2598118 A18237009 L8566311 S10634589 AUI 52461-1 HL7_FIELD_SUBFIELD_ID PID-5.3 Middle name:Pn:Pt:^Patient:Nom
C2599456 A18392642 L8574230 S10636831 AUI 54125-0 HL7_FIELD_SUBFIELD_ID PID-5 Name:Pn:Pt:^Patient:Nom
C2599464 A18315223 L8533789 S10619641 AUI 54131-8 HL7_FIELD_SUBFIELD_ID PID-8 Gender:Type:Pt:^Patient:Nom:USSG-FHT
C2599465 A18392646 L8561320 S10655787 AUI 54132-6 HL7_FIELD_SUBFIELD_ID PID-24 Twin:Arb:Pt:^Patient:Ord
C2599466 A18354028 L8564118 S10679437 AUI 54133-4 HL7_FIELD_SUBFIELD_ID PID-22 Ethnicity:Type:Pt:^Patient:Nom:USSG-FHT
C2598508 A18315225 L8560151 S10646044 AUI 54134-2 HL7_FIELD_SUBFIELD_ID PID-10 Race:Type:Pt:^Patient:Nom:USSG-FHT

LCB

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0484575 A18213782 L3157795 S7418808 AUI 10332-5 LCB HYDROCORTISONE Cortisol^pre 250 ug corticotropin IM:MCnc:Pt:Ser/Plas:Qn
C0484996 A18252334 L2424741 S7376002 AUI 10342-4 LCB SULFAMETHOXAZOLE Sulfamethoxazole:MCnc:Pt:Ser/Plas:Qn
C0485000 A18136532 L0869625 S7377691 AUI 10343-2 LCB TEMAZEPAM Temazepam:MCnc:Pt:Ser/Plas:Qn
C0485012 A18175255 L6422616 S7381580 AUI 10345-7 LCB TRIHEXYPHENIDYL HYDROCHLORIDE Trihexyphenidyl:MCnc:Pt:Urine:Qn
C0486101 A18329662 L6423654 S7418947 AUI 10364-8 LCB (S)-1-METHYL-5-(3-PYRIDINYL)-2-PYRROLIDINONE Cotinine:MCnt:Pt:Hair:Qn
C0486102 A18213800 L0800182 S7418944 AUI 10365-5 LCB (S)-1-METHYL-5-(3-PYRIDINYL)-2-PYRROLIDINONE Cotinine:MCnc:Pt:Ser/Plas:Qn
C0486103 A18368442 L6403313 S7418945 AUI 10366-3 LCB (S)-1-METHYL-5-(3-PYRIDINYL)-2-PYRROLIDINONE Cotinine:MCnc:Pt:Urine:Qn
C0486106 A18252349 L6417235 S7430198 AUI 10367-1 LCB ETHYL ALCOHOL Ethanol:MCnc:Pt:Gast fld:Qn
C0486122 A18252350 L0749151 S7454069 AUI 10368-9 LCB LEAD Lead:MCnc:Pt:BldC:Qn
C0486167 A18175265 L6401626 S7356029 AUI 10370-5 LCB PHENCYCLIDINE Phencyclidine:MCnt:Pt:Hair:Qn
C0484581 A18175208 L0629012 S7437158 AUI 10449-7 LCB D-GLUCOSE Glucose^1H post meal:MCnc:Pt:Ser/Plas:Qn
C0484599 A18252272 L0623749 S7437831 AUI 10450-5 LCB D-GLUCOSE Glucose^post 10H CFst:MCnc:Pt:Ser/Plas:Qn
C0484606 A18098030 L0628943 S7393056 AUI 10452-1 LCB ALPHA-D-XYLOSE Xylose^1H post 25 g xylose PO:MCnc:Pt:Ser/Plas:Qn
C0484607 A18329600 L0628985 S7393064 AUI 10453-9 LCB ALPHA-D-XYLOSE Xylose^1H post dose xylose PO:MCnc:Pt:Ser/Plas:Qn
C0484608 A18098176 L0634918 S7393085 AUI 10454-7 LCB ALPHA-D-XYLOSE Xylose^2H post 25 g xylose PO:MCnc:Pt:Ser/Plas:Qn
C0484609 A18252434 L0634927 S7393106 AUI 10455-4 LCB ALPHA-D-XYLOSE Xylose^30M post 25 g xylose PO:MCnc:Pt:Ser/Plas:Qn
C0484610 A18213884 L0646967 S7393165 AUI 10456-2 LCB ALPHA-D-XYLOSE Xylose^post 6H CFst:MCnc:Pt:Ser/Plas:Qn
C0484672 A18252444 L1471099 S7404759 AUI 10468-7 LCB CALCITONIN Calcitonin Ag:ACnc:Pt:Tiss:Ord:Immune stain
C0484691 A18175355 L1471171 S7414175 AUI 10473-7 LCB CYMOTRYPSIN Chymotrypsin Ag:ACnc:Pt:Tiss:Ord:Immune stain

MTH_LQT

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C2973103 A18850058 L9571227 S12036224 AUI 61526-0 MTH_LQT HOW OFTEN did you take Regular One-a-Day type, Centrum![REGISTERED SIGN]! or Thera-type MULTIPLE VITAMINS? How often did you take regular one a day type, centrum or thera type multiple vitamins:Find:Pt:^Patient:Ord:PhenX
C2973104 A20848808 L10830555 S13449719 AUI 61527-8 MTH_LQT HOW MANY YEARS did you take Regular One-a-Day type, Centrum![REGISTERED SIGN]! or Thera-type MULTIPLE VITAMINS? How many Y did you take regular one a day type, centrum or thera type multiple vitamins:Time:Pt:^Patient:Qn:PhenX
C2973127 A18861191 L9575278 S12035880 AUI 61550-0 MTH_LQT How often did you drink FRUIT-FLAVORED DRINKS with sugar (such as Kool-Aid![REGISTERED SIGN]!, Hi-C![REGISTERED SIGN]!, lemonade, or cranberry cocktail)? How often did you drink fruit flavored drinks with sugar (such as kool aid, hi C, lemonade, or cranberry cocktail) in past 30D:Find:Pt:^Patient:Ord:PhenX
C2973055 A18872095 L9575270 S12035832 AUI 61478-4 MTH_LQT HOW OFTEN DID YOU DRINK Black tea such as Lipton![REGISTERED SIGN]!, or Earl Grey (Not decaffeinated-instant, bottled, and brewed)? How often did you drink black tea such as lipton, or earl grey:Find:Pt:^Patient:Ord:PhenX
C2973056 A18850020 L9582404 S12045308 AUI 61479-2 MTH_LQT What is your serving size for Black tea such as Lipton![REGISTERED SIGN]!, or Earl Grey (Not decaffeinated-instant, bottled, and brewed)? What is your serving size for black tea such as lipton, or earl grey:Find:Pt:^Patient:Ord:PhenX
C2973073 A18850030 L9571189 S12035903 AUI 61496-6 MTH_LQT HOW OFTEN DID YOU DRINK Jolt![REGISTERED SIGN]!, Surge![REGISTERED SIGN]!, Mountain Dew![REGISTERED SIGN]!, Red Bull![REGISTERED SIGN]! and other highly caffeinated sodas? How often did you drink jolt, surge, mountain dew, red bull and other highly caffeinated sodas:Find:Pt:^Patient:Ord:PhenX
C2973074 A18883246 L9572279 S12045367 AUI 61497-4 MTH_LQT What is your serving size for Jolt![REGISTERED SIGN]!, Surge![REGISTERED SIGN]!, Mountain Dew![REGISTERED SIGN]!, Red Bull![REGISTERED SIGN]! and other highly caffeinated sodas? What is your serving size for jolt, surge, mountain dew, red bull and other highly caffeinated sodas:Find:Pt:^Patient:Ord:PhenX
C2973131 A18883286 L9575288 S12036003 AUI 61554-2 MTH_LQT During the past month, how often did you eat DOUGHNUTS, sweet rolls, Danish, muffins, or Pop-Tarts![REGISTERED SIGN]!? How often did you eat doughnuts, sweet rolls, danish, muffins, or pop-tarts in past 30D:Find:Pt:^Patient:Ord:PhenX
C3173334 A19509135 L10086038 S12602695 AUI 63951-8 MTH_LQT In the past 3 years, please indicate if you have taken either of the following types of medications.Statin medications such as lovastatin (Mevacor![REGISTERED SIGN]!), atorvastatin (Lipitor![REGISTERED SIGN]!), rosuvastain (Crestor![REGISTERED SIGN]!), pravastatin (Pravachol![REGISTERED SIGN]!), simvastatin (Zocor![REGISTERED SIGN]!), fluvastatin (Lescol![REGISTERED SIGN]!) In the past 3Y have you taken statins, lovastatin - mevacor, atorvastatin - lipitor, rosuvastain - crestor, pravastatin - pravachol, simvastatin - zocor, fluvastatin - lescol:Find:Pt:^Patient:Ord:PhenX
C3173130 A19522274 L10097621 S12599062 AUI 63874-2 MTH_LQT The most frequently used estrogen is oral Premarin![REGISTERED SIGN]!. Have you ever taken Premarin![REGISTERED SIGN]! by mouth (as pills)? Have you ever taken premarin by mouth as pills:Find:Pt:^Patient:Ord:PhenX
C3173132 A19535447 L10084676 S12591062 AUI 63875-9 MTH_LQT At what age did you first take Premarin![REGISTERED SIGN]!? At what age did you first take premarin:Time:Pt:^Patient:Qn:PhenX
C3173134 A19517805 L10078583 S12591077 AUI 63876-7 MTH_LQT At what age did you last take Premarin![REGISTERED SIGN]!? At what age did you last take premarin:Time:Pt:^Patient:Qn:PhenX
C3173136 A19513457 L10097742 S12600071 AUI 63877-5 MTH_LQT How many years in total did you take Premarin![REGISTERED SIGN]! (exclude those periods when you temporarily stopped)? How many Y in total did you take premarin - exclude those periods when you temporarily stopped:Time:Pt:^Patient:Qn:PhenX
C3173138 A20090213 L10343087 S12915391 AUI 63878-3 MTH_LQT Five commonly used doses of Premarin![REGISTERED SIGN]! can be distinguished by the color of the pill. Please indicate any you have ever used and the one you used for the longest period. Which premarin pill did you use the longest:Find:Pt:^Patient:Nom:PhenX
C3173139 A19517809 L10081655 S12591072 AUI 63879-1 MTH_LQT At what age did you first use estrogens other than Premarin![REGISTERED SIGN]! pills? At what age did you first use estrogens other than premarin pills:Time:Pt:^Patient:Qn:PhenX
C3173141 A19531136 L10096637 S12591087 AUI 63880-9 MTH_LQT At what age did you last use estrogens other than Premarin![REGISTERED SIGN]! pills? At what age did you last use estrogens other than premarin pills:Time:Pt:^Patient:Qn:PhenX
C3173143 A19531137 L10091693 S12600066 AUI 63881-7 MTH_LQT How many years in total did you take estrogens other than Premarin![REGISTERED SIGN]! pills (exclude any time when you temporarily stopped)? How many Y in total did you take estrogens other than premarin pills - exclude any time when you temporarily stopped:Time:Pt:^Patient:Qn:PhenX
C3173145 A20075607 L10332847 S12899977 AUI 63882-5 MTH_LQT Sometimes another type of female hormone, progesterone (or progestin), is given for symptoms of menopause, either alone or in combination with estrogen. The most frequently used progestin is Provera![REGISTERED SIGN]! (medroxyprogestoerone acetate). Have you ever used progesterone or a progestin? Have you ever used progesterone or a progestin:Find:Pt:^Patient:Nom:PhenX
C3173153 A19526674 L10094979 S12602428 AUI 63886-6 MTH_LQT If you used Provera![REGISTERED SIGN]!, what was your usual dose? If you used provera, what was your usual dose:Find:Pt:^Patient:Nom:PhenX

MTH_LRN2

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0796873 A18368356 L6416368 S10025717 AUI 13682-0 MTH_LRN2 ; 3OH3Me-glutarate; ![LATIN SMALL LETTER SHARP S]!-hydroxy-![LATIN SMALL LETTER SHARP S]!-methylglutaric acid; dicrotalic acid; Meglutol; HMG; 3-hydroxy,3-methylglutaric acid; Creat; Crea; CR; 3Me-glutarate; 3-methylglutaric acid; 3OH3Me-glutarate; mRto; Mass concentration ratio; Point in time; Random; Ur; UR; Urn; UA; Quantitative; QNT; Quant; Quan; Drugs; Hydrox; OH; III; DRUG/TOXICOLOGY; DRUG/TOXICOLOGY; UCr 3-Hydroxy,3-Methylglutarate/Creatinine:MCrto:Pt:Urine:Qn
C0796820 A18292975 L1460275 S7450287 AUI 13629-1 MTH_LRN2 ; Il1Beta; IL-1![LATIN SMALL LETTER SHARP S]!; IL-1B; IL-1; Lymphocyte-Activating Factor; CG Antigen-Specific Helper Factor; ETAF; Epidermal Cell Derived Thymocyte-Activating Factor; Lymphocyte-Stimulating Hormone; Macrophage Cell Factor; T Helper Factor; IL1; Mass concentration; Level; Point in time; Random; SerPl; SerPlas; SerP; Serum; SR; Plasma; Pl; Plsm; Quantitative; QNT; Quant; Quan; IL; B; I; Chemistry Interleukin 1 beta:MCnc:Pt:Ser/Plas:Qn
C0797232 A18177479 L6427043 S7418846 AUI 14044-2 MTH_LRN2 11-beta HSD; 11-beta-hydroxy steroid dehydrogenase; 11-![LATIN SMALL LETTER SHARP S]!-HSD2; 11-![LATIN SMALL LETTER SHARP S]!-HSD1; 11-beta-HSD1; 11-beta-HSD2; Compound E; mRate; Mass rate; 1 day; 24 hours; 24HR; Ur; UR; Urn; UA; Quantitative; QNT; Quant; Quan; Chemistry Cortisone:MRat:24H:Urine:Qn
C0797344 A18254563 L1490331 S7418845 AUI 14159-8 MTH_LRN2 11-beta HSD; 11-beta-hydroxy steroid dehydrogenase; 11-![LATIN SMALL LETTER SHARP S]!-HSD2; 11-![LATIN SMALL LETTER SHARP S]!-HSD1; 11-beta-HSD1; 11-beta-HSD2; Compound E; Mass concentration; Level; Point in time; Random; SerPl; SerPlas; SerP; Serum; SR; Plasma; Pl; Plsm; Quantitative; QNT; Quant; Quan; Chemistry Cortisone:MCnc:Pt:Ser/Plas:Qn
C0945215 A18106114 L1848404 S7418850 AUI 25382-3 MTH_LRN2 11-beta HSD; 11-beta-hydroxy steroid dehydrogenase; 11-![LATIN SMALL LETTER SHARP S]!-HSD2; 11-![LATIN SMALL LETTER SHARP S]!-HSD1; 11-beta-HSD1; 11-beta-HSD2; Compound E; Substance concentration; Level; Point in time; Random; SerPl; SerPlas; SerP; Serum; SR; Plasma; Pl; Plsm; Quantitative; QNT; Quant; Quan; Chemistry Cortisone:SCnc:Pt:Ser/Plas:Qn
C0942531 A18338875 L6419739 S11739456 AUI 26583-5 MTH_LRN2 ; 3OH3Me-glutarate; ![LATIN SMALL LETTER SHARP S]!-hydroxy-![LATIN SMALL LETTER SHARP S]!-methylglutaric acid; dicrotalic acid; Meglutol; HMG; 3-hydroxy,3-methylglutaric acid; Creat; Crea; CR; 3Me-glutarate; 3-methylglutaric acid; 3OH3Me-glutarate; sRto; Substance concentration ratio; Point in time; Random; Ur; UR; Urn; UA; Quantitative; QNT; Quant; Quan; Drugs; Hydrox; OH; III; DRUG/TOXICOLOGY; DRUG/TOXICOLOGY; UCr 3-Hydroxy,3-Methylglutarate/Creatinine:SCrto:Pt:Urine:Qn
C1113793 A18263269 L6423097 S10025725 AUI 29867-9 MTH_LRN2 ; 3Me-glutarate; 3-methylglutaric acid; 3OH3Me-glutarate; ![LATIN SMALL LETTER SHARP S]!-hydroxy-![LATIN SMALL LETTER SHARP S]!-methylglutaric acid; dicrotalic acid; Meglutol; HMG; 3-hydroxy,3-methylglutaric acid; Arbitrary concentration; Point in time; Random; Ur; UR; Urn; UA; Ql; Ordinal; QL; Qualitative; Qual; Screen; Drugs; Hydrox; OH; III; DRUG/TOXICOLOGY; DRUG/TOXICOLOGY 3-Hydroxy,3-Methylglutarate:ACnc:Pt:Urine:Ord
C1113972 A18263362 L6416889 S7418844 AUI 30072-3 MTH_LRN2 11-beta HSD; 11-beta-hydroxy steroid dehydrogenase; 11-![LATIN SMALL LETTER SHARP S]!-HSD2; 11-![LATIN SMALL LETTER SHARP S]!-HSD1; 11-beta-HSD1; 11-beta-HSD2; Compound E; Mass concentration; Level; 1 day; 24 hours; 24HR; Ur; UR; Urn; UA; Quantitative; QNT; Quant; Quan; High pressure liquid chromatography; High performance liquid chromatography; Chemistry Cortisone:MCnc:24H:Urine:Qn:HPLC
C1114354 A18109347 L6413483 S7418841 AUI 30511-0 MTH_LRN2 11-beta HSD; 11-beta-hydroxy steroid dehydrogenase; 11-![LATIN SMALL LETTER SHARP S]!-HSD2; 11-![LATIN SMALL LETTER SHARP S]!-HSD1; 11-beta-HSD1; 11-beta-HSD2; Compound E; Creat; Crea; CR; mRto; Mass concentration ratio; Point in time; Random; Ur; UR; Urn; UA; Quantitative; QNT; Quant; Quan; Chemistry; UCr Cortisone/Creatinine:MCrto:Pt:Urine:Qn
C1830843 A18233773 L6401988 S7370575 AUI 46765-4 MTH_LRN2 HBSS; HbS![LATIN SMALL LETTER SHARP S]!o Thalassemia; SS; Hb S/S; Falciform anemia; Interpretation; Interp; Impression; Impressions; Point in time; Random; DBS; Filter paper; FP; Dried blood spot; Blood; WB; Whole blood; Ql; Ordinal; QL; Qualitative; Qual; Screen; Chemistry Sickle cell anemia:Imp:Pt:Bld.dot:Ord
C1830845 A18350006 L6414139 S7442920 AUI 46767-0 MTH_LRN2 ; Hb S/bTh; HbS![LATIN SMALL LETTER SHARP S]!+; Hb S/A; Hgb S; Sickle cell; Sickle cells; HbS; Haemoglobin; Interpretation; Interp; Impression; Impressions; Point in time; Random; DBS; Filter paper; FP; Dried blood spot; Blood; WB; Whole blood; Ql; Ordinal; QL; Qualitative; Qual; Screen; S prime; B; Chemistry; Sickle cell screen; Sicklequik; Sickledex Hemoglobin S beta thalassemia:Imp:Pt:Bld.dot:Ord
C1977101 A18274188 L6884205 S8017368 AUI 49717-2 MTH_LRN2 ; Il1Beta; IL-1![LATIN SMALL LETTER SHARP S]!; IL-1B; IL-1; Lymphocyte-Activating Factor; CG Antigen-Specific Helper Factor; ETAF; Epidermal Cell Derived Thymocyte-Activating Factor; Lymphocyte-Stimulating Hormone; Macrophage Cell Factor; T Helper Factor; IL1; Mass concentration; Level; Point in time; Random; BF; Fluid; Body fluid; B/F; FLU; Fl; Quantitative; QNT; Quant; Quan; IL; B; I; Chemistry Interleukin 1 beta:MCnc:Pt:Body fld:Qn
C1954752 A18389890 L6694573 S7802084 AUI 49029-2 MTH_LRN2 ; Cortis F; 11-beta HSD; 11-beta-hydroxy steroid dehydrogenase; 11-![LATIN SMALL LETTER SHARP S]!-HSD2; 11-![LATIN SMALL LETTER SHARP S]!-HSD1; 11-beta-HSD1; 11-beta-HSD2; Compound E; Coritsol; Cort; hydrocortisone; Compound F; 17-Hydroxycorticosterone; mRto; Mass concentration ratio; Point in time; Random; Ur; UR; Urn; UA; Quantitative; QNT; Quant; Quan; FR; Non-protein bound; Chemistry Cortisol.free/Cortisone.free:MCrto:Pt:Urine:Qn
C1977635 A18158617 L6886484 S11739455 AUI 49819-6 MTH_LRN2 ; 3OH3Me-glutarate; ![LATIN SMALL LETTER SHARP S]!-hydroxy-![LATIN SMALL LETTER SHARP S]!-methylglutaric acid; dicrotalic acid; Meglutol; HMG; 3-hydroxy,3-methylglutaric acid; Creat; Crea; CR; 3Me-glutarate; 3-methylglutaric acid; 3OH3Me-glutarate; sRto; Substance concentration ratio; 1 day; 24 hours; 24HR; Ur; UR; Urn; UA; Quantitative; QNT; Quant; Quan; Drugs; Hydrox; OH; III; DRUG/TOXICOLOGY; DRUG/TOXICOLOGY; UCr 3-Hydroxy,3-Methylglutarate/Creatinine:SCrto:24H:Urine:Qn
C2598770 A18121963 L8548058 S10673316 AUI 53777-9 MTH_LRN2 11-beta HSD; 11-beta-hydroxy steroid dehydrogenase; 11-![LATIN SMALL LETTER SHARP S]!-HSD2; 11-![LATIN SMALL LETTER SHARP S]!-HSD1; 11-beta-HSD1; 11-beta-HSD2; Compound E; Mass concentration; Level; Point in time; Random; Ur; UR; Urn; UA; Quantitative; QNT; Quant; Quan; FR; Non-protein bound; Chemistry Cortisone.free:MCnc:Pt:Urine:Qn
C3259230 A20068664 L10330541 S12899660 AUI 66388-0 MTH_LRN2 ; Txs; Tx; Deltasone; Cortan; Meticorten; Prednicen-M; Orasone; Liquid Pred; Panasol-S; Child steroids anti-CA drugs; Drug; 11-beta HSD; 11-beta-hydroxy steroid dehydrogenase; 11-![LATIN SMALL LETTER SHARP S]!-HSD2; 11-![LATIN SMALL LETTER SHARP S]!-HSD1; 11-beta-HSD1; 11-beta-HSD2; Compound E; Finding; Findings; Point in time; Random; Ql; Ordinal; QL; Qualitative; Qual; Screen; Ste; Steriods; Steroid; Othr Has the child take cortisone, prednisone, other steroids, or anticancer drugs or had x-ray treatments in the past 3Mo:Find:Pt:^Patient:Ord:PhenX
C3259220 A20075957 L10334790 S12896578 AUI 66378-1 MTH_LRN2 ; Txs; Tx; Deltasone; Cortan; Meticorten; Prednicen-M; Orasone; Liquid Pred; Panasol-S; Drug; Steroids anti-CA drugs radiation; 11-beta HSD; 11-beta-hydroxy steroid dehydrogenase; 11-![LATIN SMALL LETTER SHARP S]!-HSD2; 11-![LATIN SMALL LETTER SHARP S]!-HSD1; 11-beta-HSD1; 11-beta-HSD2; Compound E; Finding; Findings; Point in time; Random; Ql; Ordinal; QL; Qualitative; Qual; Screen; Ste; Steriods; Steroid; Othr Do you take cortisone, prednisone, other steroids, or anticancer drugs, or have you had radiation treatments:Find:Pt:^Patient:Ord:PhenX
C3481886 A20867953 L10814866 S13440720 AUI 69832-4 MTH_LRN2 ; 3Me-glutarate; 3-methylglutaric acid; 3OH3Me-glutarate; ![LATIN SMALL LETTER SHARP S]!-hydroxy-![LATIN SMALL LETTER SHARP S]!-methylglutaric acid; dicrotalic acid; Meglutol; HMG; 3-hydroxy,3-methylglutaric acid; Substance concentration; Level; Point in time; Random; Cerebral spinal fluid; Spinal Fluid; Cerebrospinal Fl; Spinal Flu; Spinal Fld; Quantitative; QNT; Quant; Quan; Drugs; Hydrox; OH; III; DRUG/TOXICOLOGY; DRUG/TOXICOLOGY 3-Hydroxy,3-Methylglutarate:SCnc:Pt:CSF:Qn
C3481887 A20864229 L10817785 S13440719 AUI 69833-2 MTH_LRN2 ; 3Me-glutarate; 3-methylglutaric acid; 3OH3Me-glutarate; ![LATIN SMALL LETTER SHARP S]!-hydroxy-![LATIN SMALL LETTER SHARP S]!-methylglutaric acid; dicrotalic acid; Meglutol; HMG; 3-hydroxy,3-methylglutaric acid; Substance concentration; Level; Point in time; Random; Amn; Amniotic fluid; Amn fl; Amniotic flu; AF; Quantitative; QNT; Quant; Quan; Drugs; Hydrox; OH; III; DRUG/TOXICOLOGY; DRUG/TOXICOLOGY 3-Hydroxy,3-Methylglutarate:SCnc:Pt:Amnio fld:Qn

MTH_LFO

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C1315557 A18226363 L8896462 S11031936 AUI 33086-0 MTH_LFO Gestational age from Biparietal Diameter: GA = EXP (0.04557*BPD-0.0061838*BPD * ln(BPD) + 1.985); SD: ![PLUS-MINUS SIGN]! 0.0002531* BPD+0.02988; Derived output: 12-39 week; Published input: BPD 21-89 mm Gestational age:Time:Pt:^Fetus:Qn:US.estimated from O-I BPD.Chitty 1997
C1315558 A18226364 L8869958 S11031937 AUI 33087-8 MTH_LFO Gestational age from Biparietal Diameter: GA = EXP (0.044653*BPD-0.0060089*BPD * ln (BPD) +1.961)SD: ![PLUS-MINUS SIGN]! 0.0002577* BPD+0.03061Derived output: 12-39 weeks Published input: BPD 22-91 mm Gestational age:Time:Pt:^Fetus:Qn:US.estimated from O-O BPD.Chitty 1997
C1315569 A18381116 L8881079 S11031896 AUI 33098-5 MTH_LFO Gestational age from Femur Length: GA = Exp (0.034375*FL-0.0037254*Fl*loge (Fl)+2.306); SD: ![PLUS-MINUS SIGN]! 0.00025215*Fl+0.03165; Derived output: 12-39 weeks; Published input: 10-67 mm Gestational age:Time:Pt:^Fetus:Qn:US.estimated from FL.Chitty 1997
C1315581 A18342548 L8896460 S11031919 AUI 33110-8 MTH_LFO Gestational age from Head Circumference: GA = Exp (0.010451*HC - 0.000029919*HC2 + 0.43156*10-7*HC3 + 1.854); SD: ![PLUS-MINUS SIGN]! 0.000059454*HC+0.024261; Derived output: 12-39 weeks; Published input: 85-325 mm Gestational age:Time:Pt:^Fetus:Qn:US.estimated from HC measured.Chitty 1997
C1315582 A18110735 L8877427 S11031918 AUI 33111-6 MTH_LFO Gestational age from Head Circumference: GA = Exp (0.010611*HC-0.00003032*HC2+0.43498*10-7*HC3+0.08024); SD: ![PLUS-MINUS SIGN]! 0.0005263*HC + 0.000014204*HC2 + 0.08024; Derived output: 12-39 weeks; Published input: 80-320 mm Gestational age:Time:Pt:^Fetus:Qn:US.estimated from HC derived.Chitty 1997
C1315603 A18265011 L8892569 S11031949 AUI 33132-2 MTH_LFO Gestational age from Transverse Cerebella Diameter: GA = Exp (0.79107* loge (TCD)+0.6439)SD: ![PLUS-MINUS SIGN]! 0.0078877*TCD2+0.1225Derived output: 12-39 weeks Published input: 13-36 mm Gestational age:Time:Pt:^Fetus:Qn:US.estimated from TCD.Chitty 1994
C3172439 A19517533 L10093763 S12592800 AUI 63369-3 MTH_LFO CUI = (a/![LATIN SMALL LETTER SHARP S]!)*10, where a represents the amount of histamine released by the donor basophils and associated leukocytes in response to the patient serum; and ![LATIN SMALL LETTER SHARP S]! represents the normalized baseline of histamine release. Chronic urticaria index:ACnc:Pt:Ser:Qn

MTH_SOS

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C2971984 A19511818 L8882611 S11044703 CODE LP90326-7 MTH_SOS MULTI-AXIAL:Resident mood interview (PHQ-9![COPYRIGHT SIGN]!) &#124; patient Resident mood interview (PHQ-9©) &#124; patient
C2972165 A19511858 L8871556 S11046619 CODE LP90310-1 MTH_SOS MULTI-AXIAL:Signs and symptoms of delirium (from CAM![COPYRIGHT SIGN]!) &#124; patient Signs and symptoms of delirium (from CAM©) &#124; patient
C2972261 A19516299 L8879113 S11047672 CODE LP90366-3 MTH_SOS MULTI-AXIAL:Staff assessment of resident mood (PHQ-9-OV![COPYRIGHT SIGN]!) &#124; patient Staff assessment of resident mood (PHQ-9-OV©) &#124; patient
C2971984 A18896503 L8882611 S11044703 CODE LP110193-2 MTH_SOS SUPERSYSTEMMULTI-AXIAL:Resident mood interview (PHQ-9![COPYRIGHT SIGN]!) &#124; patient Resident mood interview (PHQ-9©) &#124; patient
C2972165 A18862947 L8871556 S11046619 CODE LP110185-8 MTH_SOS SUPERSYSTEMMULTI-AXIAL:Signs and symptoms of delirium (from CAM![COPYRIGHT SIGN]!) &#124; patient Signs and symptoms of delirium (from CAM©) &#124; patient
C2972261 A18873925 L8879113 S11047672 CODE LP110212-0 MTH_SOS SUPERSYSTEMMULTI-AXIAL:Staff assessment of resident mood (PHQ-9-OV![COPYRIGHT SIGN]!) &#124; patient Staff assessment of resident mood (PHQ-9-OV©) &#124; patient

FROMRSAB

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C2706621 A16924870 L6107611 S7015223 CODE MTHU031471 FROMRSAB LNC LNC215 to CPT2005 Mappings

FROMVSAB

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C2706621 A16924870 L6107611 S7015223 CODE MTHU031471 FROMVSAB LNC215 LNC215 to CPT2005 Mappings

MAPSETRSAB

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C2706621 A16924870 L6107611 S7015223 CODE MTHU031471 MAPSETRSAB LNC LNC215 to CPT2005 Mappings

MAPSETTYPE

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C2706621 A16924870 L6107611 S7015223 CODE MTHU031471 MAPSETTYPE LOINC has associated CPT code LNC215 to CPT2005 Mappings

MAPSETVERSION

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C2706621 A16924870 L6107611 S7015223 CODE MTHU031471 MAPSETVERSION 200707 LNC215 to CPT2005 Mappings

MAPSETVSAB

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C2706621 A16924870 L6107611 S7015223 CODE MTHU031471 MAPSETVSAB LNC224 LNC215 to CPT2005 Mappings

MTH_MAPFROMCOMPLEXITY

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C2706621 A16924870 L6107611 S7015223 CODE MTHU031471 MTH_MAPTOEXHAUSTIVE SINGLE CODE LNC215 to CPT2005 Mappings

MTH_MAPFROMEXHAUSTIVE

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C2706621 A16924870 L6107611 S7015223 CODE MTHU031471 MTH_MAPFROMEXHAUSTIVE N LNC215 to CPT2005 Mappings

MTH_MAPSETCOMPLEXITY

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C2706621 A16924870 L6107611 S7015223 CODE MTHU031471 MTH_MAPSETCOMPLEXITY N_TO_ONE LNC215 to CPT2005 Mappings

MTH_MAPTOCOMPLEXITY

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C2706621 A16924870 L6107611 S7015223 CODE MTHU031471 MTH_MAPTOEXHAUSTIVE SINGLE CODE, MULTIPLE CODE LNC215 to CPT2005 Mappings

MTH_MAPTOEXHAUSTIVE

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C2706621 A16924870 L6107611 S7015223 CODE MTHU031471 MTH_MAPTOEXHAUSTIVE N LNC215 to CPT2005 Mappings

TORSAB

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C2706621 A16924870 L6107611 S7015223 CODE MTHU031471 TORSAB CPT LNC215 to CPT2005 Mappings

TOVSAB

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C2706621 A16924870 L6107611 S7015223 CODE MTHU031471 TOVSAB CPT2005 LNC215 to CPT2005 Mappings